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ABSTRACT 
 
This thesis outlines the emerging role of the patient, central in the transition from a 
volume driven towards a patient-driven healthcare. Healthcare systems, regardless of 
region or economic status, must develop new ways to deliver care whilst at the same 
time improving both quality of care and containing costs. Today’s society is 
increasingly ‘horizontal’ shaped by affiliations and networks, and this changes the 
way information flows, increasing people’s willingness to participate in the decision-
making process. Encouraging more patient involvement by promoting feedback will 
increase communication between system and users, this is important as it can 
improve quality of service. The inception and preliminary results of a national 
programme based around patient-reported health surveys, i.e. PROMs, are discussed 
together with the potential of the programme and its limited evidence on how this 
translates to quality of care for patients.  
The feasibility of PROMs data, in order to investigate important difference as 
reported by patients in this large national cohort, is tested by segmentation into 
individual procedures. A subsequent risk analysis of important confounders 
demonstrates that poor mobility and self-reported depression are significant 
predictors of poor HRQoL outcomes as well as self-reported adverse events. A 
further comparison between self-reported and administrative collected comorbidities 
is undertaken to substantiate the reliability of self-reported comorbidities followed by 
the development of an accumulated risk prediction score generated from self-
reported comorbidities to identify individual patient segments before treatment. And 
finally, a mixed method study is undertaken into factors behind poor unit response 
rates by exploring the patients’ views on PROMs and their place in quality of care.  
This thesis demonstrates the limitations of the current data dissemination of national 
PROMs data and proposes several steps of improvement to increase relevance to 
both patients and clinicians.   
 4 
STATEMENT OF ORIGINALITY  
 
All the work presented in this thesis is my own and it is the work upon which I 
expect to be examined. This work has not been previously submitted for a degree or 
diploma at any other higher education institution. To the best of my knowledge and 
belief, this thesis contains no material previously published or written by another 
person except where due references are made. 
 
Signed: 
 
 
Date: 
 
 
 
 
 
 
 
 5 
COPYRIGHT DECLARATION 
 
‘The copyright of this thesis rests with the author and is made available under a 
Creative Commons Attribution Non-Commercial No Derivatives licence. 
Researchers are free to copy, distribute or transmit the thesis on the condition that 
they attribute it, that they do not use it for commercial purposes and that they do not 
alter, transform or build upon it. For any reuse or redistribution, researchers must 
make clear to others the licence terms of this work’ 
 
 
ACKNOWLEDGEMENTS  
 
I would like to thank my supervisors Professor Ara Darzi, Professor Pete Smith and 
Mr Erik Mayer for providing me with the opportunities to develop my skills in both 
the academic and clinic world. My role within the department, although, tough at 
times and in particular during early morning meetings with Prof after a night on call 
and operating, was perfectly suited to develop an even stronger sense of the 
importance of the role of the patients. I am grateful for been given the opportunity 
and responsibility to implement the ‘gold standard’ of short-term outcomes research 
programme from the American College of Surgeons that has accelerated my 
understanding of the health system.  
I would also like to thank all those people at the department that where like mind and 
hearted and in no particular order; Myutan, you little big man, we could have been 
twins if it wasn't for being the exact physical opposites, keep up your clinical drive 
and I will be calling you Professor soon. Mark, working together was like therapy, 
the importance of our collaboration has already changed the world. Further big 
 6 
thanks to TP, Suba, Shantanu and Alex. And last but not least, a special thanks to 
Chris, for helping me through some though times and keeping my sanity throughout 
my time at the department and beyond.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7 
TABLE OF CONTENTS 
DEDICATION ...................................................................................................................................... 2 
ABSTRACT .......................................................................................................................................... 3 
STATEMENT OF ORIGINALITY .................................................................................................... 4 
COPYRIGHT DECLARATION ......................................................................................................... 5 
ACKNOWLEDGEMENTS ................................................................................................................. 5 
TABLE OF CONTENTS ..................................................................................................................... 7 
LIST OF FIGURES ........................................................................................................................... 11 
LIST OF TABLES ............................................................................................................................. 12 
LIST OF ACRONYMS ..................................................................................................................... 14 
CHAPTER 1 ...................................................................................................................................... 16 
LITERATURE REVIEW – INTRODUCTION ............................................................................. 16 1.1 INTRODUCTION ................................................................................................................................. 17 
1.1.1 Defining quality of care ............................................................................................................19 
1.1.2 Measuring quality of care .......................................................................................................21 
1.1.3 The need for risk adjustment .................................................................................................23 
1.1.4 Quality of life .................................................................................................................................25 
1.1.5 Defining patient-reported outcomes measures (PROMs) ........................................28 
1.1.6 EQ-5D index score .......................................................................................................................31 
1.1.7 Identification and development of a valid PROMs ......................................................33 
1.1.8 Current and past PROMs initiatives ...................................................................................37 
1.1.9 The potential of nationally collected PROMs data ......................................................44 
1.1.10 Methodological challenges using PROMs ......................................................................45 
1.1.11 PROMs and technology ..........................................................................................................47 
1.1.12 Public health implications....................................................................................................49 
1.1.13 Conclusion ....................................................................................................................................51 
1.1.14 Key points arising from chapter 1 ....................................................................................53 
CHAPTER 2 ...................................................................................................................................... 54 
ROUTINE MEASUREMENT OF PATIENT-REPORTED OUTCOMES IN ELECTIVE 
INGUINAL HERNIA REPAIR: RETROSPECTIVE ANALYSIS OF NATIONALLY 
COLLECTED DATA IN ENGLAND .............................................................................................. 54 2.1 INTRODUCTION ................................................................................................................................. 55 2.2 MATERIALS AND METHODS ............................................................................................................ 57 
2.2.1 Study population .........................................................................................................................57 
2.2.2 Data extraction ............................................................................................................................57 
2.2.3 Clinical outcome variables .....................................................................................................60 
 8 
2.2.4 Statistical methodology ...........................................................................................................61 2.3 RESULTS ............................................................................................................................................. 62 
2.3.1 Demographics ...............................................................................................................................62 
2.3.2 Baseline HRQoL............................................................................................................................64 
2.3.3 Clinical outcomes ........................................................................................................................64 
2.3.4 Postoperative HRQoL and satisfaction .............................................................................65 2.4 DISCUSSION ....................................................................................................................................... 71 
2.4.1 Principal findings ........................................................................................................................71 
2.4.2 Strengths and weaknesses of the study ............................................................................71 
2.4.3 Comparison with other studies .............................................................................................73 2.5 CONCLUSIONS ................................................................................................................................... 76 2.6 KEY POINTS ARISING FROM STUDY ONE ....................................................................................... 77 
CHAPTER 3 ...................................................................................................................................... 78 
RISK PREDICTION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN GROIN 
HERNIA PATIENTS ....................................................................................................................... 78 3.1 INTRODUCTION ................................................................................................................................. 79 3.2 MATERIAL AND METHODS .............................................................................................................. 80 
3.2.1 Candidate predictors .................................................................................................................80 
3.2.2 Statistical Analysis .....................................................................................................................81 3.3 RESULTS ............................................................................................................................................. 88 
3.3.1 Prediction of baseline HRQoL ................................................................................................88 
3.3.2 Prediction of HRQoL outcomes .............................................................................................89 3.4 DISCUSSION ....................................................................................................................................... 95 
3.4.1 Principal findings ........................................................................................................................95 
3.4.2 Strengths and weaknesses of the study ............................................................................96 
3.4.3 Comparison with other studies .............................................................................................97 3.5 CONCLUSIONS ................................................................................................................................. 100 3.6 KEY POINTS ARISING FROM STUDY TWO .................................................................................... 101 
CHAPTER 4 ....................................................................................................................................102 
THE CONCORDANCE BETWEEN PATIENT-REPORTED AND ADMINISTRATIVE 
DATA RECORDED COMORBIDITIES: ARE WE MISSING IMPORTANT INFORMATION 
FROM OUR PATIENTS? .............................................................................................................102 4.1 INTRODUCTION .............................................................................................................................. 103 4.2 MATERIALS AND METHODS ......................................................................................................... 104 
4.2.1 Study population ...................................................................................................................... 104 
4.2.2 Data collection .......................................................................................................................... 104 
4.2.3 Data analysis .............................................................................................................................. 106 
 9 
4.3 RESULTS .......................................................................................................................................... 107 
4.3.1 Prevalence of comorbidity reporting .............................................................................. 108 
4.3.2 Levels of agreement ................................................................................................................ 109 4.4 DISCUSSION .................................................................................................................................... 113 
4.4.1 Principal findings ..................................................................................................................... 113 
4.4.2 Strengths and weaknesses of the study ......................................................................... 113 
4.4.3 Comparison with other studies .......................................................................................... 115 
4.4.4 Explaining overreporting ..................................................................................................... 116 
4.4.5 Explaining underreporting .................................................................................................. 116 4.5 CONCLUSIONS ................................................................................................................................. 117 4.6 KEY POINTS ARISING FROM STUDY THREE ................................................................................ 118 
CHAPTER 5 ....................................................................................................................................119 
RISK PREDICTION IN HIP REPLACEMENT SURGERY USING A SIMPLE SELF-
REPORTED COMORBIDITY ADJUSTED RISK (SCAR) INDEX ........................................119 5.1 INTRODUCTION .............................................................................................................................. 120 5.2 MATERIALS AND METHODS ......................................................................................................... 121 
5.2.1 Study population ...................................................................................................................... 121 
5.2.2 Data extraction ......................................................................................................................... 121 
5.2.3 Outcomes ..................................................................................................................................... 121 
5.2.4 Construction of Self-reported Comorbidity Adjusted Risk (SCAR) index ....... 122 
5.2.5 Adjusting Charlson’s comorbidity index for the sample population ................ 122 
5.2.6 Model validation ....................................................................................................................... 123 5.3 RESULTS .......................................................................................................................................... 125 
5.3.1 Validation of the SCAR index .............................................................................................. 125 
5.3.2 Adjusting Charlson’s comorbidities index .................................................................... 125 
5.3.3 Model performance ................................................................................................................. 130 5.4 DISCUSSION .................................................................................................................................... 134 
5.4.1 Principal findings ..................................................................................................................... 134 
5.4.2 Strengths and weaknesses of the study ......................................................................... 135 
5.4.3 Comparison with other studies .......................................................................................... 136 5.5 CONCLUSIONS ................................................................................................................................ 138 5.6 KEY POINTS ARISING FROM STUDY FOUR ................................................................................... 139 
 
 
CHAPTER 6 ....................................................................................................................................140 
 10 
EXPLORING PATIENTS’ ACCEPTANCE ON ELECTRONIC ALTERNATIVE IN 
ROUTINELY COLLECTED PROMS IN VARICOSE VEINS PATIENTS: A MIXED 
METHOD STUDY ..........................................................................................................................140 6.1 INTRODUCTION .............................................................................................................................. 141 6.2 MATERIALS AND METHODS ......................................................................................................... 142 
6.2.1 Study population ...................................................................................................................... 142 
6.2.2 Development of electronic version of PROMs questionnaire ............................... 142 
6.2.3 Recruitment and follow-up ................................................................................................. 143 
6.2.4 Patient pilot interview ........................................................................................................... 146 
6.2.5 Development of patient survey .......................................................................................... 147 
6.2.6 Statistical analysis ................................................................................................................... 148 6.3 RESULTS .......................................................................................................................................... 148 
6.3.1 Randomised trial ...................................................................................................................... 148 
6.3.2 Qualitative assessment of patients’ views .................................................................... 150 6.4 DISCUSSION .................................................................................................................................... 153 
6.4.1 Principle findings ..................................................................................................................... 153 
6.4.2 Strengths and weaknesses of the study ......................................................................... 153 
6.4.3 Comparison with other studies .......................................................................................... 154 6.5 CONCLUSIONS ................................................................................................................................ 156 6.6 KEY POINTS ARISING FROM STUDY FIVE .................................................................................... 157 
CHAPTER 7 ....................................................................................................................................158 
CONCLUSIONS AND FUTURE WORK .....................................................................................158 7.1 CONCLUSIONS ................................................................................................................................. 159 7.2 UNANSWERED QUESTIONS AND FUTURE RESEARCH ............................................................... 164 
APPENDIX T ..................................................................................................................................169 
APPENDIX U ..................................................................................................................................170 
APPENDIX V ..................................................................................................................................171 
APPENDIX W ................................................................................................................................174 
APPENDIX X ..................................................................................................................................178 
APPENDIX Y ..................................................................................................................................184 
APPENDIX Z ..................................................................................................................................186 
REFERENCES.................................................................................................................................190 
 11 
 
LIST OF FIGURES 
Figure 1-1 Assessing quality of care ................................................................................... 21 
Figure 1-2 Examples of types and indicators as proposed by Donabedian..................... 23 
Figure 1-3: Schematic overview of Quality of Life ........................................................... 26 
Figure 1-4: EuroQol's EQ-5D-3L questionnaire (UK version) ........................................ 36 
Figure 1-5: Elements of the PROMs questionnaires in the NHS national PROMs 
programme ................................................................................................................... 40 
Figure 2-1: Flowchart describing data segmentation into primary unilateral "open" 
and "laparoscopic"inguinal hernia repair in the national PROMs programme ...... 
 ....................................................................................................................................... 59 
Figure 2-2 a&b: Bar charts showing baseline (2.2a) and differences between baseline 
and follow-up HRQol (EQ-5D) (2.2b), distribution by EQ-5D index group .......... 68 
Figure 5.1: Distribution of SCAR index in validation set ............................................... 131 
Figure 5.2: Distribution of empirically asigned CCI ...................................................... 131 
Figure 5.3: ROC curve for 6 month mortality models of empirical CCI with inclusion 
of demographics and general health ........................................................................ 133 
Figure 5.4: ROC curve for 6 month mortality models of SCAR index with inlcusion of 
demographics and general health ............................................................................ 133 
Figure 6-1: Flowcharts recruitment into randomised trial evaluating an electronic 
alternative to traditional paper-based PROMs questionnaire .............................. 145 
Figure 6.2: General themes and their subsequent prompt used during semi-structured 
interview study .......................................................................................................... 147 
Figure 7-1: Proposed PROMs feedback loop to improve relevance of national PROMs 
programme ................................................................................................................. 163 
Figure 7-2: Three level data for outcome measurement within the surgical care 
pathway ...................................................................................................................... 167 
 
 12 
LIST OF TABLES 
Table 1-1: Summary of most commonly used types of HRQoL measures ..................... 30 
Table 1-2: Eight criteria to necessary to select most suitable PROM instrument ......... 36 
Table 1-3 Total volume of responses for the first three years of the national PROMs 
programme ................................................................................................................... 41 
Table 1-4: PROMs response rates for the national PROMs programme in the first 3 
years after inception .................................................................................................... 41 
Table 1-5: Response rates for all eligible patients in England and Wales by baseline and 
follow-up questionnaire response rates and per individual PROMs index 
procedure ..................................................................................................................... 42 
Table 2-1: OPCS-4 codes used to determine primary unilateral MESH inguinal hernia 
repair ............................................................................................................................ 58 
Table 2-2: Baseline characteristics of all primary unilateral MESH inguinal hernia 
repair patients by technique and response/ non-response with consequent p-values 
or standardised residuals ............................................................................................ 63 
Table 2-3: Mean EQ-5D index scores at baseline (pre) and at follow-up (post). Higher 
scores equals better perceived wellbeing. Differences are shown between 
responders and non-responders, outcomes are only shown for responders 
(readmission (yes or no)), length of stay, complications and sensitivity analysis) . 67 
Table 2-4: Distribution of patients reporting postoperative adverse events overall and 
by age group. (Differences are reported as unadjusted Odds ratios with 95% C.I. 
and p-value) Open technique acted as reference group) ......................................... 69 
Table 2-5: EQ-5D individual dimensions by treatment group ......................................... 70 
Table 2-6: Patients' satisfaction three months after surgery ........................................... 70 
Table 3-1: Univariate analysis of all PROMs and HES recorded variables in open and 
laparoscopic technique by baseline EQ-5D index groups (EQ-5D=1) and EQ-5D<1
 ................................................................................................................................ 82&83 
Table 3-2: Univariate analysis of candidate predictors between Group 1 (Improvement) 
and Group 2 (Reduction) in HRQoL outcomes following "Open" surgery ... 84&85 
Table 3-3: Univariate analysis of candidate predictors between Group 1 (Improvement) 
and Group 2 (Reduction) in HRQoL outcomes following "Laparoscopic" surgery
 ................................................................................................................................ 86&87 
 13 
Table 3-4: Formation of groups differences between baseline ......................................... 88 
Table 3-5: Multivariate (logistic regression) analysis of potential predictors of patients 
reporting baseline “non” perfect HRQoL (EQ-5D of 1) in "OPEN" surgery ....... 91 
Table 3-6: Multivariate (logistic regression) analysis of potential predictors of patients 
reporting baseline “non” perfect HRQoL (EQ-5D<1) in "LAPAROSCOPIC" 
surgery .......................................................................................................................... 92 
Table 3-7: Multivariate (logistic regression) analysis of potential predictors of 
reduction of HRQoL following "OPEN" surgery .................................................... 93 
Table 3-8: Multivariate (logistic regression) analysis of potential predictors of 
reduction of HRQoL following "LAPARASCOPIC" surgery ............................... 94 
Table 4-1: PROMs comorbidities with top 5 most commonly coded ICD-10-CM 
secondary diagnostic codes and total number within PROMs comorbidity in HES 
data ............................................................................................................................. 106 
Table 4-2: Demographics for each PROMs procedure .................................................. 108 
Table 4-3: Prevalence of comorbidities and agreement between administrative and 
PROMs data per individual procedure ................................................................... 111 
Table 4-4: Measures of sensitivity, specificity, positive and negative predictive value of 
comorbidities per procedure (HES administrative data served as gold standard 
for all measures) ........................................................................................................ 112 
Table 5-1: Weighted index of PROMs comorbidities ..................................................... 125 
Table 5-2: Empirically assigned Charlson comorbidities weightings ........................... 124 
Table 5-3: Demographics of patients undergoing hip replacement in the national 
PROMs programme between 2009-2011 ................................................................. 127 
Table 5-4: Logistic regression analysis of PROMs comorbidities predicting 6-month 
mortality for patient undergoing hip replacement ................................................. 128 
Table 5-5: Logistic regression analysis of Charlson's comorbidities predicting 6-month 
mortality for patients undergoing hip replacement ............................................... 129 
Table 5-6: Summary of model performance for the 3 individual scores for elective hip 
replacement patients ................................................................................................. 132 
Table 6-1: Demographics and follow-up rate of patients in paper-based and electronic 
group undergoing minimally invasive varicose veins surgery .............................. 150 
 
 14 
 
LIST OF ACRONYMS 
 
ACS NSQIP American College of Surgeons National Surgical Quality     
Improvement Program 
CCG Clinical Commissioning Group 
CCI Charlson Comorbidity Index 
DoH  Department of Health 
HES  Hospital Episode Statistic 
HRQoL Health-related Quality of Life 
HSCIC Health and Social Care Information Centre 
ICD-9 / 10 International Classification of Disease (Ninth and tenth revision) 
MID  Minimally Important Difference 
NCD  Non-Communicable Disease 
NHS  National Health Service 
OECD  Organisation for Economic Cooperation  
OPCS-4 Office of Population Censuses and Surveys Classification of Surgical 
Operations and Procedures 4th revision 
PROMs Patient-reported Outcome Measures 
QoL  Quality of Life 
SCAR index Self-reported Comorbidity Adjusted Risk index 
 
 
 15 
 
 
 
 
“It is far more important to know what sort of person has the disease than 
to know what sort of disease the person has” 
-Hippocrates (c. 460-400 BC) 
“The physician should not treat the disease but the patient who is 
suffering from it” 
-Maimonidis (c. 1137-1204 AD) 
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INTRODUCTION 
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1.1 INTRODUCTION 
 
Increasing awareness of variations in the quality of healthcare has helped propel a 
quality improvement movement. This growing attention for assessing quality of care 
has been a catalyst for assessing and improving healthcare on a local and 
international platform1. Traditionally, quality assessment of hospitals has primarily 
been based around primary endpoints (i.e. mortality) and more recently with the use 
of evidence-based process measures, such as VTE prophylaxis in patients 
undergoing surgical interventions. To date, beyond a few specialist datasets the 
broader picture of quality of care in the United Kingdom is from administrative data, 
such as Hospital Episode Statistics (HES), which has presented researchers and 
policymakers with a means to assess quality on a national level2,3. Administrative 
data is readily available as it is collected routinely for the purposes of financial 
reimbursement and provides no additional burden for hospitals. However, data 
generated by clinical registries abstracted from clinical notes is found to be more 
reliable and accurate4, particularly in collecting outcomes that occur in the 
community5. Moreover, clinical registries contain more detailed information that can 
provide more fitting risk adjustment. Nevertheless, the adoption of clinical registries 
is slow due to the additional resources required to collect data.  
Therefore, health systems have looked for alternative opportunities to identify 
important trends in the provision of care in their search for more patient-centred and 
value-based care6. Patients themselves could provide a key element in re-designing 
performance measurement emphasising the need to measure the wider impact of 
medical and surgical conditions on overall wellbeing and Quality of Life (QoL). 
Measuring this directly at source (the patient) is far less expensive compared to 
bespoke clinical databases. These types of measures, frequently called Patient-
reported Outcome Measures (PROMs), allow for direct comparison between 
symptoms, functional status and Health Related Quality of Life (HRQoL) in order to 
effectively measure the outcome of the care they received.  PROMs data can be an 
effective tool to assess the performance of individual practitioners and large-scale 
 18 
data collection could allow for analysis of variation in outcomes and test of 
appropriateness of treatment in particular patient groups.  
This introduction forms a narrative review, which outlines current practices in 
assessing quality of care in surgery. Followed by a discussion of patient-reported 
outcomes and their emerging place in evaluating the effectiveness of care. Concluded 
by a description of the role for Information Technology (IT) that aims to facilitate 
users of routinely collected patient-reported outcome data in surgery and the 
importance of utilising technology to further advance our understanding of quality of 
care.  
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1.1.1 Defining quality of care 
 
Surgical science has gone through landmark developments over the past centuries. 
Although, surgical techniques have been described as early as ancient Mesopotamia, 
it wasn’t until John Hunter, a Scottish scientist, applied an empirical and 
experimental approach to reconstruct surgical knowledge. His work led to important 
innovations in the diagnosis and treatment of diseases, but he is most renowned for 
his position on surgical procedures, which he felt should only be used as a last resort7. 
The further introduction of ether as an anaesthetic in surgery, pioneered in Europe by 
Nikolay Pirogov, continued to increase our ability to safely undertake surgical 
procedures and make invasive treatment less traumatic to our patients. Pirogov, 
generally known as the founder of field surgery, derived many of his concepts from 
the Crimea War, where he piloted the earliest form of risk assessment, i.e. a triage 
system, in emergencies8. This early warning system of severity of injury or disease 
can arguably be seen as the first risk adjustment strategy in medicine.  
Although, quality of care has significantly improved since those early years, 
hospitals and health systems alike still struggle with defining what good quality of 
care constitutes and there is no consensus what the best way is to appraise it. There 
are several definitions of quality of care, however, quality can have different 
meanings for health consumers and professionals. Whilst patients might desire a 
good overall experience, conversely, clinicians are primarily focussed on clinical 
outcomes by minimising complications and reducing length of stay and readmission 
rates.  For a whole systems approach, however, these six pillars should be contained 
in defining quality: 
x Effective; delivering healthcare that is adherent to an evidence base and 
results in improved health outcomes for individuals and communities, based 
on need; 
x Efficient; delivering healthcare in a manner which maximises resource 
utilisation and avoidance of waste; 
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x Accessible, delivering health are that is timely, geographically reasonable, 
and provided in a setting where skills and resources are appropriate to 
medical need; 
x Acceptable/patient-centered, delivering healthcare which takes into account 
the preferences and aspirations of individual service users and the cultures of 
their communities; 
x Equitable, delivering healthcare which does not vary in quality because of 
personal characteristics such as gender, race, ethnicity, geographical location, 
or socioeconomic status; 
x Safe, delivering health care, which minimises risks and harm to service users9.  
 
Incorporating all six core dimensions to form an overall encompassing definition of 
quality of care is seemingly impossible. The Institute of Medicine’s (IOM) definition 
is most widely used but remains vague and lacks clarity to what it actually exactly 
entails: 
“The degree to which health services for individuals and populations 
increase the likelihood of desired health outcomes and are consistent with 
current professional knowledge”10 
Quality in healthcare is a multidimensional concept and understanding it may require 
an interaction between several different measures or indicators to provide a 
comprehensive insight. Before adopting any measure to evaluate quality, it must pass 
against a wide range of technical criteria, principally: validity (Does the measure 
capture what is it supposed to?), reliability (How reproducible is the measure when 
taken at different times or in different circumstances?) and sensitivity to change (Will 
the measure discriminate between good and poor quality, and will it be able to detect 
perhaps small but worthwhile improvements?). Poor validity has been shown to 
undermine conclusions, while collecting unblinded data can undermine reliability11,12.
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1.1.2 Measuring quality of care 
 
In the current economical climate, assessment of performance by measuring quality 
of care is essential to identify areas of poor performance and should act as the basis 
for health reforms. For proper quality assessment, it is required to develop and apply 
performance measures, i.e. explicit standards of care, against which actual care is 
judged13. This process might seem a simple endeavour, beginning with a decision on 
what to measure, identifying the proper measures along with their respective data 
sources, and culminating in the analysis, aggregation, understanding and 
dissemination of the results. However, as with most deceptively straightforward tasks, 
the difficulties lie in the details14.  
The various elements that define quality of care can be derived from clinical pathway 
measures, such as outcomes, or can be directly measured from the patients 
themselves using health surveys (Figure 1.1).  
 
Figure 1-1 Assessing quality of care  (reproduced from Mayer et al15) 
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The traditional approach to measure quality of care involved drawing indicators from 
a model proposed by Avendis Donebedian in the early eighties16. He developed a 
framework consisting of three dimensions: “structure”, “process” and “outcomes” 
that forms a basic process, where “outcomes” are determined by what is known 
about the environment (“structure”) in which they occur and whether medical 
practice is concurrent with best evidence (“process”) (Figure 1.2). He further 
emphasised that outcomes remained the ultimate validator of health care quality and 
effectiveness. In wider terms, outcomes attempt to describe the overall effect of care 
on patient populations. These end-points of healthcare delivery, such as mortality, 
usually have excellent face validity, however, the correlation between the quality of 
clinical practice and mortality is low and therefore it is neither a sensitive nor 
specific test for quality of care17. Despite these criticisms, governments have 
predominately been using mortality data in their attempt to identify variation in the 
provision of care and aim to publically report this data (i.e Hospital Standardised 
Mortality Ratios). Hospitals with higher than expected rates will be subject to in-
depth analyses of clinical performance, however, the methodology applied has been 
heavily criticised and is mainly directed at the lack of proper case-mix and risk 
adjustment.  
However, even if adequate case-mix or risk adjustment has been applied, the criteria 
used for each variable can lead to bias within the sample. In addition, there is 
insufficient evidence that quantifies the appropriateness of decision-making in 
surgical practice. For this reason, Clinical Commissioning Groups (CCG’s), that 
organise the delivery of NHS services, are increasingly introducing referral 
guidelines in order to provide guidance on whether treatment is appropriate based on 
best available evidence18,19. This is normally a single guidance for all patients in that 
particular group and it doesn’t provide guidance on which treatment is most relevant 
to the individual patient. The traditional decision-making process is based around 
presentation of clinical symptoms, such as pain, but if these symptoms fail to impact 
on daily activities, treatment will not be approved. The formation of these guidelines 
have benefited from the introduction of patient-related outcomes, such as health-
related quality of life, as a means to provide additional information that was normally 
not available to influence this process and by doing so has expanded our 
understanding of quality of care.  
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Figure 1-2 Examples of types and indicators as proposed by Donabedian16 
  
 
1.1.3 The need for risk adjustment 
To account for variations in outcomes, information on explanatory variables is 
fundamental to provide the evidence base that is needed to improve our 
understanding and initiate quality improvements. Risk adjustment is essential to 
explain the heterogeneity between individual patients as many risk factors (i.e. pre-
existing illnesses, functional and socio-economic status) can impact on clinical 
outcomes following routine surgery. The majority of risk adjustment strategies are 
preformed retrospectively relying on variables made available from medical records, 
clinical application systems and administrative data.  
Medical records review, currently considered the ‘gold standard’, provides the most 
accurate description of a patient health status. For small-scale studies, it can be 
feasible to obtain information directly from the medical notes and extend it with 
information available from clinical application systems. Claims or administrative 
data, designed for financial reimbursement, can provide an alternative source of 
health information from risk adjustment. This data source collects information on 
outcomes, such as mortality, contains information about outputs of care, such as 
length of stay and records a set of codes that describes the primary diagnosis and 
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treatment for which the patient was admitted in hospital. In addition, secondary 
diagnostic codes are collected that may influence the level of payment, however, this 
is dependent on local funding arrangements, meaning that priorities for collecting 
certain chronic diseases for coding departments can lead to either over- or 
underreporting. For researchers, these secondary codes have provided them with an 
opportunity to develop risk strategies. Charlson’s Comorbidity Index (CCI), first 
described in the 1980s, is the most favoured strategy as it combines a set of pre-
existing conditions, i.e. comorbidities, to form an overall score20. The score was 
developed on a sample of medical patients and its primary focus was to estimate one-
year mortality in that sample. Many studies have used this score in their risk 
adjustment of administrative data2,21. However, the accuracy of pre-existing 
conditions recorded in administrative data is predominately impacted by its 
underestimation of comorbid conditions compared to medical record review22.   
For surgical patients specifically, there are several risk adjustment strategies 
available that are collected prospectively and can inform clinicians immediately of 
risk of complications. In the early sixties, the American Society of Anaesthetist 
(ASA) adopted a 5-point scoring system developed by Saklad23, to assess the fitness 
of a patient before surgery, commonly known as ASA grade or score. Although, the 
score is used prospectively to inform both anaesthetist and surgeon before the 
procedure and there is extensive evidence for its use retrospectively to predict 
mortality2,3, it is still used with caution. The main criticism is based around the lack 
of consistency in assigning patient an ASA score of 3 (Middle group)24, as it is 
subjected to clinician’s interpretation leading to poor inter-rater reliability25.    
The P-POSSUM (Physiological and Operative Severity Score for the enUmeration of 
Mortality and Morbidity) developed by Copeland et al26, is not dependent on 
interpretation and has similar predictive qualities as the ASA score. The 
disadvantage is that all variables need to be present, such as blood test results and 
intraoperative data for the score to be completed.  
More recently, the increasing need for robust case-mix and risk adjusted outcome 
data collected by bespoke clinical registries has provided the evidence needed for 
quality improvement initiatives27,28. The American College of Surgeons National 
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Quality Improvement Program (ACS NSQIP) based on the Veterans Affairs (VA) 
surgical outcomes programme, collects a wide range of variables that are updated 
yearly on their relevance to explain variation. The programme was designed to 
capture outcomes occurring within 30-days, either in-hospital or in the community.  
However, there is significant cost associated with the programme that requires 
engaging hospital management and clinicians. The burden of data collection could be 
reduced provided hospitals use more procedure-specific quality measures, thereby 
reducing the number of variables needed to be collected29.  
Information contained in medical records can provide the basis for all data sources 
available for quality assessment. Without the availability of fully integrated care with 
less fragmentation that increased the likelihood of information transfer errors, 
patients will continue to play a central role in retaining their own health information. 
Some argue that technology will provide the ultimate solution, however, there are 
concerns in terms of electronic health system fostering errors rather than reduce 
them30.  
 
1.1.4 Quality of life 
As healthcare is slowly moving away from the traditional physician-led to a more 
patient-driven care31, the importance of collecting outcomes that matter to patients 
has increasingly been highlighted by several important government reports, business 
reviews and a wide range of academic papers6,32. Particularly in areas in healthcare 
where endpoints, such as mortality, are low and new treatments are relatively 
expensive, the ability to identify treatments and/or interventions, which are most cost 
effective and therefore should be endorsed, is pertinent. Improving a populations’ 
overall health is the ultimate goal of any health system and therefore measuring 
treatment impact from the patients’ perspective should have priority. The rationale 
behind this understanding is that outcomes, as reported by patients, are driven by the 
belief that individuals are the best narrator of their own wellbeing.  
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An individual’s Quality of Life (QoL) is influenced by an array of factors that can 
change from day to day (Figure 1.3). This multi-dimensional concept is principally 
influenced by a person’s needs over its inabilities. 
 
Figure 1-3: Schematic overview of Quality of Life (adopted from Doward et al33) 
 
 
Life satisfaction derives its quality from our ability and capacity to satisfy human 
needs33. The socio-economic environment we grow up and reside in; our social 
interaction level; personal traits; employment and educational status are all part of 
this multi-dimensional concept. Each of these individual dimensions influences how 
a person, i.e. patient, perceives its own QoL. For healthcare specifically, the area that 
can directly be influenced is Health-Related Quality of Life (HRQoL) and this is 
thought to be of most value to the individual when illness affects role performance34. 
Therefore, Guyatt and colleagues defined HRQoL broadly as: 
 
“the capacity to perform the usual daily activities for a person’s age and 
major social role”35 
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When an individual has no diseases and experiences no disabilities or symptoms and 
has full capacity to perform their usual daily activities, one can assume that their 
HRQoL is full/perfect. Given that the individual is affected by symptoms from either 
physical or cognitive origin then his or her HRQoL will be impaired. However, 
concerns have been raised with the term HRQoL, as it may imply that QoL is 
measured. Misinterpretation of study results can therefore occur when both terms are 
used interchangeably36. There exists a natural decline in a population’s self-reported 
sense of wellbeing, which is a direct consequence of ageing, with no observable 
difference between men and women. Moreover, there is evidence for a worsening 
perceived HRQoL in patients with comorbidities, who already display impaired 
HRQoL as a consequence to disease37.  
 
In addition, HRQoL scales might also not always address the primary concerns of the 
patient with that particular condition. Patients with chronic conditions can adjust 
their usual activities to their condition, replacing them with activities that are equally 
satisfying. This limitation is known to become particularly evident in outlier 
patients38. For this reason, it is difficult to control for variation that occurs due to 
patient’s experience of symptoms from conditions in a different way. However, 
HRQoL assessment was not intended to guide treatment choice in individual patients 
but to determine the appropriateness of treatment in patient groups.  
 
The routine administration of HRQoL measures, i.e. PROMs, in specific patient 
populations can provide means to identify areas where the impact of symptoms of 
disease is greatest on experienced HRQoL and there is increased need for 
improvements. 
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1.1.5 Defining patient-reported outcomes measures (PROMs) 
 
Patient-reported outcome measures are a widely described addition to our current 
understanding of measuring quality of care39. Their ability to detect physical or 
psychological symptoms that are otherwise overlooked have broadened our 
perspective of the patients’ views on healthcare. PROMs can measure both a single 
condition and its associated symptoms or can have a multi-dimensional character and 
can include any of the following concepts such as symptoms, health status, HRQoL 
and patient satisfaction.  
The Food and Drug Administration (FDA) in the U.S. defines a patient-reported 
outcome as:  
“Any report of the status of a patient’s health condition that comes 
directly from the patient, without interpretation of the patient’s response 
by a clinician or anyone else”40.  
PROMs can provide a unique real-time approach to understanding utilisation and 
outcomes of treatments across many conditions41. It has been argued that capturing 
the patient's perspective is central to comparative effectiveness research (CER) 
which provides the evidence-base for decision making in healthcare42. They can 
combine several elements to investigate specific areas, provide an overall score on a 
patient’s wellbeing and can contain questions on patient satisfaction.  
Most PROMs are based on the inclusion of a HRQoL measure, which refers to those 
that evaluate the broader impact of disease on the functioning and wellbeing of a 
patient. These measures can typically be divided into two kinds; the first is 
specifically designed for one group or condition, i.e. disease-specific measures, the 
second can be used across different populations and is independent of the underlying 
condition, i.e. generic measures. Disease-specific measures are designed to study the 
most important effects of a disease, however, they are not suited to compare 
treatment results across a variety of diseases. Their main aim is to assess specific 
impact of a single disease on HRQoL and can assist in the clinical decision-making43. 
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They are constructed to report on clinical symptoms alone and rarely include overall 
wellbeing elements, however they can produce a single accumulated score, which 
makes them desirable for evaluating treatment efficacy. Examples include, the 
Oxford Hip Score, frequently used to establish HRQoL in patients with osteoarthritis 
of the hip joint44 and the Disability of Arm, Shoulder and Hand Questionnaire 
(DASH) that measures physical function and symptoms in people with any of several 
musculoskeletal disorders of the upper limb45. 
Generic measures can be used for different patient populations and are generally 
categorized into generic (or non preference-based) and preference-based measures 
(Table 1.1). The latter focuses on choice and strength of preference of health 
outcomes and if the value that patients attach to improvement is known, it can be 
used as an utility measure in economical evaluations46. Generic measures of overall 
health status aim to provide a structured summary of the self-reported health of an 
individual by scoring distinct domains of wellbeing. The SF-36 is one of the most 
commonly used non-preference/generic measures of HRQoL and assesses health 
across eight dimensions, generating individuals’ scores for each dimension, but does 
not allow these individual scores to be combined to a single index score47.  Another 
set of scores that were specifically constructed to provide a single index, such as 
EuroQol’s measure EQ-5D index and Health Utility Index (HUI), allow for 
calculation of Quality Adjusted Life Years (QALYs)34. Although, QALYs can assess 
a person’s quality-adjusted life expectancy, their main use is within a framework of 
cost-effective analysis in order to assess the improvements as a consequence of an 
intervention in comparison to no intervention48. Projects that do not use economical 
estimation measures can use mapping models to convert non preference-based 
measures to the EQ-5D scores, but they have a tendency to over-predict worse health 
states49. When generic measures are not regarded to be appropriate for a condition, 
mapping cannot be used50. 
Patient satisfaction is measured by the perceived health experience and is moderated 
by the patients’ expectations. This measure is important in assessing subjective 
quality of provision of care and processes, and is regarded as an important factor 
especially in health systems where patients have freedom of choice. In some areas 
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patient satisfaction has been relatively underrepresented even though it provides an 
ultimate endpoint to quality assessment51. 
 
 
HRQoL measure Most commonly used 
questionnaire 
Advantages Disadvantages 
Generic / non 
preference-based 
SF-36 - Widely 
evaluated/validated 
 
- Lack of overall index score 
- Limited specificity / 
responsiveness 
 
    
Generic / 
preference-based 
/ utility 
EQ-5D 
QWC-SA 
Health Utilities Index 2 
and 352 
SF-6D53 
- Single index to 
estimate 
- Quality of adjusted 
life years (QALYs) 
- -Cost utility analysis 
- Copyright, initial cost and 
user fees 
- Lack of specific findings 
    
Condition-
specific 
Oxford Hip Score 
(OHS)44  
Disability of Arm, 
Shoulder and Hand 
Questionnaire (DASH)45  
 
- Symptoms 
comparison 
- High acceptability to 
evaluate a specific 
condition 
- Only relevant to condition it 
was intended for. 
- Lack of comparability to 
other conditions 
    
Table 1-1: Summary of most commonly used types of HRQoL measures 
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1.1.6 EQ-5D index score 
 
The EuroQol group, established in 1987, is an international network of 
multidisciplinary researchers responsible for the development of the EQ-5D index 
(Figure 1.4) widely used in research and service evaluations54.  The EQ-5D index is a 
single index on a -0.59 to 1 scale, which can be used to calculate the cost-
effectiveness of interventions using QALYs on population level. Although, a license 
fee will apply for service evaluations, it is estimated that around 50% of researchers 
use it in their studies evaluating HRQoL43. The concept behind QALY is that 
outcomes from treatment consist of two components, the quantity and quality of life. 
QALY incorporate both and is the product of life expectancy and the quality of the 
remaining life-years. The amount of QALYs is dependent on the number of years of 
life added as a consequence of treatment. It is based on the assumption that one year 
lived in perfect health (utility of 1) is worth 1 QALY.  When a patient requiring a hip 
replacement without treatment lives with a HRQoL of 0.5 for another 20 years, and 
after the intervention lives with a HRQoL of 0.75, the added number of QALYs is 5. 
Combining this with the costs that are associated with a particular intervention, the 
cost utility ratio can be calculated and this can subsequently be used for economical 
evaluations.  In the UK, the costs associated with one additional QALY resulting 
from treatment should be less than the willingness to pay, which is currently set at 
£30,000 by the National Institute of Health and Care Excellence (NICE)55. However, 
there are several challenges with estimating QALYs after interventions; the increase 
or decrease in utility score may have resulted from unrelated events, the inability to 
compare two competing treatments with similar profile, in chronic conditions where 
survival is not the main issue and the dependency on life context. However, it does 
provide policymakers with a means to prioritise treatment with maximum health gain 
in resource limited health system.  
For researchers, the meaningfulness of the EQ-5D index depends predominately on 
their ability to interpret the scores that are generated within clinical conditions. The 
first approach and most frequently used is the Minimally (Clinically) Important 
Difference (MID), that is defined as the smallest change that is perceived by the 
 32 
patient as beneficial or that would result in a change in treatment56, which can be 
estimated using an anchor-based approach. Anchor-based approaches compare 
changes seen in an individual's HRQoL to an external criterion, such as a clinical 
measure or using a patient rated global change question57. However, there is no 
universal anchor that can be used as a reference and has to be specific to each patient 
group. Although, average MIDs have been reported for general use58, it is considered 
best practice to establish a MID for each condition of interest. Several MIDs have 
been reported for a variety of conditions57,59 and established the responsiveness of 
the index in specific populations.  
The second approach is based around the assumption that analysis of individual 
PROMs items is more responsive than at aggregated level and introduces less bias 
caused by introduction of exogenous variation when using a single value based on 
weightings60. The distribution of individual elements can provide explanation about 
the heterogeneity between different providers61. For example if in a specific 
population impaired HRQoL is predominantly caused by the mental component 
rather than a consequence of other pre-existing conditions impacting on the physical 
component, then improvements resulting from treatment are less sensitive to change 
in experienced HRQoL.  
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Figure 1-4: EuroQol's EQ-5D-3L questionnaire (UK version) 
 
1.1.7 Identification and development of a valid PROMs 
 
For both researchers and policymakers identification of the appropriate PROM is 
vital to achieving a project’s goals and several classification schemes have been 
proposed that can help facilitate this. Valderas and Alonso based their validated 
conceptual model mostly on Wilson and Cleary’s concepts of bio-psychosocial 
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health outcomes model dating from 90s62,63. Narrowing down to the three most 
relevant concepts, construct, population and measurement model, there is a 
requirement of at least 2 concepts to be present for the tool to be classifiable. These 
models can, however, be limited by oversimplification in their attempt to provide 
universal coverage. Research or clinical practice might only be interested in one 
particular symptom, such as pain, and these classification schemes don’t allow 
identification of a single measure.  
In the absence of a validated measure or when there is no possibility to use and adapt 
an existing one or collect validation data, an entirely new one can be developed using 
mixed methodology from quantitative and qualitative sources64. The first step in the 
process is characterised by a conceptualisation phase, which gathers information 
from all available sources (patients, experts and literature). This concept then forms 
into a draft, where individual items are tested qualitatively by individual or focus 
groups interviews, to assess the content validity. This has been the focus of much 
debate following guidance published by the FDA40. They argued that direct 
solicitation of the patients is necessary to ensure appropriate endpoints were used. 
The specific weight assigned to patients versus expert input in the decision to include 
or exclude elements is now central to the debate65.  
Practically, the most suitable PROMs should be identified using eight criteria (Table 
1.2). It is important to establish the appropriateness by identification of any of three 
main measurement objectives. In the event there is no external validator, the ability 
to discriminate (measuring differences between patients) should be considered. Is the 
measure primarily used to evaluate a particular treatment effect before and after 
(where responsiveness of an instrument can also be tested), or is the measure used in 
the prediction of eligibility for treatment of individual patients or patient groups. 
This can then be followed by an assessment of the interpretability or meaningfulness 
of the data results; several strategies can be used to assess important significant 
differences that need to be established for a new treatment to provide benefit over no 
treatment; interpretation of scores using normative data, for example using 
information on normal values for age groups; or comparing results to previously 
published change scores using the same instrument in a different condition.  
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The precision of an instrument is concerned with the scaling of items that construct 
the questionnaire, the simplest form of observation is Yes or No and a seven point- 
Likert scale (for example, strongly disagree to strongly agree) is normally the most 
complicated observation for a patient. This should be considered as an important 
cause of patient compliance. Furthermore, this can be influenced by the acceptability 
of the instrument to the patient, such as instrument design, which can have a 
significant impact on unit response rate and therefore requires careful consideration 
when selecting an instrument.  
The reliability of an instrument is concerned with measurement error and this is 
related to the sample size. Studies with a large measurement error require a larger 
sample size to reduce noise in order to obtain a signal. The validity of instruments 
consists of content and face validity (does it measure the domain of interest and 
construct validity that needs to be considered, in particular in multidimensional 
instruments with several constructs).  
For smaller scale studies, the means to collect data can be burdensome, relying on 
interview techniques administered individually and this can impact on the feasibility 
of using a certain instruments. This is usually not available for large-scale population 
cohorts, which as a consequence rely completely on self-administration of 
questionnaires.  
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Criteria Concepts 
    
Appropriateness Discrimination (if no external validator) 
 
Evaluation to track changes overtime 
 
Prediction of eligibility 
  Acceptability Mode 
 
Questionnaire design 
 
Health status respondents 
  Feasibility Administration (self or interviewer) 
 
Processing 
  
Interpretability 
Comparison of changes to same instrument in different 
conditions 
(Meaningfulness) Minimally clinical important difference 
 
Comparison to normative data 
  Precision Scaling of items 
 
Range of constructs 
  Reliability Internal consistency 
 
Reproducible 
  Validity Construct  
 
Content & Face  
  Responsiveness Change in score following treatment 
to change 
  
Table 1-2: Eight criteria to necessary to select most suitable PROM instrument 
(generated from text available online at http://phi.uhce.ox.ac.uk/inst_selcrit.php) 
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However, most researchers will opt for an existing measure, provided it has been 
validated in the patient population. For easy identification of a measure, The Patient-
Reported Outcome and Quality of Life Instruments Database (PROQOLID) can be 
consulted to find the best suitable PROM66. A similar database, On-Line Guide to 
Quality-of-life Assessment (OLGA)67, categorises thousands of patient-reported 
outcomes measures. Both are best considered a reference source to potential users.   
The ultimate choice for a specific PROMs measure should primarily be based around 
the aims of the project. The suitability of specific tool relies predominately on the 
content validity that determines the appropriateness of the measure for use in the 
target population.   
 
 
 
 
1.1.8 Current and past PROMs initiatives 
 
PROMs are widely used in early adopting countries such as the United States (U.S.), 
Canada and the UK. The Federal Drug Agency (FDA) in the U.S. currently 
recommends and publishes guidance for industry in medical product development to 
support labelling claims68. When used correctly, they can provide support and 
information is therefore available on labels in medication for chronic conditions69. In 
Europe, the European Medicines Agency (EMA) avoided publishing particular 
guidance and opted to only provide recommendations to existing guidance70. 
Although, the uptake of PROMs in cancer studies and other clinical trials is variable 
and requires improvement42, the experience in observational studies and surveys in 
chronic conditions, such as HIV, has been more extensively reported71,72. The 
experience of routine use of PROMs in medical management of patients with 
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Rheumatoid Arthritis (RA) over longer periods is also considerable73. However, in 
more prevalent Non Communicable Diseases (NCDs), such as diabetes, PROMs 
have rarely been used and there is therefore potential to improve quality of care in 
these conditions for larger patient populations if applied routinely74. 
In surgery specifically, there is extensive evidence of the use of HRQoL measures to 
evaluate surgical practice. Measures, such as SF-36, have been used to objectify 
important differences in surgical outcomes for many procedures that aimed to 
establish patient preference for certain procedures75,76. However, most of these 
studies collected these measures only as secondary outcomes, therefore limiting the 
interpretation of the data77. Researchers have used systematic analysis to provide an 
exhaustive summary of the use of PROMs in different specialities to compensate for 
specifically designed trials. In particular in aesthetic surgery, there seems to be a lack 
of reliable and responsive measures, which is counterintuitive as improving a 
patients’ wellbeing is the primary aim of the intervention78.   
One of the earliest large-scale attempts to investigate the feasibility of routine 
collection of PROMs data was the Regional Evaluation of Surgical Indications and 
Outcomes (RESIO) Project in British Columbia79. During the late 1990s, HRQoL 
outcomes data using the SF-36 on six elective surgical procedures were collected at 
different time points and results were fed back to clinicians in real time. A 
substantial proportion (31%) of patients undergoing cataract surgery reported a 
perfect condition-specific score before their surgery, raising questions about the 
clinical need for intervention in this particular group. Although, the cost incurred for 
each patient was reasonable at $12 a patient, clinicians were generally not positive 
about the project and it was therefore recommended that for PROMs data to be 
successful, shared accountability between management and clinicians was required80. 
During the same period, private sector hospitals in the UK had used SF-36 to 
evaluate surgical performance in support of clinical governance decisions81. Control 
charts were used to evaluate outcomes by alerting on variation or in the event of 
unusual results, prompting a review or improve processes by initiation of local audits 
or ideas about ways to improve response rates. The success of this programme led to 
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the inception of the national PROMs programme in the NHS in England and Wales 
after initial piloting by Browne et al82. The main aims of the programme are:  
x To assist clinicians to provide better and more patient-centred care by 
monitoring of patients’ conditions to help decision-making on patient groups;  
x To allow for assessment and comparison between providers in order for 
patients to choose provider based on what other patients say; PROMs data 
can influence commissioning; increase providers’ public accountability by 
publishing data; data can help with revalidation of doctor’s. 
x Providing a means of enhancing the calculation of healthcare productivity by 
including the outcome as well as the quantity of care83. 
  
PROMs have since formed an integral component of the quality accounts in the 
NHS84. Following Lord Darzi’s Next Stage Review of the NHS in 2008, routine 
collection now covers four elective surgical procedures; joint replacements (Hip and 
Knee), groin hernia and varicose veins. The PROMs questionnaire used in the 
national programme, contains several elements; the EQ-5D measure, which forms 
the basis for all individual procedure questionnaires; a condition specific HRQoL 
measure where available; patient satisfaction questions; twelve patient-reported 
comorbidities and general questions about health and disability (Figure 1.5). 
Annually, approximately 250,000 eligible episodes are recorded across the four 
index procedures. The response rates to the baseline PROMs increased overall from 
66% in 2010 to 75% in 2012 from inception mainly determined by adequate 
response rates in joint replacements and their substantial proportion on overall 
questionnaires collected. However, there was a decline in the amount of follow-up 
questionnaires collected towards year 3 (Table 1.3& 1.4).  
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Figure 1-5: Elements of the PROMs questionnaires in the NHS national PROMs 
programme 
 
 
Condition-specific 
HRQoL score 
(Oxford Hip or Knee Score,  
       Aberdeen Varicose Veins  
         Score) 
Adverse events 
(Allergy to drugs,  
Urinary problems, 
Bleeding & Wound 
Problems) 
Self-reported  
comorbidities 
 
Satisfaction 
  (Results, comparison 
      of symptoms) 
Self-reported  
General health/ 
disability 
General questions  
(Timeframe of symptoms 
Previous surgery) 
EQ-5D 
index & 
VAS 
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Table 1-3 Total volume of responses for the first three years of the national PROMs 
programme (adapted from PROMs annual report 2012) 
 
Table 1-4: PROMs response rates for the national PROMs programme in the first 3 
years after inception (adapted from source: Information Centre websites: PROMs 
annual report 2012) 
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Table 1-5: Response rates for all eligible patients in England and W
ales by baseline and follow-up questionnaire response rates and per individual 
PROM
s index procedure (adapted from source Health and Social Care Information Centre)
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The response rates for both joint replacement procedures to the baseline 
questionnaire were all above 75%, however, for the day-case procedures and in 
particular Varicose Veins were less than 50% (Table 1.5).  
According to results published by the Department of Health (DoH), the majority 
(95%) of patients undergoing joint replacement improved their condition-specific 
score following surgery85. Analysis of the average gain in EQ-5D index score, 
specifically looking at hip replacement, showed an average gain of 5.2 years of full 
health. The cost effectiveness ratio was only £1,800, which was significantly lower 
than the threshold as set by NICE55. Currently, this initiative does not provide 
comprehensive patient-level feedback to clinical teams, which aside from acting as a 
method of closing an audit loop could provide the opportunity for improving 
interaction with patients. 
Smaller scale initiatives include PatientViewPoint, championed by a team at Johns 
Hopkins hospital, linking routinely collected PROMs in cancer patients to electronic 
health record to aid patient management86. Here, clinicians are provided with 
suggestions following from the completed questionnaires, allowing for a more 
patient-centred comparative approach. For patients, the ability to communicate 
directly with their doctors was of most interest. They are currently undertaken 
studies to evaluate the impact it has on patient care and outcomes.  
The use of HRQoL measures in smaller-scale studies is extensive but is limited by 
their relative small size and the fact that HRQoL outcomes are predominately 
secondary outcomes in the trial design. Moreover, the relative small sample sizes 
hampers risk adjustment for important explanatory variables, such as age and gender, 
and equally important pre-existing conditions, i.e. comorbidities. Population cohort 
studies, such as the national PROMs programme, are unique in terms of their design 
as they aim to capture as many patients as possible. Therefore, they might provide an 
opportunity to investigate the impact of treatment on HRQoL by allowing for better 
segmentation of patient groups within the population.  
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1.1.9 The potential of nationally collected PROMs data 
 
PROMs have the potential to transform and accelerate the way healthcare is 
delivered. It allows for tracking of performance over time and in the event the patient 
mix remains unchanged, improved outcomes could be contributed to improved 
processes or better quality of care. Although, PROMs to some may seem only a tool 
that quantifies health status, it can actually provide a deeper understanding of the 
relationship between healthcare inputs (human resources, capital, etc.) and outputs 
(units of service) to health outcomes that patients consider to be important87. For 
many years, health systems have focussed primarily on measuring productivity by 
inputs and outputs and based performance on achieved volume. If PROMs are 
successful in their ability to establish the need and appropriateness of intervention in 
each patient, interventions that are not considered cost-effective can be avoided 
without impacting on the overall health status of the population.  
Besides the opportunity to establish cost-effectiveness of treatments, the national 
PROMs linked to HES data includes a variety of patient-reported variables (Figure 
1.6) that can facilitate our understanding of variation between patients. The four self-
reported adverse events (allergy to drugs, urinary problems, bleeding and wound 
problems) were considered relevant by the PROMs programme board for patients in 
the postoperative period. Several studies have described that patients can identify a 
mixture of complications and process indicators reliably that occur in hospital88.  
Complications that occur in-hospital should be recorded by clinical coders, however, 
as was previously discussed the accuracy of data collection depends on their 
potential to influence payment. If they are not considered relevant to the tariff then it 
is likely they will not be recorded. A recent study showed that the accuracy of HES 
data compared to medical record review was poor, highlighting the need to capture 
complication using alternative methods89. The opportunity for PROMs lies in 
complementing the inaccuracies of in-hospital generated data, but more importantly 
to provide an insight into adverse events that occur in the community.  In addition, 
the influence of adverse events on HRQoL outcomes is underreported in the 
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literature. This is a required step in further validation of patients reporting adverse 
events on a national setting.  
To assist in risk adjustment of the data, the twelve patient-reported comorbidities 
(heart disease, high blood pressure, problems caused by stroke, leg pain due to poor 
circulation, lung disease, diabetes, kidney disease, nervous system disease, liver 
disease, cancer (within the last 5 years), depression and arthritis) could provide an 
alternative source of health status information on pre-existing conditions. If they are 
found to be important confounders in HRQoL outcomes in the national programme, 
than there is a need for assessment of the reliability of patient reporting information 
on comorbidities within the national programme. Bayliss and Katz, previously 
reported that patients can reliably report on their own conditions, however, this 
evidence comes from small sample sizes with designated follow-ups by 
researchers90,91.   
In conclusion, PROMs can facilitate the collection of outcomes that matter to 
patients in order to provide patient relevant information to improve patient 
engagement. As we are moving away from a ‘one size fits all’ approach in the 
decision-making process, data generated by the patient themselves, i.e. PROMs data, 
can assist in further segmentation of patients. Identification of important prognostic 
factors that determine the risks of success or failure and complication can be directly 
extracted and used in the decision-making process. Methodological issues, such as 
failing response rates, can influence the quality of the evidence that PROMs data can 
provide.  
 
1.1.10 Methodological challenges using PROMs 
 
Both research and clinical practice orientated towards patient-reported outcomes can 
be limited by incomplete data and variable response rates or unit non-response92. 
Unit response rates in smaller (more focused) studies are often better than those of 
larger studies but both can be affected by publication bias85,93.  Unit response rates 
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are a direct consequence of the method of data collection, which traditionally uses 
paper-based questionnaires. The underlying constructs in terms of patient-related 
factors that are frequently associated with non-response to follow-up questionnaires 
are young age and lower socio-economic status83,94,95. Responding participants have 
normally better subjective health96-98. The importance of responder bias has been 
highlighted previously in the literature and non-response has been associated with 
poorer outcomes92. Controlling for this type of bias can improve statistical 
modelling99. In addition, the inclusion of irrelevant content, be it only to the patient, 
can potentially alienate participants and form part of the explanation of lower 
response rates of overall questionnaires and incomplete forms100. In addition, 
incomplete forms can also be impacted by item non-response, a concept that is not 
well documented in the literature but potentially can influence data quality101 .  
The content of a PROM can be divided into several elements; specific wording and 
instructions chosen for questions/statements; use of examples; response categories; 
visual design elements and questionnaire order. All these elements can influence the 
likelihood of response to each PROM questionnaire and item-response. Therefore 
qualitative research is required to evaluate the impact that these elements will have in 
order for successful implementation into routine practice. Even translation into 
another language can impact on the content validity of a specific score and validation 
is therefore required102.  
The mode103 and instrument design104 are considered to be the two areas of interest in 
identifying potential concerns with data methodology. The mode of a questionnaire 
can be divided into two main groups; traditional or paper-based format relying on 
manual data collection in care settings (or postal in nature) and Health Information 
Technology (HIT) based, which employ any form of technology platform for data 
collection. The use of HIT in collecting healthcare data throughout the process 
remains disappointing, and this is not different in PROMs studies. Even though the 
rapid onset and availability of mobile technology platforms have provided 
opportunities to collect information from the patient and thereby reducing costs that 
are associated with paper data collection, resistance against the use of NTP remains, 
predominately around the inability of patients who do not have access to technology. 
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However, digitalising data from the time it is generated can bring about cost savings 
that struggling health systems desperately need.  
1.1.11 PROMs and technology 
 
As the previous section has highlighted, one of the most noticeable methodological 
challenges is to improve the way in which the data is collected. Traditional paper-
based questionnaires are resource intensive and time consuming. Manual 
transformation of paper questionnaires to IT databases seems unnecessary in this day 
and age, where the Personal Computer (PC) has penetrated our homes so rapidly. In 
contrast to other industries, there has been a relative slower adoption of technology 
in healthcare105. In recent years a surge in the use of technology to improve processes, 
i.e. the move from paper to electronic medical record keeping, has demanded a rapid 
increase in adoption from its users, in this case professionals. Besides collecting 
patient information with the help of automated processes, technology has also 
allowed for improvement and cost reduction in providing (customised) information 
to the patient, another step forward in improving communication between doctor and 
patient106.   
Technology’s role in improving productivity is frequently dismissed based on cost 
grounds. However, as Brynjolfsson and Saunders indicate, information technology 
can increase productivity, but this has to be complemented with other interventions 
such as organisational restructuring, process changes and training107. For healthcare 
an important dimension to this is the role of the patient, and facilitating their 
involvement through the use of technology has the potential to improve both quality 
and contribution to service productivity if combined with other interventions. 
The scale and pace in society’s use of technology highlights how the public has 
accepted this and arguably its role can be potentially unlimited. Technology’s social 
ubiquity means that usage penetration is democratised across age groups and socio-
economic classifications. For example, in 1994, 3 million people were connected to 
the Internet, today that number is approximately 2.1 billion or one-third of the 
world’s population.  
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There are important factors that moderate the publics’ acceptance of technology in 
healthcare. The latest model, described by Venkatesh et al, highlighted several 
constructs that influence this acceptance108. Whilst the difference in eventual usage 
based on gender has been explored in a number of studies, age is often an important 
consideration in healthcare109,110. There exists an inverse correlation between age and 
the extent to which an individual found using technology is free from effort111. 
Young individuals tend to require less support and feature increased adaptation 
compared to older individuals. However, Fisk et al. describe that despite age-related 
decline in physical abilities, older adults are remarkably adaptive and can continue to 
perform at a high level112. It can be assumed that with increasing exposure to 
technology, the gap between young and old will gradually diminish, and this makes 
decision making about using technology less burdensome. 
Computer Adaptive Testing (CAT) based tools have tested the advances in computer 
technology and the strengths of modern measurement theory. Computer adaptive 
testing in patient-reported outcomes provides the opportunity to tailor the 
questionnaires to the individual. They already have been applied to osteoarthritis and 
showed that a higher degree of precision can be achieved with shorter questionnaires, 
and statistical similarity was noted with the regular patient-reported outcome 
measures113. Computer adaptive testing based tools require a large pool of items 
from which the computer selects the most appropriate items for a patient. All items 
are calibrated on a common metric and allows for comparison irrespective of which 
items are answered.  
One initiative that is based on computer adaptive testing principles is the Patient 
Reported Outcome Measurement Information System (PROMIS) project. The 
development of this project followed a programme initiated by the National Institute 
of Health (NIH). The programme promises to utilise rigorous qualitative and 
quantitative methods to develop, validate, and standardise PROMs tools114. Several 
areas in healthcare have reported satisfying completion rates using the ‘PROMIS’ 
item bank for specific populations115,116. Access is currently not limited by licensing 
fees, however a technology platform, i.e. PC or tablet is needed. It is also possible to 
predict EQ-5D index scores from studies using the PROMIS item bank that lacks 
assessment of health preferences117.  
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Better access via multiple platforms to obtain self-reported HRQoL from disabled 
patients, more flexibility in form, more rapid collection of data and less processing 
errors and easier feedback to healthcare providers and researchers have been 
reported118. Leidy et al. previously discussed the movement in patient-reported 
outcomes towards paperless data capture but identified difficulties in adapting 
existing questionnaires because of validation of only one format119. 
To date, integrated technology for patient-reported outcomes data collection has been 
underreported and looking forward provides the opportunity, not only to facilitate 
data collection, but achieve this in a cost effective and labour efficient manner. 
Currently most existing patient-reported outcome measures are validated and 
standardised but recent interest in customisation, which takes in the perspective of a 
single patient rather than the average patient, will add an extra ‘dimension’ to 
patient-reported outcome measurement.  
 
1.1.12 Public health implications 
 
The national PROMs programme has the potential to improve quality of care for 
patient undergoing elective surgical procedures.  Moving away from volume-based 
care towards a more patient-centered approach, the patients can provide us with a 
unique insight into their health leading up to and following treatment. For this reason, 
routinely collected PROMs forms part of the NHS Outcomes Framework84, which 
holds NHS England as overall provider of care accountable for performance. The 
data of all four procedures are now being consolidated into two indicators, one 
physical and one mental health, in line with the Government’s focus on raising the 
profile and importance of mental health84. However, PROMs data is a much richer 
data source that can provide the evidence needed to make important decisions about 
the ‘value for money’ of interventions.  For commissioners, there is a constant 
requirement to establish the need for treatment in specific patient population that is 
delivered in a cost-effective way. Commissioning has traditionally focussed on 
single outputs of care and thereby sustaining a fragmented system that did not 
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encourage integration of care. The NHS Confederation, an organisation that 
represents institutions that commission and provide NHS services, has called for 
Outcome-based commissioning, a system where outcomes and experiences of 
patients are at the very centre of payment for health and care services. For surgical 
procedures, such as joint replacements, a pathway approach is preferred, which 
allows for longitudinal following of the patient120. The Swedish Hip Arthroplasty 
Register has successfully adopted this approach as it encourages local and national 
improvement following analysis of routinely collected PROMs data121. However, no 
further information is provided as to how this can be achieved and the data is not 
shared publically. By contrast, the data generated by the NHS PROMs programme 
are disseminated online via the government website 
[http://www.hscic.gov.uk/proms], however, there is no evidence that it has become 
meaningful to both patients and providers. This highlights the trend of a lack of 
publically available data that can inform patients in their health choices. It is difficult, 
if not impossible, for patients to make the right informed decision about which 
provider supplies the best quality of care.  
For providers, the ability to compare performance using PROMs data could be the 
first step in quality improvement. Although, the fear of ‘naming and shaming’ in 
benchmarking can be justified, the approach hospitals should take its learning from 
better performers. For this, adequate case-mix and risk adjustment is required to 
allow for further segmentation of data on the individual procedures. Clinicians 
themselves should be encouraging data collection by patients, as they play a vital 
role in the success of PROMs. Explaining the importance of PROMs data to facilitate 
a patient-centered approach will hopefully close the gap between what they think is 
important and what patients believe is important. This misalignment between 
patients and clinicians is highlighted by evidence that describes that clinicians report 
fewer problems in association with conditions122, underestimate the severity of 
problems and overestimate the improvements causal to treatment123,124.  
For now, further adoption is prevented by a lack of evidence that utilising PROMs 
data actually has a positive impact on health outcomes125-127. Therefore, augmenting 
traditional outcomes with PROMs might provide us with a more holistic approach to 
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measuring quality of care. Further focus on the individual, the team and the overall 
organisation in the health system can lead to accelerated multi-level change128. 
As services will continue to move towards a more integrated format, the richness of 
data collected by primary care in a system that is patient-centred could pave the way 
to better understand true outcomes after surgery.  
 
 
1.1.13 Conclusion 
 
Established healthcare systems are struggling to deal with the socio-economic and 
health challenges now being witnessed globally. The ageing population carries with 
it a consequential increase in consumption of healthcare, forcing health systems to 
develop innovative ways to deliver care whilst improving quality of care and 
containing costs. One approach health systems are aiming to contain cost is by 
restricting access to treatments that are either too costly or provide no additional 
benefit to the patients by means of cost-effective analysis. This is measured by 
QALYs, which reflect how many years of high quality of life a patient gains from the 
intervention. These QALYs can be calculated from HRQol outcomes collected 
before and after treatment directly from patients. Newly developed treatments can be 
compared to existing by calculating the cost-effectiveness ratio to determine the best 
value treatment. The importance of these analyses in the decision-making on a policy 
level highlights that outcomes that matter to patients are becoming central to the way 
care is measured and organised.  
Although, the cost-effectiveness of most (new) treatments is predominately assessed 
in a small clinical trial setting, the measures that collect HRQoL outcomes, i.e. 
PROMs, on a national scale can facilitate the transformation of the way we evaluate 
treatments and improve our means to evaluate quality of care. These end-points of 
care provide a more comprehensive view on the impact of treatment on quality of 
care compared to traditional clinical outcomes, such as mortality and morbidity. 
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These measures will therefore likely be extended to cover a wider range of treatment 
available in the NHS.  
The current use of nationally collected PROMs data, covering four index procedures, 
is limited to informing policymakers about overall improvement in the entire 
population. There is a deficiency of evidence of their influence on the decision-
making process by clinicians or patients. It is here, where they might provide the 
most value in their ability to segment patient groups to allow for a more 
individualised decision-making process. By knowing which patient is at risk of a 
deterioration of HRQoL or adverse events, quality improvement can be directly 
targeted at those patients.  
The success of PROMs will depend on clinicians’ engagement, they should share 
accountability for outcomes produced and collected by PROMs data. The 
opportunity to compare performance, provided the methodological concerns are 
addressed, can promote sharing of experiences to improve quality. Moreover, it will 
improve patient engagement, as outcomes that matter to both stakeholders will be the 
priority. 
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1.1.14 Key points arising from chapter 1 
 
x A multidimensional approach with a focus on patient-relevant outcomes to 
measuring quality of care is required to facilitate the transition from physician 
to patient-centered care models. 
x Collecting PROMs on a national level have the potential to improve quality, 
however, current evidence generated from outputs of the national PROMs 
programme are limited to a policy level. 
x Failing unit response rates, in particular for Varicose Veins patient, in the 
national PROMs programme, necessitate further research into explaining 
variables both quantitative and qualitative in origin. 
x Clinicians’ engagement is vital in the successful utilisation of PROMs data in 
terms of initiating quality improvement efforts. 
x Health systems alike need to investigate the value of Information Technology 
(IT) solutions to promote cost-savings. 
x PROMs can provide a bridge between primary and secondary care by 
objectifying what happens in ‘real life’ to patients in terms of their health 
status (HRQoL and pre-existing conditions), adverse events and patient 
satisfaction. 
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Chapter 2  
 
ROUTINE MEASUREMENT OF 
PATIENT-REPORTED 
OUTCOMES IN ELECTIVE 
INGUINAL HERNIA REPAIR: 
RETROSPECTIVE ANALYSIS OF 
NATIONALLY COLLECTED 
DATA IN ENGLAND 
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2.1 INTRODUCTION 
 
The introduction has highlighted the value of routinely collected PROMs data, 
particularly in joint replacement surgery, on a national setting. The impact of 
symptoms on daily activities associated with osteoarthritis of the hip joint on daily 
activities is well established through wide acceptance of the disease-specific score, 
i.e Oxford Hip Score (OHS). For inguinal hernia, one of the four index procedures, 
the use of a disease-specific score is not common practice, making it more 
challenging to assess change following treatment. The decision to include inguinal 
hernia in the national PROMs programme was primarily based around the direction 
of the National Audit Commission, a governing body in charge of protecting public 
spending. They consider an elective inguinal hernia operation mainly a ‘cosmetic’ 
procedure and therefore an area of interest to potentially restrict access129.  
Inguinal hernia repair is one of the most common general surgical procedures; 
around 60,000 are performed annually in England and Wales. Traditionally, this 
procedure is performed using the ‘Lichtenstein’ technique, a ‘tension free’ open 
approach where a MESH (synthetic patch) is placed over the defect. For patients, the 
decision-making process currently relies on individual surgeons assisted by national 
guidelines, suggesting that healthy male patients, with symptoms affecting daily life, 
should be offered open repair for a ‘simple’ primary unilateral hernia130 and 
laparoscopic approach should be reserved for recurrent and/or bilateral repairs131. In 
asymptomatic patients, particularly in higher risk categories, a ‘watchful waiting’ 
approach can be considered132, although contemporary data has questioned the 
longevity of this approach133.   
The final decision making process, however, not only relies on the preferences and 
technical abilities of the surgeon, but also on the local availability of equipment, 
local hospital policies and funding arrangements. There is a significant amount of 
evidence exploring the differences between the open and laparoscopic approaches 
but a deficiency of evidence in adherence to clinical guidelines in the decision-
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making process. Recent evidence suggests that pain, and in particular chronic pain, 
should be the driving factor in decision-making134. 
For inguinal hernia surgery, evidence from randomised trials reporting on Health-
related Quality of Life (HRQoL) outcomes after different surgical techniques have 
marginally favoured laparoscopic repair over open, principally by demonstrating 
only early difference in the postoperative period whilst these differences normalise 
after three months and beyond135-140. These early differences in outcomes may not be 
considered relevant on a population health level, as the ultimate goal is to improve 
overall health status of patients irrespectively of better short-term performance. 
Although, patients undergoing laparoscopic repair reported less pain and their return 
to usual activities is faster, the latter is very dependable on a patients’ compliance to 
postoperative instructions. 
Population level data has the opportunity to augment the evidence derived from 
RCTs and additionally provides a novel viewpoint. RCTs and their inherent strict 
inclusion criteria may fail to appreciate heterogeneity in patient demographics and 
the resulting variation in health needs. This can limit the applicability of evidence 
from RCTs to all patient groups.  
The primary objective of this study was to assess the usability of population level 
routinely collected PROMs data for inguinal hernia repair to assess appropriateness 
of treatment and determine differences in patient-centred outcomes between the two 
approaches. 
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2.2 MATERIALS AND METHODS 
2.2.1 Study population  
The study cohort was identified from patients who participated in the national 
PROMs programme in the NHS in England141, between January 2009 and February 
2011. This programme, mandatory for healthcare providers, offers all patients 
undergoing groin hernia repair the preoperative questionnaire in either the pre-
assessment clinic or on admission asking them about their general wellbeing and two 
condition-specific questions (“Have you had a previous hernia operation on the side 
on which you are about to have surgery” and “For how long have you had symptoms 
of a hernia”). They are then posted a follow-up questionnaire at three months, where 
the same questions are repeated and extended with their views on the outcomes of 
their operation. All patients, responders and non-responders, who completed a 
preoperative PROMs questionnaire, were included in the baseline analysis, and 
patients who completed the follow-up questionnaire at three months, were included 
in the postoperative analysis. The raw dataset was obtained from the Health and 
Social Care Information Centre (HSCIC). At source, PROMs data was linked to the 
patient level Hospital Episode Statistics (HES) record to validate the individual 
patient. Both the baseline and the follow-up questionnaires are included (Appendix 
W).  
 
2.2.2 Data extraction 
Data for elective primary repair of inguinal hernia using insert of prosthetic material 
(Office of Population Censuses and Surveys Classification of Surgical Operations 
and Procedures 4th revision (OPCS-4) code T20.2), appearing in the primary 
procedural group, with or without Y75.X (Y75.1 or Y75.2), indicating laparoscopic 
approach to the abdomen, were extracted (Table 2.1). 
 
 
 58 
                       
Primary procedure code 
 
Primary repair of inguinal hernia using insert of natural material (T20.1) 
Primary repair of inguinal hernia using insert of prosthetic material (T20.2)* 
Primary repair of inguinal hernia using sutures (T20.3) 
 
  
Primary repair of inguinal hernia and reduction of sliding hernia (T20.4) 
Other specified primary repair of inguinal hernia (T20.8) 
 
  
Unspecified primary repair of inguinal hernia (T20.9) 
 
  
            
For laparoscopic group: T20.2 plus code(s) 
 
  
     
  
Laparoscopically assisted approach to abdominal cavity (Y75.1)*   
Laparoscopic approach to abdominal cavity NEC (Y75.2)*   
  
    
  
Site           
  
    
  
Right (Z94.2)* 
    
  
Left (Z94.3)* 
    
  
Bilateral (Z94.1) 
   
  
Unilateral (Z94.4)* 
   
  
Laterality (Z94.9)* 
   
  
 
Table 2-1: OPCS-4 codes used to determine primary unilateral MESH inguinal hernia 
repair 
 
Cases were excluded if they were emergencies, if the patient was under the age of 16, 
a bilateral or recurrent repair, the case was recorded as a mortality or a bowel 
resection was performed as part of the operation. All duplicate cases were identified 
(Figure 2.2) 
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Assessed for eligibility  
(n= 53529) 
Excluded  (n=12991) 
i Non MESH repair (n=4549) 
i Bilateral repairs (n=4444) 
i Recurrent (n=3630) 
i Mortalities (n=169) 
i Duplicates (n=148) 
i Bowel resection (n=19) 
i < 16 years (n=12) 
i Emergencies (n=20) 
 
 
Analysed  (n=24424) 
72% 
 
Allocated to open technique (n=33816) 
 
Analysed  (n=4682) 
70% 
 
 
ALLOCATION 
ANALYSIS 
FOLLOW-UP 
Sample (n= 40538) 
Primary unilateral MESH 
inguinal hernia repair 
Allocated to laparoscopic technique 
(n=6722) 
 
Lost to follow-up (n=9395) 
28% 
27& 
 
Lost to follow-up (n=2040) 
30% 
 
Figure 2-2: Flowchart Figure 2-1: Flowchart desc ibing data segmentation into primary unilateral 
"open" and "laparoscopic" inguinal hernia repair in national PROMs 
programme 
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The NHS classification service, responsible for maintaining clinical coding standards 
and promoting consistency of classification, was used to verify the OPCS-4 codes 
and coding combinations to ensure that the patient data extracted was consistent with 
the clinical question being asked.  
 
2.2.3 Clinical outcome variables 
The following parameters were obtained from the preoperative questionnaire, 
patients’ age and gender and self-reported general health, comorbidities, duration of 
symptoms and having had previous surgery. Symptom duration was defined by two 
groups based on whether symptoms had been present for greater or less than one year. 
General health was scored using a Likert scale, with 1 being excellent and 5 being 
poor. Self-reported comorbidities were categorised into heart disease, high blood 
pressure, problems related to stroke, leg pain on walking due to poor circulation, 
lung disease, diabetes, kidney disease, liver disease, cancer, depression and arthritis. 
The primary outcome measures, derived by virtue of their inclusion on the PROMs 
questionnaire, were self-reported postoperative adverse events, hospital readmissions 
(defined as a new hospital admission after discharge from either outpatient surgery or 
an inpatient stay), length of stay, patient satisfaction, and the EQ-5D index score. 
Postoperative adverse events were classified as: (1) allergy or reaction to drug, (2) 
urinary problems, (3) bleeding and (4) wound problems. Patients’ level of 
satisfaction was scored with two questions (“How would you describe the results of 
your operation? and “Overall, how are your hernia problems now, compared to 
before your operation?”), with answers based on a five point likert scale (“excellent, 
very good, good, fair and poor” and “much better, a little better, about the same, a 
little worse and much worse” respectively). 
In addition, socioeconomic deprivation and ethnicity were identified in the HES 
component of the dataset. Socioeconomic deprivation was measured using the 
English Index of Multiple Deprivation (IMD) for 33,482 areas based on patients’ 
residential postcode142, that cover areas of about 400 households. The IMD is a 
weighted average of eight indices that cover income, employment, health and 
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disability, education skills and training, barriers to housing, living environment and 
crime. Quintile groups were formed, where group 1 was considered most deprived 
and group 5 was considered least deprived. Two categories were formed for ethnicity, 
white and non-white because of the small numbers in each of the ethnic subgroups. 
Both the baseline and follow-up questionnaires included the EQ-5D index score (a 
generic preference-based measure of HRQoL)54. This score is composed from five 
individual dimensions (mobility, self-care, daily activities, pain/discomfort and 
anxiety/depression), which are scored on a three point likert scale. These can be 
individually analysed or combined into a single index score  (scores range from -0.59 
(worse than death) to 1.00 (perfect health status). For the purpose of the analysis, the 
single index score was categorised into seven groups (-.59 to 0, 0.01 to 0.2, 0.21 to 
0.4, 0.41 to 0.6. 0.61 to 0.8, 0.81 to 0.99 and 1) to allow for identification of 
differences between groups.  
 
2.2.4 Statistical methodology 
Categorical variables were analysed with the X2 test. For test of significance p values 
< 0.05 were considered statistically significant. SPSS version 19.0 (SPSS, IBM 
Chicago, Illinois, USA) was used for statistical analysis. The EQ-5D index score and 
individual dimensions were reported as means with standard deviation. The changes 
between baseline and three months (follow-up) were calculated and independent 
samples t-test in normally distributed data was used to determine whether statistical 
difference was seen. Linear trend was tested between length of stay and EQ-5D 
index means by linear by linear association X2 statistic. 
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2.3 RESULTS 
2.3.1 Demographics 
Across English NHS hospitals, 53,529 patients were identified having undergone a 
groin hernia procedure between January 2009 and February 2011. Of these 33,816 
underwent open and 6,711 underwent laparoscopic primary unilateral open or 
laparoscopic inguinal repair and met the inclusion criteria. 29,106 (71.8%) patients 
completed the three-month follow-up questionnaire. Response rates were similar 
between both treatment groups 72% vs. 70% (Figure 2.1).  
Table 2.2 shows the baseline characteristics of the patients according to the treatment 
groups. Across both groups, the majority of patients were white males. In the 
laparoscopic group, patients were on average younger compared with those in the 
open group (54.3 years SD 15.9 vs. 58.9 years SD 16.7 respectively), reported fewer 
comorbidities and were more likely to have had symptoms for less than a year. 
Patients in the laparoscopic group lived more frequently in the least deprived group 
and less frequently in more deprived areas due to smaller than expected proportions 
in group 1 (most) 2 and 3, compared with a greater than expected proportion of 
patients in the least deprived group (shown as standardised residuals).  
Overall in both treatment groups, non-responders were significantly younger (62.3 
years vs. 50.1 years in the open and 58.1 years vs. 45.6 years in the laparoscopic 
group), more frequently of non-white ethnicity and were living in more deprived 
areas. They also reported a lower prevalence of comorbidities with exception of 
depression.  
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Table 2-2: Baseline characteristics of all primary unilateral MESH inguinal hernia 
repair patients by technique and response/ non-response with consequent p-values or 
standardised residuals 
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2.3.2 Baseline HRQoL 
In the laparoscopic treatment group, patients reported proportionally better general 
health and patients in the open treatment group reported proportionally more fair and 
poor health than expected (Table 2.2). 
The mean baseline EQ-5D index score of all patients in the open group was 0.78 and 
in the laparoscopic group was 0.80 (Table 2.3). This was similar when only 
considering responders who had completed a follow-up questionnaire (0.79 vs. 0.81). 
Non-responders reported a lower EQ-5D index mean. The majority of patients 
reported an EQ-5D index score between 0.61 and 0.80 irrespective of treatment 
group (58% versus 60%). 27.4% and 30.2% of patients reported perfect preoperative 
health in the open and laparoscopic group respectively (Figure 2.2a). 
 
2.3.3 Clinical outcomes 
Open repair, compared with laparoscopic repair, was associated with a reduced odd 
of urinary problems (OR 0.55, 95% C.I=0.49-0.61, p<0.01). This was predominately 
determined by patients in all age groups above 35 (Table 2.4). There was an 
observed association between the number of reported urinary problems and 
increasing length of stay for patients irrespective if they were in the open or 
laparoscopic group (Appendix U). This association was more pronounced for the 
laparoscopic group with more than 50% of patients who stayed three or more nights 
reporting urinary problems. 
Younger patients (<25 and between 35-44) undergoing open procedure reported 
significantly more bleeding (OR 3.2, 95% C.I=1.24-8.23 and OR 2.14. 95% 
C.I.=1.02-4.47 resp) and wound problems (OR 2.14, 95% C.I=1.02-4.47, p=0.04 and 
OR 1.70, 95% C.I=1.22-2.35, p<0.01 resp). There was a trend towards decreased 
reporting of readmission across all age categories in open repair, however, only in 
two categories (25-34 and 35-44) this was significant (OR 0.54, 95% C.I=0.30-0.98, 
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p=0.04 and OR 0.51, 95% C.I=0.32-0.82, p<0.01 resp) (Table 2.4) Readmitted 
patients undergoing open repair were more likely to be older, more frequently report 
comorbidities along with fair and poor baseline general health. They were also more 
likely to be from socioeconomic deprivation group 1 (most) and less likely to be 
from socioeconomic deprived group 5 (least) and more likely to have had previous 
surgery (Appendix T). 
 
2.3.4 Postoperative HRQoL and satisfaction  
In both groups there was an increase in the mean postoperative EQ-5D index score 
(Table 2.3), with the open group reaching a mean of 0.87 and the laparoscopic group 
a mean of 0.90. The proportion of patients reporting a perfect health score of 1 
increased significantly in both groups (27.4% to 55.8% in the open group and 30.2% 
to 66.4% in the laparoscopic group), with a similar decrease in the proportion of 
patients reporting a value of 0.61-0.80 (60.2% to 30.3% and 60.3% to 23.3% 
respectively) (Figure 2.2b).  
A sensitivity analysis (Table 2.3), which excluded patients reporting perfect health 
preoperatively, resulted in larger difference between baseline and follow-up EQ-5D 
index score predominantly from a lower baseline score (open group 0.71 to 0.84, 
laparoscopic group 0.73 to 0.88). 
Table 2.5 shows the difference in proportions for the five dimensions that generated 
the EQ-5D index score. Postoperatively the predominant change was the increased 
number of patients reporting a score of 1 (no problems / no) for the dimensions 
‘usual activities’ and ‘pain/discomfort’. This increase was more pronounced for the 
laparoscopic group (10.8% and 38.6% respectively) compared with the open group 
(6.5% and 32.6%). 
Patients who were readmitted reported a smaller increase in their follow-up EQ-5D 
index score (open group 0.73 to 0.75, laparoscopic group 0.75 to 0.81), compared 
with non-readmitted patients (open group 0.79 to 0.88, laparoscopic group 0.81 to 
0.91). For both open and laparoscopic repair, the occurrence of a complication 
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reduced the reported improvement in mean EQ-5D scores. Similarly, when patients 
were not treated as outpatient or overnight stay, the increase in postoperative EQ-5D 
was reduced, although for the laparoscopic group this was only true if the patient had 
a length of stay of three or more nights (Table 2.3). There was also an association 
between an increasing length of stay and a lower reported baseline EQ-5D (linear 
trend in both groups p<0.01).  
For both the open and laparoscopic groups, the majority of patients reported 
‘excellent’, ‘very good’ or ‘good’ satisfaction three months after surgery (total 
92.6% and total 93% respectively) (Table 2.6). Similarly, 94.6% (open) and 95% 
(laparoscopic) of patients reported improvement in their symptoms following surgery. 
  
 67 
 
Table 2-3: Mean EQ-5D index scores at baseline (pre) and at follow-up (post). Higher 
scores equals better perceived wellbeing. Differences are shown between responders 
and non-responders, outcomes are only shown for responders (readmission (yes or no)), 
length of stay, complications and sensitivity analysis) 
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Figure 2-2 a&b: Bar charts showing baseline (2.2a) and differences between baseline 
and follow-up HRQol (EQ-5D) (2.2b), distribution by EQ-5D index group (-.59 to 0, 
0.01 to 0.20, 0.21 to 0.40, 0.41 to 0.60, 0.61 to 0.80, 0.81 to 0.99, 1) 
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Table 2-4: Distribution of patients reporting postoperative adverse events overall and 
by age group. (Differences are reported as unadjusted Odds ratios with 95% C.I. and 
p-value) Open technique acted as reference group) 
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Table 2-5: EQ-5D individual dimensions by treatment group 
 
    Open Laparoscopic 
Satisfaction response (%) (%) Excellent 32.8 38.4 Very good 39.3 38.4 Good 20.5 16.2 Fair 5.7 4.5 Poor 1.7 2.5       
Comparison of symptoms pre and post      Much better 84.7 87.7 A little better 9.9 7.3 About the same 3.3 2.8 A little worse 1.6 1.4 Much worse 0.6 0.8 
 
Table 2-6: Patients' satisfaction three months after surgery 
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2.4 DISCUSSION 
2.4.1 Principal findings 
The main finding of this study was that, irrespective of whether a patient underwent 
open or laparoscopic inguinal hernia repair, there was an improvement in reported 
HRQoL principally resulting from reporting a decrease in pain and discomfort and an 
improvement in the ability to undertake usual activities. These differences were 
accentuated when patients who reported perfect health preoperatively were excluded 
from the analysis. The laparoscopic group attained a statistically significant greater 
improvement in the measured mean EQ-5D index score, however, this group had 
more favourable demographics.   
In both techniques, younger patients attained a larger improvement, primarily caused 
by a lower baseline HRQoL compared to their counterparts in the general population 
matched by gender and age. However, compared with older patients, they reported 
significantly more bleeding and wound problems in the event they underwent an 
open procedure. The laparoscopic approach was associated with increased odds of 
urinary problems, and this increased with age and was the principle cause of 
prolonged length of stay and readmission when it occurred. Wound problems were 
more likely to be associated with patient readmission (40% increased odds) for the 
open group compared with the laparoscopic group.  
 
2.4.2 Strengths and weaknesses of the study 
The methodology of the PROMs programme, questionnaires used and outcomes 
chosen, were determined centrally by government prior to inception of the national 
programme and therefore the analysis was unbiased in its aim of assessing the value 
of routinely collected PROMs to determine the appropriateness of hernia repairs 
currently being undertaken and subsequent implications from a health policy 
perspective. 
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Although a mandatory national programme, the annual report of the PROMs 
programme for the period that this data was extracted only indicated a 55% return 
rate of the preoperative questionnaire85. As this analysis is primarily based on 
administrative data, it does ensure that it is representative of patients treated in 
England but also compares favourably, in terms of patient characteristics, to a large-
scale randomised controlled trial in the U.S24 potentially allowing for extrapolation 
more widely. The non-response rate, after inclusion to the programme was 28% for 
the analysed period, with age, social deprivation and prevalence of comorbidities 
predicting the likelihood of patients’ non-response, which correlates with findings of 
a previous study92. In addition, a lower proportion of patients reporting preoperative 
perfect health (22.1% in open group, 23.6% in laparoscopic group) was responsible 
for a lower baseline EQ-5D index in this group. It is not possible to fully explain the 
reasons behind non-response postoperatively, but poor understanding of the purpose 
of the programme and the traditional paper-based data collection methodology may 
have contributed. Improved response rates may result from using technology 
platforms to collect data, which has already been successful in collecting PROMs119. 
There has always been a concern with the accuracy of HES data although audit data 
shows a continual improvement in data quality143. Selecting only patients with 
primary hernia repair in the primary operation field reduced the potential for 
heterogeneity including patients undergoing hernia repair as part of another operation 
and allowed for a like for like comparison between techniques. It is acknowledged 
that laparoscopic repair is recommended in bilateral or recurrent repairs. Although 
patients were coded as primary repair there is still the possibility for them to have 
had a previous operation on either the ipsi- or contralateral side. The HES dataset 
provided by the HSCIC did not allow for revisiting of the original operation notes to 
investigate the clinical indication of the intervention or if it was performed under 
local or general anaesthetic. In addition, the dataset lacked information on important 
confounders, such as BMI, which might have influenced outcomes. Obese patients 
are known to have increased risk of wound infection for open compared with 
laparoscopic surgery144. 
Furthermore, it was not possible from the data to discriminate between the two most 
commonly used laparoscopic techniques, Transabdominal Preperitoneal (TAPP) and 
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Total Extraperitoneal (TEP) repair. TAPP repair carries the risk of more serious 
complications, such as bowel perforation, in the event they occur145. However, 
intraoperative conversion rates and postoperative complications are more common in 
TEP146. 
In both groups the majority of patients reported symptoms for less than one year; the 
questionnaire did not give the option of reporting ‘no symptoms’, meaning that over-
reporting of the existence of symptoms might have occurred. This is evidenced by a 
percentage of patients who reported EQ-5D score of 1 (perfect health/no pain or 
discomfort), but also symptoms for less than one year. The ability to identify, 
preoperatively, patients with no symptoms, along with those reporting perfect health 
on the EQ-5D score, may allow for better stratification of patients offered surgery. 
Adopting a watchful waiting policy in asymptomatic patients needs to be considered, 
as acute complications of incarcerated bowel leading to strangulation are rare147,148, 
although development of symptoms does lead to surgical repair ultimately in a 
reasonable proportion of patients133. 
This analysis was limited by the relatively short three months follow-up mandated by 
the national programme, meaning that more traditional measures of outcome, 
recurrence rates and long-term pain i.e. neuralgia, at one year could not be compared 
between the surgical techniques. Future changes to the timing of questionnaire 
administered to patients could therefore encompass longer-term follow-up, as 
reported by patients, to improve the richness of data collected. 
 
2.4.3 Comparison with other studies 
The improvements in overall health status in our study, as a result of treatment, are 
consistent with findings in other studies76,135,136,149. When compared with a UK 
population matched by age and gender150, although the baseline EQ-5D index mean 
for the open group was comparable, that of the laparoscopic group was lower. This is 
probably explained by the relatively greater proportion of younger patients in the 
laparoscopic group who are known to report more severe pain both before and after 
surgery compared to older patients76, which influences HRQoL outcomes. The 
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dataset lacked specific data on England and Wales, which form approx. 85% of the 
UK, using aggregate data from UK as whole was therefore necessary.   
It is worth noting that current measures do not take account of expectations and 
cannot distinguish between changes in the experience of disease and changes in 
expectations of health151. Adaptation behaviour and different scales of reference can 
bias self-assessments of wellbeing by individuals. It is found that the scale of 
reference of the subjective health measure changes with age152. For example, when 
asked to complete a self-reported HRQoL focusing on their inguinal hernia 
symptoms, younger patients who might have limited exposure to ill health, might 
report worse health than older patients who might be more accepting of their 
symptoms due to their experience with ill health. Easily observed and distinctive 
differences between health states will be given more weight in judgments of health 
than they will have in reality. This conceptual contrast between internal perception of 
the patient and external observation by the medical expert, has been commented on 
by Sen153, who warns that over-reliance on self-reported HRQoL can be misleading 
when used to inform policy. 
Two methods have been proposed that evaluate treatment impact using the EQ-5D 
index score. The first, known as the Minimally Important Difference (MID), 
describes the smallest change in the EQ-5D index score that is perceived by patients 
as beneficial or that would result in a change in treatment56 and has been reported in 
inguinal hernia at 0.03154. Both treatment groups, in our study, increased well above 
the MID threshold. The second includes an analysis of individual dimensions of the 
EQ-5D index, which has been shown to be more discerning in variability of 
treatment impact61. Although changes in reported pain and discomfort were 
responsible for most of the improvement in EQ-5D index in our study, and was 
therefore a valid means of identifying treatment impact, the questionnaire itself and 
its timing did not allow for further characterisation of the pain (e.g. scrotal vs. groin) 
or differentiation between immediate postoperative pain and latent pain caused by 
neuralgia as well as detecting early differences in pain and return to usual activities, 
which are known to be present in the first few weeks after intervention137,138. Pain 
after hernia repair is considered an important issue and outcome measure, 
particularly with hernia recurrence rates being so low with modern repair techniques. 
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The higher rate of bleeding and wound problems in open repair has been previously 
described155 and is explained by the relatively larger wound size makes it more prone 
to haematoma formation and infection. In the laparoscopic approach, the greater risk 
of urinary problems may be attributable to the use of an indwelling urethral 
catheter137,156, although other factors such as general anaesthetic and opioids are also 
associated with an increased frequency of urinary problems and in particular urinary 
retention157. The postoperative questionnaire does not specify beyond ‘urinary 
problems’ and it is therefore impossible to comment further. A previous study 
reported that half of the patients undergoing laparoscopic repair reporting urinary 
problems were related to urinary retention158. A further strategy to reduce urinary 
complications, and the associated morbidity of increased length of stay and 
readmission, has been to better risk stratify patients preoperatively based on history 
of pre-existence of lower urinary tract symptoms, female gender, diabetes and older 
age159.  
Readmission rates in inguinal hernia have not been commonly reported in the 
literature. Analysis of a preliminary administrative dataset from Southern England 
reported readmission rates of 1% for day case and 1.5% for inpatient stay160. A more 
recent study, that used HES data, reported readmission rates of 0.7% and 0.8% in 
open and laparoscopic repair respectively161. This study has demonstrated that self-
reported readmission rates, ≥ 5%, were higher when compared with that extracted 
from administrative (HES) data during the same period162. The inability to identify 
an association between readmission and the index procedure and the longer follow-
up period used for the PROMs questionnaire (90 days), compared with the 30 days 
used for HES analysis, may have contributed to this difference. Self-reported 
comorbidities have been shown to be accurate as those extracted from administrative 
data91 and this adds weight to patients also being a reliable source for readmission 
data, which can be used as a cost-effective means of identifying variation between 
providers. The relevance of using readmission rates as a means to measure quality 
after inguinal hernia is unknown and warrants further investigation.  
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2.5 CONCLUSIONS  
 
 
PROMs have provided the opportunity to better understand the impact of symptoms 
on daily life associated with an inguinal hernia, particularly in younger patients. 
Whilst younger patients (<55) reported worse baseline HRQoL and older patient 
(>64) better HRQoL compared to their counterparts in the general population, the 
use of the metric (EQ-5D index) chosen by the programme board to establish clinical 
need seems mostly acceptable in younger patients but not in older patients, who are 
also more likely to be affected by other pre-existing conditions. However, whilst the 
overall improvements in HRQoL demonstrated in both techniques and across all ages 
largely justified treatment in the majority of patients, a significant proportion of 
patients (>30%) reported perfect health and therefore showed no improvement. It 
seems unlikely that there is such a degree of intervention that will have had no 
opportunity to improve HRQoL, which if left untreated would result in a health 
burden beyond the timeframe of the PROMs programme's follow-up. These patients 
might therefore benefit from more careful decision-making and treatment by 
watchful waiting seems appropriate. Younger patients affected in their daily life, due 
to the ‘focusing effect’ of their hernia, could be offered laparoscopic technique as it 
can lead to improved HRQoL outcomes, however, for providers who are currently 
only assessed on their entire patient group, would not be inclined to offer 
laparoscopic technique as better HRQoL performance is not rewarded. Therefore, it 
can be argued that laparoscopic technique should be avoided entirely as 
complications associated with this technique predominately occur in hospital, such as 
length of stay and readmission, and have impact on important performance indicators. 
Whilst complications associated with open technique occur more frequently in the 
community and have no financial implication for providers. This approach should be 
avoided in older patients as it can cause increased hospital stay and readmission. 
Health policy makers should have some reservations, using PROMs in its current 
format, in drawing firm conclusions as to the appropriateness of surgical 
interventions being undertaken on a national level. Certainly as applied to hernia 
repair, the response rates and the lack of risk adjustment limit the translatability to 
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the clinical setting. Future work should aim to identify important variables that can 
predict HRQoL between the two techniques to further add value to the data. 
 
2.6 KEY POINTS ARISING FROM STUDY ONE 
 
x The use of PROMs in inguinal hernia patients is appropriate in their ability to 
discriminate between different patients sub-groups with the assistance of 
administrative data and using it to evaluate HRQoL outcomes. 
x The current PROMs questionnaire is unable to establish clinical need due to 
the inclusion of a generic HRQoL index (EQ-5D) that is limited by a 
significant ceiling effect and a large proportion of patients reporting 
full/perfect health.   
x Patients provide important additional information regarding incidence of 
postoperative adverse events that occur both in the community and in-
hospital. 
x Older patients are generally healthier than their counterparts in the general 
population and previous experience with other condition may moderate their 
experience of hernia symptoms. 
x Young patient with symptoms affecting daily life would benefit from 
laparoscopic over open repair due to the improved HRQoL outcomes that are 
associated with that technique. 
x Laparoscopic repair is associated with an increased incidence in urinary 
problems potentially leading to increased length of stay and possible 
explanation for self-reported readmission. 
x Satisfaction rates following both open and laparoscopic procedure are 
generally high. 
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Chapter 3  
 
RISK PREDICTION OF HEALTH-
RELATED QUALITY OF LIFE 
OUTCOMES IN GROIN HERNIA 
PATIENTS 
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3.1 INTRODUCTION 
 
The previous study reported on important differences in patient-reported outcomes 
between the two most commonly performed techniques for treating a primary 
inguinal hernia in England and Wales. The improvements in HRQoL outcomes 
justified treatment in both groups, however, these improvements were lower than 
expected due to a significant proportion (>30%) of patients in both groups who 
reported perfect HRQoL, as measured by the EQ-5D index, and were thereby 
insensitive to change as a consequence of surgical intervention. In addition, the 
finding that older patients were reporting better HRQoL at baseline compared to their 
counterparts in the general population could fuel a debate as to whether treatment is 
appropriate at that stage.  
Although, the appropriateness of the EQ-5D index to establish clinical indication was 
questioned in the previous chapter, its use will remain important to measure variation 
between providers. For these providers it will be pertinent to understand their patient 
population to make full use of PROMs data. The elements of the PROMs 
questionnaire described in the introduction (Figure 1.5) augmented with variables 
from administrative data available from the HES dataset component can provide an 
opportunity to identify significant predictors that help with risk adjustment of the 
data.  
The primary aim of this study was to identify important patient-related predictors 
between patients reporting perfect health (EQ-5D=1) and patients who were not (EQ-
5D<1) reported at baseline, followed by an investigation into the differences in 
factors that predict HRQoL outcomes following treatment between open and 
laparoscopic technique to add further predictive value to PROMs data.  
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3.2 MATERIAL AND METHODS 
The data extraction from the PROMs linked to HES database and the outcome 
measure used (EQ-5D index score) has been previously described in section 2.2.   
3.2.1 Candidate predictors 
The candidate predictors for both study aims were collected from two separate 
sources. The primary independent, or predictor, variables of interest were extracted 
from data generated by the baseline PROMs questionnaire, which provided self-
reported general health (Excellent, very good, good, poor and fair) and has been 
shown to be a strong predictor of HRQoL163. Patients were also asked, as part of the 
baseline questionnaire, if their doctor had told them they had any of twelve common 
medical conditions. Each of these comorbidities were considered relevant as 
potential predictors, due to their potential to impact on either both physical and 
mental aspects of a generic HRQoL measure164. From the postoperative PROMs 
questionnaire, information on self-reported adverse events was extracted as they 
were thought to be relevant to their potential negative impact on HRQoL experience 
following treatment and were used as independent variables in the second part of the 
study. Other included patient-related predictors have been previously described in 
section 2.2.1. The secondary independent variables of interest were extracted from 
the administrative data component (HES). The reliability of demographical variables, 
such as age; ethnicity and social deprivation, and Charlson’s comorbidities20 
contained in administrative data is widely accepted. 
For each of the techniques (open and laparoscopy) candidate preoperative patient and 
administrative reported variables available for risk adjustment at baseline were 
collected (Table 3.1). The dependent, or outcome, variable was the baseline EQ-5D 
index score separated into two groups of patients reporting perfect health (EQ-5D 
index of 1) and patients not reporting perfect health (EQ-5D index less than 1). The 
same variables extended with information available from follow-up were made 
available for the risk adjustment of patients reporting HRQoL outcomes following 
treatment (Table 3.2&3.3). In order to segment patients into groups to allow for 
regression analysis, HRQoL change score were calculated by subtracting the score 
obtained at three months follow-up from the baseline score. This led to the formation 
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of three groups, where an improvement of ≥0.03 was deemed improvement (Group 
1), decrease of ≥ -0.03 was designated decrease (Group 2) and a score between -0.03 
and + 0.03 was designated the same (Group 3) displayed in Table 3.3. The dependent 
variable here was the postoperative EQ-5D index score from Group 1 (Improvement) 
and 2 (Reduction).   
 
3.2.2 Statistical Analysis 
All analyses were performed using SPSS version 19.0 (SPSS, IBM Chicago, Illinois, 
USA). Patient preoperative characteristics and postoperative adverse events were 
compared by univariate analysis, with Chi-square test or Fisher’s exact test where 
appropriate. Independent variables that demonstrated a significant difference and 
were associated with a p-value less than or equal to 0.05 were considered significant 
predictors of either patient reporting perfect health at baseline or patients reporting a 
reduction following treatment. Individual levels from multi-level variables, such as 
general health, were included in the event they were significant provided their 
Standardised Residual (SR) was smaller than -1,96 or larger than 1,96. Formation of 
a dummy variable in this case was therefore necessary. Odds ratios were calculated 
for each of the independent variable in the multivariable models and 95% 
Confidence Intervals (C.I.) were calculated using maximum likelihood methods. .  
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Variable Open technique   Laparoscopic technique 
  EQ-5D     EQ-5D     
  1 <1 p-value 1 <1 p-value 
 
N (%) N (%) 
 
N (%) N (%) 
 Number (N) 8554 23993  1853 4665  
       Female gender 517 (6) 1636 (6.8) 0.01 87 (4.7) 244 (5.2) 0.37 
       Age groups          
1 (16-30) 680 (7.9) 1706 (7.1) <0.01 190 (10.2) 445 (9.5) <0.01 
2 (31-40) 659 (7.7) 2048 (8.5)   196 (10.5) 556 (11.9)   
3 (41-50) 1114 (13) 3325 (13.9) 
 
286 (15.4) 831 (17.7) 
 4 (51-60) 1498 (17.5) 4368 (18.2)  379 (20.3) 998 (21.3)  
5 (61-70) 2485 (29.1)^ 5959 (24.8)* 
 
502 (26.9) 1101 (23.5) 
 6 (71-80) 1650 (19.3) 4745 (19.8)  262 (14.1) 619 (13.2)  
7 (>81) 468 (5.5)* 1842 (7.7)^ 
 
48 (2.6) 134 (2.9) 
 Ethnicity           
White 6918 (80.9) 20064 (83.6) <0.01 1476 (79.1) 3885 (82.9) <0.01 
Mixed 26 (.3) 4 (.3)   10 (.5) 11 (.2)   
Asian 189 (2.2) 449 (1.9) 
 
41 (2.2) 106 (2.3) 
 Black 97 (1.1) 286 (1.2)  11 (.6) 43 (.9)  
Unknown 1261 (14.7) 2954 (12.3) 
 
315 (16.9) 607 (13) 
 General Health           
Excellent 1564 (18.3)^ 1777 (7.4)* <0.01 374 (20.1)^ 430 (9.2)* <0.01 
Very good 4330 (50.6)^ 8494 (35.4)*   970 (52.1)^ 1893 (40.4)*   
Good 2327 (27.2) 9616 (40.1)^ 
 
461 (24.7)* 1828 (39)^ 
 Fair 226 (2.6)* 3347 (13.9)^  38 (2)* 444 (9.5)^  
Poor  5 (.1)* 464 (1.9)^ 
 
0* 42 (.9) 
 Social deprivation           
1 (most) 981 (11.5)* 3828 (16)^ <0.01 217 (11.6) 660 (14.1) <0.01 
2 1436 (16.8)* 4484 (18.7)   274 (14.7) 785 (16.8)   
3 1921 (22.5) 5160 (21.5) 
 
375 (20.1) 954 (20.4) 
 4 2043 (23.9) 5328 (22.2)  472 (25.3) 1068 (22.8)  
5 (least) 2134 (24.9)^ 5048 (21)* 
 
519 (27.9) 1197 (25.6) 
 Symptom period           
< 1year 5890 (68.9) 16139 (67.3) 0.03 1324 (71.1) 3328 (71.1) 0.98 
>1 year 2587 (30.2) 7687 (32)   531 (28.5) 1337 (28.5)   
Previous surgery 
      No 8131 (95.1) 22626 (94.3) 0.01 1739 (93.9) 4391 (93.7) 0.86 
Yes 384 (4.5) 1246 (5.2) 
 
11 (6.1) 277 (5.9) 
 PROMs comorbidities           
Heart disease 577 (6.7) 2527 (10.5) <0.01 78 (4.2) 298 (6.4) <0.01 
High blood pressure 2037 (23.8) 6472 (27) <0.01 386 (20.7) 1032 (22) 0.24 
Problems with stroke 69 (.8) 461 (1.9) <0.01 18 (1) 42 (.9) 0.79 
Problems with poor 
circulation 99 (1.2) 1409 (5.9) <0.01 20 (1.1) 42 (.9) <0.01 
Lung disease 367 (4.3) 1653 (6.9) <0.01 62 (3.3) 186 (4) 0.09 
Diabetes 356 (4.2) 1272 (5.3) <0.01 55 (3) 199 (4.2) 0.09 
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Kidney disease 86 (1) 359 (1.5) <0.01 8 (.4) 37 (.8) 0.11 
Nervous system disease 35 (.4) 293 (1.2) <0.01 9 (.5) 35 (.7) 0.24 
Liver disease 31 (.4) 145 (.6) <0.01 3 (.2) 12 (.3) 0.47 
Cancer within 5 years 331 (3.9) 1099 (4.6) <0.01 41 (2.2) 122 (2.6) 0.34 
Depression 102 (1.2) 1387 (5.8) <0.01 24 (1.3) 233 (5) <0.01 
Arthritis 797 (9.3) 4564 (19) <0.01 163 (8.7) 699 (14.9) <0.01 
Charlson Comorbidities 
      Myocardial infarction 53 (.6) 159 (.7) 0.67 2 (.1) 18 (.4) 0.07 
Chronic heart failure 23 (.3) 160 (.7) <0.01 0 9 (.2) 0.06 
Peripheral Vascular Disease 32 (.4) 188 (.8) <0.01 6 (.3) 18 (.4) 0.71 
CVD 11 (.1) 29 (.1) 0.86 0 0 n/a 
Dementia 3 (0) 53 (.2) <0.01 0 6 (.1) 0.12 
Pulmonary disease 535 (6.3) 2207 (9.2) <0.01 106 (5.7) 305 (6.5) 0.22 
Rheumatic disease 22 (.3) 194 (.8) <0.01 5 (.3) 26 (.6) 0.13 
Peptic ulcer disease 3 (0) 18 (.1) 0.21 1 (.1) 0 0.11 
Mild liver disease 7 (.1) 54 (.2) <0.01 0 5 (.1) 0.16 
Diabetes no CC 282 (3.3) 978 (4.1) <0.01 49 (2.6) 151 (3.2) 0.21 
Diabetes with CC 2 (0) 22 (.1) 0.04 2 (.1) 0 0.03 
Hemiplegia  3 (0) 25 (.1) 0.06 0 1 (0) 0.53 
Renal disease 45 (.5) 202 (.8) <0.01 4 (.2) 17 (.4) 0.34 
Any malignancy 63 (.7) 198 (.8) 0.43 12 (.6) 16 (.3) 0.09 
Liver disease 0 6 (0) 0.15 0 0 n/a 
Metastatic cancer 1 4 (0) 0.75 0 0 n/a 
Aids 0 0 n/a 0 0 n/a 
(*) SR < -1.96             
(^) SR > 1.96 
      (-) -1.96 < SR < 1.96        
Table 3-1: Univariate analysis of all PROMs and HES recorded variables in open and 
laparoscopic technique by baseline EQ-5D index groups (EQ-5D=1) and EQ-5D<1
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Group 
  
  
  
Group 
  
  
 
1 
2 
 
 
1 
2 
 
 
Improvement 
Reduction 
p-value 
 
Improvement 
Reduction 
p-value 
Variable 
N
 (%
) 
N
 (%
) 
 
Variable 
N
 (%
) 
N
 (%
) 
 
 
 
 
 
 
 
 
 
N (number) 
11389 
4055 
 
General Health 
  
 
 
 
  
 
 
Excellent 
1009 (8.9)^ 
280 (7)* 
<0.01 
Age (average) 
61.8 (14.64) 
63 (15) 
 
V
ery good 
4532 (40)^ 
1307 (32.6)* 
 
 
  
 
 
G
ood 
4459 (39.4) 
1607 (40.1) 
 
Female gender 
690 (6) 
349 (8.6) 
<0.01 
Fair 
1194 (10.5)* 
704 (17.6)^ 
 
 
  
 
 
Poor  
125 (1.1)* 
110 (2.7)^ 
 
 
  
 
 
 
  
 
 
PROM
s comorbidity 
  
 
 
Age groups 
  
 
 
H
eart disease 
1166 (10.2) 
558 (13.7) 
<0.01 
1 (16-30) 
423 (3.7) 
128 (3.1) 
<0.01 
H
igh B
lood pressure 
3404 (29.7) 
1256 (30.8) 
0.19 
2 (31-40) 
657 (5.7) 
212 (5.2) 
 
Problem
s w
ith stroke 
190 (1.7) 
108 (2.7) 
<0.01 
3 (41-50) 
1303 (11.4) 
515  (12.6)^ 
 
Problem
s w
ith poor 
circulation 
549 (4.8) 
319 (7.8) 
<0.01 
4 (51-60) 
2199 (19.2) 
671 (16.5)* 
 
Lung disease 
757 (6.6) 
341 (8.4) 
<0.01 
5 (61-70) 
3381 (29.5) 
1118 (27.4) 
 
D
iabetes 
610 (5.3) 
255 (6.3) 
0.03 
6 (71-80) 
2589 (22.6) 
996 (24.5) 
 
K
idney disease 
169 (1.5) 
92 (2.3) 
<0.01 
7 (>81) 
891 (7.8)* 
433 (10.6)^ 
 
N
ervous system
 disease 
103 (0.9) 
81 (2) 
<0.01 
 
  
 
 
Liver disease 
59 (0.5) 
27 (0.7) 
0.28 
Social deprivation 
  
 
 
C
ancer w
ithin 5 years 
550 (4.8) 
238 (5.8) 
0.01 
1 (m
ost) 
1437 (12.6)* 
639 (15.8)^ 
<0.01 
D
epression 
486 (4.2) 
248 (6.1) 
<0.01 
2 
1962 (17.3) 
757 (18.7) 
 
A
rthritis 
1912 (16.7) 
1092 (26.8) 
<0.01 
3 
2478 (21.8) 
911 (22.5) 
 
 
  
 
 
4 
2797 (24.6) 
905 (22.5) 
 
Charlson Comorbidities 
  
 
 
5 (least) 
2698 (23.7) 
842 (20.8)* 
 
M
yocardial infarction 
85 (0.7) 
36 (0.9) 
0.38 
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C
hronic heart failure 
69 (0.6) 
32 (0.8) 
0.21 
 
  
 
 
Peripheral V
ascular D
isease 
89 (0.8) 
51 (1.3) 
<0.01 
Symptom period 
  
 
 
C
V
D
 
8 (0.1) 
8 (0.2) 
0.03 
  < 1 year 
7923 (69.7) 
2744 (68) 
0.05 
D
em
entia 
13 (0.1) 
12 (0.3) 
0.01 
  > 1 year 
3451 (30.3) 
1292 (32) 
 
Pulm
onary disease 
984 (8.6) 
405 (9.9) 
0.01 
 
  
 
 
R
heum
atic disease 
71 (0.6) 
53 (1.3) 
<0.01 
Previous surgery 
  
 
0.02 
Peptic ulcer disease 
9 (0.1) 
1 (0) 
0.24 
N
o 
10860 (95.4) 
3828 (94.4) 
 
M
ild liver disease 
22 (0.2) 
10 (0.2) 
0.52 
Y
es 
       529 (4.6) 
       227 (5.6) 
 
D
iabetes no C
C
 
481 (4.2) 
204 (5) 
0.03 
 
  
 
 
D
iabetes w
ith C
C
 
10 (0.1) 
2 (0) 
0.45 
Complications 
  
 
 
H
em
iplegia  
10 (0.1) 
3 (0.1) 
0.8 
A
llergy to drug 
419 (3.9) 
213 (5.9) 
<0.01 
R
enal disease 
93 (0.8) 
55 (1.4) 
<0.01 
U
rinary problem
s 
673 (6.4) 
454 (12.5) 
<0.01 
A
ny m
alignancy 
101 (0.9) 
45 (1.1) 
0.2 
B
leeding 
559 (5.3) 
340 (9.4) 
<0.01 
Liver disease 
0 
1 (0) 
0.09 
W
ound problem
s  
1105 (10.3) 
759 (20.2) 
<0.01 
M
etastatic cancer 
0 
1 (0) 
0.09 
 
  
 
 
A
ids 
n/a 
n/a 
n/a 
Self-reported 
readmission 
471 (4.2) 
328 (8.2) 
<0.01 
 
  
 
 
 
  
 
 
Ethnicity 
  
 
 
 
  
 
 
W
hite 
9704 (91.5) 
3439 (85) 
<0.01 
 
 
  
 
M
ixed 
22 (0.2) 
8 (0.2) 
 
 
 
 
 
A
sian 
133 (1.2)* 
90 (2.2)^ 
 
 
 
 
 
B
lack 
95 (0.8) 
47 (1.2) 
 
 
 
 
 
U
nknow
n 
1428 (12.5) 
460 (11.4) 
 
 
 
 
 
(*) SR
 < -1.96 
  
 
 
 
 
 
 
(^) SR
 > 1.96 
  
 
 
 
 
 
 
(no sign) -1.96 < SR
 < 1.96 
  
 
 
 
 
 
 
 Table 3-2: Univariate analysis of candidate predictors between Group 1 (Improvement) and Group 2 (Reduction) in HRQoL outcomes following 
"Open" surgery 
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Group 
  
  
  
Group 
  
  
 
1 
2 
 
 
1 
2 
 
 
Improvement 
Deterioration 
p-value 
 
Improvement 
Deterioration 
p-value 
Variable 
N
 (%
) 
N
 (%
) 
 
Variable 
N
 (%
) 
N
 (%
) 
 
 
 
 
 
 
 
 
 
N (number) 
2331 
627 
 
General Health 
  
 
 
 
  
 
 
Excellent 
268 (11.6) 
45 (7.2)* 
<0.01 
Age (average) 
57.4 (14.6) 
60 (13.7) 
 
V
ery good 
1027 (44.3) 
217 (34.9)* 
 
 
  
 
 
G
ood 
868 (37.5) 
252 (40.5) 
 
Female gender 
105 (4.5) 
44 (7) 
0.03 
Fair 
149 (6.4)* 
101 (16.2)^ 
 
 
  
 
 
Poor  
5 (0.2) 
7 (1.1)^ 
 
 
  
 
 
 
  
 
 
PROM
s comorbidity 
  
 
 
Age groups 
  
 
 
H
eart disease 
159 (6.8) 
50 (7.9) 
0.32 
1 (16-30) 
122 (5.2) 
18 (2.9)* 
<0.01 
H
igh B
lood pressure 
571 (24.4) 
173 (14.3) 
0.12 
2 (31-40) 
207 (8.8) 
43 (6.8) 
 
Problem
s w
ith stroke 
23 (1) 
9 (1.4) 
0.34 
3 (41-50) 
366 (15.6) 
84 (13.3) 
 
Problem
s w
ith poor 
circulation 
72 (3.1) 
45 (7.1) 
<0.01 
4 (51-60) 
523 (22.4) 
153 (24.3) 
 
Lung disease 
87 (3.7) 
35 (5.6) 
0.04 
5 (61-70) 
682 (29.2) 
179 (28.4) 
 
D
iabetes 
93 (4) 
37 (5.9) 
0.04 
6 (71-80) 
364 (15.6) 
120 (19) 
 
K
idney disease 
20 (0.9) 
8 (1.3) 
0.34 
7 (>81) 
75 (3.2) 
33 (5.2) 
 
N
ervous system
 disease 
15 (0.6) 
7 (1.1) 
0.22 
 
  
 
 
Liver disease 
7 (0.3) 
2 (0.3) 
0.94 
Social deprivation 
  
 
 
C
ancer w
ithin 5 years 
70 (3) 
26 (4.1) 
0.15 
1 (m
ost) 
241 (10.3) 
92 (14.6)^ 
0.02 
D
epression 
68 (2.9) 
41 (6.5) 
<0.01 
2 
335 (14.4) 
98 (15.6) 
 
A
rthritis 
302 (12.9) 
158 (25.1) 
<0.01 
3 
498 (21.4) 
140 (22.2) 
 
 
  
 
 
4 
567 (24.3) 
149 (23.7) 
 
Charlson Comorbidities 
  
 
 
5 (least) 
690 (29.6) 
151 (24)* 
 
M
yocardial infarction 
12 (0.5) 
1 (0.2) 
0.23 
 
  
 
 
C
hronic heart failure 
3 (0.1) 
2 (0.3) 
0.3 
Symptom period 
  
 
 
Peripheral V
ascular D
isease 
6 (0.3) 
4 (0.6) 
0.15 
   < 1 year 
1726 (74.1) 
431 (68.8) 
0.01 
C
V
D
 
n/a 
n/a 
n/a 
   > 1 year 
603 (25.9) 
195 (31.2)^ 
 
 
87 
D
em
entia 
3 (0.1) 
2 (0.3) 
0.3 
 
  
 
 
Pulm
onary disease 
130 (5.6) 
39 (6.2) 
0.54 
Previous surgery 
  
 
 
R
heum
atic disease 
13 (0.6) 
3 (0.5) 
0.81 
N
o 
2204 (94.6) 
580 (92.5) 
0.05 
Peptic ulcer disease 
n/a 
n/a 
n/a 
Y
es 
127 (5.4) 
47 (7.5) 
 
M
ild liver disease 
1 (0) 
1 (0.2) 
0.32 
 
  
 
 
D
iabetes no C
C
 
82 (3.5) 
29 (4.6) 
0.2 
Adverse events 
  
 
 
D
iabetes w
ith C
C
 
0 
1 (0.2) 
0.06 
A
llergy to drug 
110 (5) 
34 (6.2) 
<0.01 
H
em
iplegia  
1 (0) 
0 
0.6 
U
rinary problem
s 
236 (10.8) 
122 (21.6) 
<0.01 
R
enal disease 
10 (0.9) 
3 (0.5) 
0.87 
B
leeding 
105 (4.9) 
47 (8.7) 
<0.01 
A
ny m
alignancy 
12 (0.5) 
4 (0.6) 
0.71 
W
ound problem
s  
197 (9.1) 
94 (17) 
<0.01 
Liver disease 
n/a 
n/a 
n/a 
 
  
 
 
M
etastatic cancer 
n/a 
n/a 
n/a 
Self-reported 
readmission 
124 (5.4) 
49 (8.1) 
<0.01 
A
ids 
n/a 
n/a 
n/a 
 
 
 
 
 
  
 
 
 
 
 
 
Ethnicity 
  
 
 
 
 
 
 
W
hite 
1991 (85.6) 
517 (82.3) 
0.03 
 
 
 
 
M
ixed 
4 (0.2) 
1 (0.2) 
 
 
 
 
 
A
sian 
35 (1.5) 
19 (3)^ 
 
 
 
 
 
B
lack 
9 (0.4) 
6 (1) 
 
 
 
 
 
U
nknow
n 
287 (12.3) 
85 (13.5) 
 
 
 
 
 
(*) SR
 < -1.96 
 
 
 
 
 
 
 
(^) SR
 > 1.96 
 
 
 
 
 
 
 
(no sign) -1.96 < SR
 < 1.96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 3-3: Univariate analysis of candidate predictors between Group 1 (Improvement) and Group 2 (Reduction) in HRQoL outcomes following 
"Laparoscopic" surgery
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Groups EQ-5D index score 
  
(Postoperative score - baseline 
score) 
Group 1  
"Improvement" ≥ 0.03  
Group 2  
"Decrease" ≥ -0.03  
Group 3  
"Same" -0.03<EQ-5D< 0.03 
 
Table 3-4: Formation of groups differences between baseline 
 
 
3.3 RESULTS 
3.3.1 Prediction of baseline HRQoL 
A total of 39,065 patients underwent inguinal hernia surgery, of which 83.3% 
underwent open and the remainder (16.7%) underwent laparoscopic repair. Of those, 
26.3% and 28.4% respectively reported perfect health at baseline.  In the open group, 
the univariate analysis revealed that there were significant differences between 
patients reporting perfect health and patients reporting any other EQ-5D index score 
(Table 3.1). These differences, i.e. variables, were considered potential predictor and 
used as independents in multivariate modelling. For patient undergoing open surgery 
and reporting perfect health, 25 variables were considered potential predictors of 
patient not reporting perfect health. These were age groups (5&7), general health (all 
except good), social deprivation (1,2 and 5), all PROMs comorbidities and nine of 
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the Charlson’s’ comorbidities. Of these, the most positively predictive variables were 
excellent general health (OR 3.34, 95% C.I 3.06 to 3.63, p<0.01), very good general 
health (OR 1.97, 95% 1.85 to 2.10, p<0.01) and age between 61 and 70 (OR 1.27, 
95% C.I. 1.20 to 1.35, p<0.01). Conversely, there was a negative association with 
patients reporting perfect health for poor and fair general health (OR 0.06, 95% C.I. 
0.02 to 0.15, p<0.01 and OR 0.34, 95% C.I 0.29 to 0.39, p<0.01 resp.) and three of 
the PROMs comorbidities; depression (OR 0.31 95% C.I. 0.25 to 0.38, p<0.01), leg 
pain when walking due to poor circulation (OR 0.42, 95% C.I. 0.33 to 0.52, p<0.01) 
and arthritis (OR 0.64, 95% C.I. 0.59 to 0.70, p<0.01). For the laparoscopic group, 
where 6 variables were considered, only excellent general health in patients 
undergoing laparoscopic surgery was positively associated with perfect health at 
baseline (OR 1.67, 95% C.I. 1.42 to 1.96, p<0.01) and fair general health (OR 0.20, 
95% C.I 0.14 to 0.28, p<0.01), and the same PROMs comorbidities as in the open 
procedure group were negatively associated with perfect health at baseline (Table 
3.5&3.6).   
3.3.2 Prediction of HRQoL outcomes 
The response rate for the follow-up questionnaire at three months was 47%. In Table 
3.2 & 3.3, the baseline characteristics of patients in the different group are compared. 
In the open technique, patients with a reduction (>0.03) in the baseline EQ-5D score 
differed significantly from patients with an improvement (>0.03) on 26 variables. 
These were female gender, Asian ethnicity, PROMs comorbidities (Heart Disease, 
High Blood Pressure, Problems due to stroke, Problems due to poor circulation, 
Diabetes, Lung Disease, Kidney Disease, Nervous system disease, Cancer within 5 
years, Depression and Arthritis) and HES comorbidities (Peripheral Vascular Disease, 
Dementia, Pulmonary Disease, Rheumatic disease and Renal Disease), general health 
(Excellent, Very good, Fair and Poor), age >81, social deprivation, all four self-
reported adverse events and readmission (Table 3.2). In the multivariate risk model, 
poor general health (OR 2.20 (95% C.I. 1.61 to 3.02, p-value<0.001) was most 
predictive of reduction in HRQoL, followed by wound problems (OR 1.81, 95% C.I. 
1.58 to 2.1, p-value<0.001), Nervous system disease (OR 1.74, 95% C.I. 1.25 to 
2.42, p-value=0.001), Arthritis (OR 1.64, 95% C.I. 1.48 to 1.81, p-value<0.001 and 
Asian ethnicity (OR 1.64, 95% C.I. 1.20 to 2.24, p-value=0.002) (Table 3.7).  
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In the laparoscopic group, there were 17 variables significantly different in univariate 
analysis, which were subsequently considered potential predictors of reduction in 
HRQoL following surgery. These were, female gender, Asian ethnicity, age group 1 
Problems due to poor circulation, Diabetes, Lung disease, Depression, Arthritis, 
general health (fair, poor), symptom period (>1 year), previous surgery and all four 
self-reported adverse events and readmission (Table 3.8). Only 5 of these – fair 
general health (OR 2.08 95% C.I. 1.51 to 2.87, p-value<0.001), Arthritis (OR 2.03, 
95% C.I. 1.58 to 2.62, p-value<0.001), Depression (OR 1.64, 95% C.I. 1.02 to 2.65, 
p-value=0.045) and urinary problems (OR 1.63, 95% C.I. 1.19 to 2.23, p-
value=0.002) –independently predicted a reduction in HRQoL.  
Both models in the open and laparoscopic group had moderate discriminative power 
(ROC 0.634 and 0.694 resp.) In addition, there was no value greater than 0.8 in both 
correlation matrixes, in other words, none of the independent predictors were 
correlated. 
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Variable Coefficient SE  p-value OR  95% CI 
Demographics 
     Female gender 0.044 0.06 0.440 1.05 0.94 to 1.17 
Age >81 0.056 0.06 0.350 1.06 0.94 to 1.19 
Age 61-70 0.24 0.03 0.000 1.27 1.20 to 1.35 
Social deprivation (worst)^ -0.253 0.04 0.000 0.78 0.71 to 0.85 
 Social deprivation (2) -0.111 0.04 0.003 0.90 0.83 to 0.96 
Social deprivation (best)^ 0.068 0.03 0.040 1.07 1.00 to 1.14 
General Health 
     Excellent* 1.204 0.04 0.000 3.34 3.06 to 3.63 
Very good* 0.676 0.03 0.000 1.97 1.85 to 2.10 
Fair* -1.079 0.07 0.000 0.34 0.29 to 0.39 
Poor* -2.904 0.50 0.000 0.06 0.02 to 0.15 
PROMs comorbidities 
     Heart disease 0 0.05 0.990 1.00 0.90 to 1.11 
High blood pressure 0.068 0.03 0.040 1.07 1.01 to 1.14 
Problems after stroke -0.161 0.14 0.260 0.85 0.64 to 1.13 
Problems due to poor circulation -0.88 0.11 0.000 0.42 0.33 to 0.52 
Lung disease 0.086 0.07 0.230 1.09 0.95 to 1.26 
Diabetes 0.115 0.11 0.300 1.12 0.90 to 1.39 
Kidney disease 0.274 0.14 0.050 1.32 1.00 to 1.73 
Nervous system disease -0.278 0.20 0.160 0.76 0.51 to 1.11 
Liver disease 0.41 0.23 0.070 1.51 0.96 to 2.36 
Cancer (within last 5 years) 0.116 0.07 0.100 1.12 0.98 to 1.29 
Depression -1.184 0.11 0.000 0.31 0.25 to 0.38 
Arthritis -0.45 0.04 0.000 0.64 0.59 to 0.70 
Charlson comorbidities 
     Chronic heart failure -0.27 0.24 0.260 0.76 0.47 to 1.22 
Peripheral Vascular disease -0.07 0.21 0.740 0.93 0.62 to 1.40 
Dementia -0.825 0.62 0.180 0.44 0.13 to 1.46 
Pulmonary disease -0.07 0.06 0.240 0.93 0.83 to 1.05 
Rheumatic disease -0.462 0.24 0.054 0.63 0.39 to 1.01 
Diabetes (no complications) 0.012 0.12 0.920 1.01 0.80 to 1.29 
Renal disease 0.035 0.19 0.850 1.04 0.72 to 1.49 
Mild liver disease -0.674 0.43 0.110 0.51 0.22 to 1.17 
Symptom period (>1yr) 0.046 0.04 0.292 1.05 0.96 to 1.14 
Previous surgery 0.131 0.09 0.158 1.14 0.95 to 1.37 
^Reference category: 4 
     *Reference category: Good 
     SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval 
    
Table 3-5: Multivariate (logistic regression) analysis of potential predictors of patients 
reporting baseline “non” perfect HRQoL (EQ-5D of 1) in "OPEN" surgery
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  Variable 
Coefficient 
SE 
P-value 
OR 
95%
 C.I. 
General Health 
 
 
 
 
 
Excellent* 
0.511 
0.08 
0.000 
1.67 
1.42 to 1.96 
G
ood* 
-0.652 
0.07 
0.000 
0.52 
0.46 to 0.59 
Fair* 
-1.605 
0.18 
0.000 
0.20 
0.14 to 0.28 
Poor* 
-20.219 
6086.00 
0.997 
0.00 
0 
PROM
s comorbidities 
 
 
 
 
 
H
eart disease 
-0.035 
0.14 
0.800 
0.97 
0.74 to 1.27 
Problem
s due to poor circulation 
-0.742 
0.25 
0.003 
0.48 
0.29 to 0.78 
D
epression 
-0.97 
0.22 
0.000 
0.38 
0.25 to 0.59 
A
rthritis 
-0.283 
0.10 
0.003 
0.75 
0.62 to 0.91 
Charlson comorbidities 
 
 
 
 
 
D
iabetes (w
ith com
plications) 
22.895 
28155.00 
0.990 
<0.01 
0 
^R
eference category: 4 
 
 
 
 
 
*R
eference category: V
ery G
ood 
 
 
 
 
 
SE, Standard Error; O
R
, O
dds R
atio; C
I, C
onfidence Interval 
 
 
 
 Table 3-6: M
ultivariate (logistic regression) analysis of potential predictors of patients reporting baseline “non” perfect HRQoL (EQ-5D<1) in 
"LAPAROSCOPIC" surgery 
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Variable Coefficient SE  P-value OR  95% CI 
Demographics      
Female gender 0.247 0.08 0.002 1.28 1.10 to 1.49 
Age >81 0.18 0.07 0.020 1.19 1.04 to 1.38 
Asian ethnicity 0.494 0.16 0.002 1.64 1.20 to 2.24 
Social deprivation (worst)^ 0.169 0.06 0.005 1.18 1.05 to 1.33 
Social deprivation (best)^ -0.072 0.05 0.150 0.93 0.84 to 1.03 
General Health      
Excellent* -0.137 0.08 0.090 0.87 0.74 to 1.02 
Very good* -0.102 0.05 0.030 0.90 0.82 to 0.99 
Fair* 0.43 0.06 0.000 1.54 1.36 to 1.74 
Poor* 0.79 0.16 0.000 2.20 1.61 to 3.02 
PROMs comorbidities      
Heart disease 0.125 0.07 0.056 1.13 0.98 to 1.29 
High blood pressure -0.071 0.05 0.120 0.93 0.85 to 1.02 
Problems after stroke 0.1 0.15 0.490 1.10 0.83 to 1.47 
Problems due to poor circulation 0.021 0.09 0.810 1.02 0.86 to 1.22 
Lung disease -0.023 0.08 0.780 0.98 0.84 to 1.14 
Diabetes 0.027 0.09 0.760 1.03 0.86 to 1.22 
Nervous system disease 0.55 0.17 0.001 1.74 1.25 to 2.42 
Cancer (within last 5 years) 0.052 0.09 0.570 1.05 0.88 to 1.26 
Depression 0.127 0.09 0.170 1.14 0.95 to 1.36 
Arthritis 0.492 0.05 0.000 1.64 1.48 to 1.81 
Charlson comorbidities      
Peripheral Vascular disease 0.209 0.21 0.310 1.23 0.83 to 1.84 
Dementia 0.249 0.46 0.590 1.28 0.53 to 3.14 
Pulmonary disease -0.017 0.08 0.840 0.98 0.84 to 1.16 
Rheumatic disease 0.252 0.21 0.220 1.29 0.86 to 1.93 
Diabetes (no complications) 0.126 0.16 0.430 1.14 0.83 to 1.56 
Renal disease 0.383 0.21 0.061 1.47 0.98 to 2.19 
PROMs adverse events      
Allergy to drug 0.296 0.11 0.008 1.34 1.08 to 1.68 
Urinary problems 0.465 0.08 0.000 1.59 1.36 to 1.87 
Bleeding problems 0.12 0.09 0.210 1.13 0.93 to 1.36 
Wound problems  0.59 0.07 0.000 1.81 1.58 to 2.1 
Readmission 0.33 0.09 0.000 1.39 1.16 to 1.67 
^Reference category: 4      
*Reference category: Good      
SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval   
 
Table 3-7: Multivariate (logistic regression) analysis of potential predictors of 
reduction of HRQoL following "OPEN" surgery 
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Variable 
Coefficient 
SE  
P-value 
OR  
95%
 CI 
Demographics 
 
 
 
 
 
Fem
ale gender 
0.347 
0.22 
0.12 
1.42 
0.92 to 2.19 
A
sian ethnicity 
0.658 
0.35 
0.057 
1.93 
0.98 to 3.80 
General health 
 
 
 
 
 
Fair* 
0.732 
0.17 
0 
2.08 
1.51 to 2.87 
Poor* 
1.398 
0.84 
0.1 
4.05 
0.77 to 21.17 
PROM
s comorbidities 
 
 
 
 
 
Problem
s due to poor circulation 
0.758 
0.24 
0.001 
1.42 
0.92 to 2.19 
Lung disease 
-0.138 
0.27 
0.6 
0.87 
0.51 to 1.47 
D
iabetes 
0.351 
0.24 
0.14 
1.42 
0.90 to 2.25 
D
epression 
0.497 
0.24 
0.04 
1.64 
1.02 to 2.65 
A
rthritis 
0.71 
0.13 
0 
2.03 
1.58 to 2.62 
PROM
s adverse events 
 
 
 
 
 
A
llergy to drug 
0.06 
0.28 
0.83 
1.06 
0.62 to 1.83 
U
rinary problem
s 
0.49 
0.16 
0.002 
1.63 
1.19 to 2.23 
B
leeding problem
s 
0.16 
0.25 
0.51 
1.17 
0.73 to 1.90 
W
ound problem
s  
0.48 
0.18 
0.006 
1.62 
1.14 to 2.28 
R
eadm
ission 
0.245 
0.22 
0.26 
1.28 
0.84 to 1.96 
Symptom period (>1 year) 
0.184 
0.11 
0.11 
1.2 
0.96 to 1.50 
^R
eference category: 4; *reference category: 
G
ood 
 
 
 
 
 
*R
eference category: G
ood 
 
 
 
 
 
SE, Standard Error; O
R
, O
dds R
atio; C
I, C
onfidence Interval 
 
 
 
 
 Table 3-8: M
ultivariate (logistic regression) analysis of potential predictors of reduction of HRQoL following "LAPARASCOPIC" surgery
 95 
 
3.4 DISCUSSION 
3.4.1 Principal findings 
In both groups, excellent general health as reported by patients, was significantly 
associated with patients reporting perfect baseline HRQoL. Patients not reporting 
perfect health were at significant odds of reporting fair general health and any of 
three PROMs comorbidities (arthritis, depression and leg pain when walking due to 
poor circulation) as collected by the baseline PROMs questionnaire. The significance 
of these comorbidities lies in their (in)direct association with individual dimensions 
of the EQ-5D index score, where arthritis and leg pain due to poor circulation lead to 
decreased mobility and depression influences the mental health component. 
Moreover, the same comorbidities were also predictive of patients reporting a 
reduction in HRQoL following surgery. The implication may be that these patient-
reported factors can explain variation and therefore are important in risk adjustment 
of PROMs data.  
Both wound and urinary problems after surgery were independent predictors of a 
reduction in HRQoL in both groups. Patients with a complicated postoperative 
recovery, i.e experienced a complication as recorded by the PROMs questionnaire, 
were at risk of reporting a reduction in several of the EQ-5D index dimensions. For 
example, anxiety levels may have increased as a patient was not expecting a 
complication and/or consequent treatment was inadequate, or symptoms from 
complications may have exacerbated pre-existing symptoms affecting daily life, 
either way it is not possible to understand if these changes in HRQoL present at three 
months after treatment were a direct consequence of a complication or based on a 
patients recall of the event.  
And finally, Asian patients undergoing open surgery were more likely to report 
reduction in HRQoL and there was a further trend towards Asian patients reporting a 
reduction after the laparoscopic procedure, however, this was not statistically 
significant with a p-value of 0.057.   
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3.4.2 Strengths and weaknesses of the study 
As highlighted in the previous study (Section 2.4.2), it was not possible to influence 
the selection of predictors made available from the PROMs linked to HES database. 
Of the elements available, several have been associated with predicting (HRQoL) 
outcomes. Self-reported general health has consistently been a strong predictor of 
both HRQoL and clinical outcomes165-167. Gender and ethnicity have been known to 
influence perceived health as well social deprivation168, where poor perceived health 
is associated with low incomes and educational level169. In this study, only the worst 
social deprivation categories (1 and 2) were prognostic of not reporting perfect health 
for the open technique.  
The linked data contained both patient-reported and administratively collected 
information on pre-existing conditions, i.e. comorbidities. The use of comorbidities 
extracted from administrative data for risk adjustment in surgical procedures and 
medical conditions has been widely described2,20. However, this evidence seems to 
focus on more complex surgery or sicker patients, as higher incidence in the sample 
population will lead to smaller standard errors and earlier significance. For this 
sample, it may be more appropriate to use comorbidities as reported by patients 
themselves. Bayliss et al. found patients to be a reliable source of comorbidity 
information90,91.  
The EQ-5D index scores reported in the data by the national programme were based 
on the UK population norms endorsed by NICE, which originated from Dolan’s 
Time Trade Off (TTO) data170. The preference weights used for this hernia sample 
were therefore not based on different health status, illnesses or conditions and limited 
interpretation of the data. Estimation of EQ-5D index score is difficult as it exhibits a 
ceiling effect with a significant number of respondents reporting perfect health171-173. 
To avoid bias using this data caused by this censoring, the modelling to estimate the 
baseline score should rely on Tobit analysis or Censored Least Adjusted Deviations 
(CLAD) regression, particularly in the event that the data might not be normally 
distributed and there is heteroskedasticity.  
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To determine if treatment was meaningful, the use of MID is well established, 
however, it is dependent on the baseline severity of the condition154. For example, 
symptoms associated with an inguinal hernia are considered less debilitating 
compared to patients needing joint replacement. The level of MID is therefore 
variable amongst different conditions and this impacts on our ability to undertake 
comparisons. The timing of the follow-up questionnaire in terms of demonstrating 
changes in HRQoL was appropriate to establish if the changes that occurred were 
related to the surgery. Assuming that the follow-up would be longer, although, it 
would allow for measurement of long-term pain, i.e. neuralgia, there is potential for 
additional confounders that may influence results. It is thought that this difference, 
for both an improvement as well as a reduction, is most likely related to surgical 
intervention rather than an artefact from unknown confounders.  
 
3.4.3 Comparison with other studies 
This study appears to be the first of its kind to report on both administrative and 
patient-reported variables that predict baseline or postoperative HRQoL in inguinal 
hernia repair. Traditional research focuses on short and long term outcomes, 
comparing difference between techniques in terms clinical variables, such as 
postoperative pain and recurrence rates. The role of comorbidities as predictors of 
health-related quality of life has been well described174. In other research, depression 
and anxiety were important independent predictors of HRQoL in a sample of COPD 
patients175. For this study, depression, as reported by the patient and independently 
from the EQ-5D index, was a strong predictor of patients not reporting perfect health 
at baseline for both techniques. This appears to correlate with the depression/anxiety 
dimension that is contained within the EQ-5D index score. In addition, depression 
was predictive of a reduction in HRQoL in laparoscopic patients. For hernia surgery 
in particular, it has been previously reported that female gender is a significant risk 
factor for pain/discomfort and fatigue following inguinal hernia surgery176. Patients 
with depression or depressive symptoms experience and manage pain in a different 
way, leading frequently to worsening symptoms, although, Powell et al. previously 
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did not find a relation between depression and postoperative chronic pain in inguinal 
hernia patients177. 
Two PROMs comorbidities; arthritis and leg pain due to poor circulation that are 
thought to impact on physical aspect of HRQoL, were in fact predictive of both 
patients reporting other scores than perfect health and a reduction of HRQoL 
following surgery in both groups. The influence of (osteo)arthritis on functional 
capacity primarily and mental health secondarily is well established178,179. The pre-
existence of musculoskeletal illnesses and its consequential impact on HRQoL has to 
be taken into account by researchers. Patients with reduced mobility may not 
experience the potential benefits of fixing a hernia in terms of a reduction in pain, 
and therefore in this group the potential benefits of hernia surgery when primarily 
measured by generic HRQoL will be marginal.  Leg pain due to poor circulation, as 
interpreted by the patients, further influences function and mobility. However, the 
reliability of this patient-reported comorbidity can be argued as for clinicians it will 
mean Peripheral vascular Disease (PVD) leading to difficulties whilst walking 
caused by pain, but patients probably are not able to discriminate between different 
causes, which warrants further exploration or reconsideration about including this 
particular element.  
One additional PROMs comorbidity, that was exclusively predictive of a reduction in 
HRQoL in the open group, was Nervous system disease. Patients diagnosed with 
Parkinson’s disease can be prone to reduced function in limb resulting in reduced 
mobility and capacity of self-care. These patients are prone to develop a prolonged or 
complicated postoperative recovery due to general anaesthetic used and reduced 
function. However, it was not possible to distinguish between different neurological 
conditions, further warranting examination of patients reported nervous system 
disease.  
For both techniques, the occurrence of urinary and wound problems was similarly 
predictive of reporting a reduction in HRQoL following surgery. The previous study 
reported an increased odds of urinary problems leading to prolonged Length of Stay 
(LOS) for laparoscopic technique, however, LOS was not used in the model due to 
lack of significance in univariate analysis. Patients with a prolonged length of stay 
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don’t necessarily report a reduction of HRQoL. In terms of wound problems, the 
presence of any of the features that characterise a surgical site infection (SSI) as 
defined by the Centre for Disease Control (CDC)180, are likely to impact on the 
postoperative recovery experience and lead to a reduction in HRQoL. Whitehouse et 
al. reported a greater physical limitation and a significant reduction in HRQoL for 
patients diagnosed with a SSI following orthopaedic surgery181. SSI’s are a frequent 
source of morbidity leading to increased health burden for patients. Prevention of 
both complications should not be limited to the technique with the highest incidence 
but across techniques as it can prevent reduction of HRQoL. 
Asian ethnicity was a significant predictor in open surgery and there was a trend in 
the laparoscopic group to report reduction in HRQoL following surgery. There exists 
important ethnic variation in clinical risk factors, such as comorbidity status, and 
(socio) cultural parameters, that determines a patient experience182. This is to my best 
knowledge, the first time ethnicity is an important predictor of HRQoL outcomes in 
hernia surgery. Recognition that these patients are at increased odds to report a 
reduction is important in evaluating performance at the national level.  
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3.5 CONCLUSIONS 
 
Patient-reported variables used in this study were better suited to assist in risk 
adjustment of PROMs data compared to administrative data collected. Although, 
there were differences in the amount of predictors that were significant between the 
two procedures, overall, there were predominately similarities in their ability to 
predict both baseline and changes in HRQoL. The five item-scale of self-reported 
general health and three PROMs comorbidities (depression, arthritis and leg pain due 
to poor circulation) were consistently prognostic of HRQoL at baseline and 
following surgery, emphasising the importance of these variables.  
Furthermore, results from this study and study 1 have highlighted the importance of 
collecting traditional clinical outcomes by patients, and their potential ability to 
explain variation between institutions should future comparisons be undertaken. 
Providers with high incidence(s) of adverse event(s) and poor HRQoL outcomes, can 
benefit from this data to identify areas for process change in their quality 
improvement initiatives. However, there remains a question surrounding the 
reliability of patient-reported information in this national setting, in particular, 
around the data accuracy in this predominately day-case procedure. Although, in 
smaller trials the reliability of patients reporting information about their pre-existing 
conditions was excellent, on a population health level, there is currently no evidence. 
There is therefore a need to further assess the validity of self-reported information 
against an established source of health information, i.e. HES, to establish the value 
that patients can add in the current system.   
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3.6 KEY POINTS ARISING FROM STUDY TWO 
 
x Risk adjustment of HRQoL outcomes at baseline and following inguinal 
hernia surgery is feasible using PROMs data. 
x Three self-reported comorbidities, i.e. leg pain due to poor circulation; 
depression and arthritis, were consistently prognostic of patients not reporting 
perfect health and patients reporting a reduction in HRQoL after surgery due 
to their direct influence on their corresponding dimensions contained in the 
EQ-5D index score. 
x Administratively collected comorbidities were not independent predictors of 
baseline health or HRQoL outcomes in inguinal hernia patients. 
x Self-reported adverse events (urinary and wound problems) were associated 
with a reduction in HRQoL following both open and laparoscopic treatment 
and quality improvement should be aimed at prevention to enhance overall 
performance.  
x Female gender and Asian ethnicity were predictive of patient reporting an 
impacted HRQoL at baseline and a reduction following surgery, these factors 
should be taken into account at the decision-making stage. 
x Further testing of the reliability of patient-reported comorbidities is indicated 
in order to provide validation of PROMs in terms of their ability to measure 
health status. 
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Chapter 4  
 
THE CONCORDANCE BETWEEN 
PATIENT-REPORTED AND 
ADMINISTRATIVE DATA 
RECORDED COMORBIDITIES: 
ARE WE MISSING IMPORTANT 
INFORMATION FROM OUR 
PATIENTS? 
 
 
 
 
 
 
The following chapter was presented at: 
International Forum of Quality in Healthcare in Paris 2014 
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4.1 INTRODUCTION 
 
The previous chapter identified the presence of both patient-related and 
administrative data collected variables that can predict whether a patient will report a 
worse baseline EQ-5D score, or whether a patient will report an improvement. The 
presence of self-reported comorbidities was an important confounder in both 
treatment groups.  However, the presence of administrative collected comorbidities 
was not predictive of HRQoL outcomes.  
The effectiveness of Charlson’s comorbidities index (CCI) in studies, where HRQoL 
outcomes are the primary outcomes, has been previously assessed and was not 
recommended due to its inability to explain variation in the mental aspect of the 
score used (SF-36) in the analysis183. For population health studies, the lack of high 
quality clinical databases, such as ACS’s NSQIP programme, forces researchers and 
policymakers alike to analyse administrative data. Although, it provides a relatively 
inexpensive and quick source of health information, the accuracy of administrative 
data compared to medical notes collected has been poor22,184. The recording of 
comorbidities from medical record review, carried out by clinicians is considered the 
reference or the ‘gold standard’, routine use of it is not considered cost-effective and 
is currently mainly limited to research or audits. There might be an opportunity for 
patients to add important value to administrative data. Existing studies investigating 
patient-reported comorbidities have shown promising results with similar 
performance to medical record review in smaller cohorts90,91,185. However, for 
national cohorts, such as the PROMs programme, the validity of patients reporting 
pre-existing conditions remains to be investigated. Nevertheless, patients have 
remained underutilitsed as an important resource for recording comorbidities for use 
in subsequent risk-adjusted analysis of performance outcomes. 
The primary objective of this study was to determine the agreement between directly 
patient-reported (PROMs) versus traditional administrative datasets (HES) recorded 
comorbidities for four elective surgical procedures.  
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4.2 MATERIALS AND METHODS 
 
4.2.1 Study population 
The study cohort was identified from patients participating in a national programme 
routinely measuring PROMs in England between January 2009 and February 2011. 
All patients undergoing elective joint replacement (hip or knee) and two mainly day-
case procedures (varicose veins and groin hernia surgery) who had completed a 
preoperative PROMs questionnaire were included.  
 
4.2.2 Data collection 
The data extraction from the PROMs linked to HES database has been previously 
described in section 2.2.  For the time period covered by the dataset, all hospitals in 
the English and Welsh National Health Service (NHS) were using ICD-10 CM for 
coding of up to 19 secondary diagnoses for each patient episode uploaded nationally. 
These secondary codes were considered as potential comorbidities.  
The local clinical coding department of a large teaching hospital (St. Mary’s Hospital 
part of Imperial College NHS Trust) and the NHS classification service were 
consulted to correlate all twelve PROMs comorbidities with their corresponding 
ICD-10 CM codes. (Appendix V). For each ‘group’ of ICD-10 CM codes 
corresponding to each of the PROMs comorbidity, only codes indicating chronic 
diagnoses were included and codes indicative of an acute episode, for example 
pneumonia, were excluded. In the event that was unclear whether a diagnosis was 
chronic or acute it was included so as not to exclude any potentially relevant 
comorbidities. Aggregating the data for analysis required three main steps. Firstly, to 
iterate through each of the 19 available HES columns per patient to identify any of 
the ICD-10 CM codes deemed relevant to the PROMS comorbidities. Secondly, to 
identify where the administrative-coded (HES) data correlated with the PROMs data. 
Following this a simple ‘truth’ table score was used to mark if the comorbidity was 
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found in one source, the other, or both sets of data. And finally, the top 5 codes per 
comorbidity group could be reported, comparing results of both sets (Table 4.1). The 
product of each iteration for this large sample required several millions of 
calculations and look-ups, which could only be achieved using the aggregate and 
indexing capabilities of a SQL database.  The ICD-10 CM codes provided by the 
local hospital coding team acted as the look-up table, with each code mapped to the 
PROMs comorbidity group. The main table held PROMs and HES data on a single 
row per patient, comprised of all 19 HES ICD-10 CM columns, a column for each 
PROMs comorbidity group and its corresponding ‘truth’ column. Having identified a 
relevant ICD-10 CM code in any one column, a case statement could be used to 
update the ‘truth’ value for that PROMs comorbidity group and this made it possible 
to identify the most common ICD-10 codes, grouped by disease and compared 
between sets. 
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Table 4-1: PROMs comorbidities with top 5 most commonly coded ICD-10-CM 
secondary diagnostic codes and total number within PROMs comorbidity in HES data 
 
4.2.3 Data analysis 
The level of agreement between PROMs and ICD-10 CM recorded comorbidities 
was quantified using Cohen’s kappa coefficient (κ) (A kappa value above 0.75 
indicates an excellent level of agreement beyond chance, 0.40 through 0.75 
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represents fair to good agreement and kappa value less than 0.4 indicates a poor 
agreement). Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were calculated for each comorbidity reported through 
PROMs by designating the HES data, an established source of health data, to serve 
as the gold standard. Sensitivity, for instance, was defined as the proportion a 
comorbidity registered in PROMs data was also recorded by administrative data. 
Whilst specificity was defined as the proportion of a comorbidity not ticked by 
patients and was also not recorded in HES data. A Pearson’s correlation for the 
incident of each comorbidity in both data sets was also undertaken. SPSS version 
19.0 (SPSS, IBM Chicago, Illinois, USA) was used for statistical analysis. 
 
4.3 RESULTS  
 
A total of 236,439 patients underwent elective surgery for the four index procedures 
and completed the preoperative PROMs questionnaires. Both knee and hip 
replacement surgery formed the majority of the data (35% and 32% respectively) and 
in these groups patients were on average between 68 (±11.1) and 69 (±9.4) years of 
age. In addition, most of these patients were white females, reported fair general 
health pre-operatively and had an average length of stay of between 5 and 6 days. 
Groin hernia repair and varicose veins surgery contributed 22% and 10% to the 
overall data and had a lower mean age of 58 (±15.6) and 50 (±16.4) years 
respectively. Both procedures were predominantly undertaken on a day-case basis 
(88% for varicose veins and 70% for groin hernia repair) and most patients reported 
very good pre-operative general health on their baseline questionnaire (Table 4.2).
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Table 4-2: Demographics for each PROMs procedure 
 
4.3.1 Prevalence of comorbidity reporting 
There were similar prevalence rates reported across both datasets for high blood 
pressure and diabetes in both joint replacements (hip and knee), but in both 
outpatient procedures only nervous system disease had similar prevalence rates 
(Table 4.3). Lung disease was consistently underreported in PROMs data compared 
to HES data for all four procedures (p<0.01). Although, both Heart disease and 
Nervous system disease were underreported in PROMs data in both joint 
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replacements procedures (p<0.01), the same was not true for the outpatient 
procedures, as it did not reach statistical significance (p=0.10 and p=0.12). 
In contrast, Leg pain due to poor circulation; Kidney disease; Liver disease; Cancer 
and Depression were all overreported in PROMs data across all four procedures 
(p<0.01). In addition, three further comorbidities were significantly overreported in 
outpatient-based procedures (High blood pressure, Diabetes and Arthritis) compared 
to both joint replacements (Table 4.3).  
 
4.3.2 Levels of agreement 
The level of agreement, i.e. whether HES and PROMs identified the same patient 
with or without the condition, was determined with Cohen’s kappa coefficient (κ) 
and ranged from κ = 0 (no agreement) to κ = 0.86 (excellent agreement). The highest 
kappa values were reported in Diabetes (κ =0.86), followed by High blood pressure 
(κ =0.6) in hip replacement and Heart disease (κ =0.59) in groin hernia repair. The 
lowest levels of agreement were found in Leg pain due to poor circulation (κ =0) and 
Problems due to stroke (κ =0.03), which was consistent across all procedures. In 
Heart disease and High blood pressure, other comorbidities; Nervous system disease: 
Liver disease, Cancer, Depression and Problems due to stroke showed poor 
agreement across all procedures. In day-case procedures, statistical agreement in four 
comorbidities was lower compared to joint replacements (Lung disease, Diabetes, 
Liver disease and Depression). 
Considering that HES data represented a validated means of recording comorbidities; 
sensitivity; specificity; positive and negative predictive value were calculated.  For 
all four index procedures, there were five comorbidities with sensitivity greater than 
50 percent and this indicated that patients were more likely to identify these 
comorbidities when they were also recorded in HES data in this comparison. These 
were Heart disease (56.9%), High blood pressure (76.6%), Problems due to stroke 
(62.0%), Diabetes (89.0%) and Depression (60.5%) (Table 4.4).  
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The specificity for most comorbidities was good with values of greater than 95%, 
meaning that if patients did not report them in PROMs data, they were also unlikely 
to be coded by administrative data. Lower specificity (<95%) in joint replacement 
was reported in High blood pressure, Leg pain due to poor circulation and 
Depression (with no values for Arthritis). For both outpatient groups, Arthritis had 
lowest values (<86%) followed by High blood pressure and Depression only in 
varicose veins surgery (to note, there were no values recorded for Leg pain due to 
poor circulation).  
The PPV for the comorbidities ranged from <0.01% to 85%. Four comorbidities in 
particular had PPV of less than 15 percent across all four surgical procedures. These 
conditions were: Problems due to stroke, Depression, Cancer and Kidney disease. 
Patients also significantly overreported all four of these comorbidities.  
The NPV was greater than 90% for all comorbidities recorded for groin hernia 
surgery. It was also greater than 90% for all varicose veins procedures except for 
Diabetes (40%) and Arthritis (86.9%). For knee replacement surgery, the NPV was 
less than 90% for High blood pressure (79%) and Liver Disease (79.7%). For hip 
replacement surgery, the NPV was less than 90% for Heart disease (81%), High 
blood pressure (82.9%) and Cancer (81.2%). 
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Table 4-3: Prevalence of comorbidities and agreement between administrative and 
PROMs data per individual procedure (VV=Varicose Veins and Hernia=Groin hernia) 
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Table 4-4: Measures of sensitivity, specificity, positive and negative predictive value of 
comorbidities per procedure (HES administrative data served as gold standard for all 
measures) 
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4.4 DISCUSSION 
4.4.1 Principal findings 
This large-scale study using routinely collected patient-reported data augmented with 
administrative data has investigated the feasibility of linking PROMs comorbidities 
to their corresponding ICD-10 CM codes. Although, there was moderate to excellent 
agreement in Heart disease, High blood pressure and Diabetes across all procedures, 
most comorbidities showed poor agreement, exposing potential gaps in both data 
sources. In comorbidities where there was no or poor agreement, patients 
consistently overreported these (except for Nervous system disease) and this was 
more pronounced in the day-case procedures.  
 
4.4.2 Strengths and weaknesses of the study 
This analysis used a large administrative dataset, ensuring that it was representative 
of the general population of patients undergoing routine surgical procedures in 
England and Wales, and linkage of administrative with PROMs data allowed for 
analysis at the individual patient level. Although, the response rates in joint 
replacement surgery in the investigated period were 80% of the total sample, the 
response rates in inguinal hernia repair and varicose veins surgery were only 55% 
and 43% respectively85. 
Although, previous studies have validated and shown the reproducibility of a self-
reporting instrument for comorbidities186, which performed similarly to medical 
notes review91, the large dataset used to determine the concordance between both 
datasets has its own limitations. Firstly, comorbidity is generally measured by 
medical record extraction but due to the sample size in this study it was not 
economic and ethically feasible to further investigate the validity of our findings with 
the aid of medical records review. Comparison of routinely collected patient-reported 
data to medical records could assist in this further. Secondly, the retrospective nature 
of the data analysis did not allow for the investigation of characteristics of non-
responders to the preoperative questionnaire in any of the four procedures. Although, 
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this programme is mandatory for providers, engagement of clinical teams in offering 
patients the PROMs questionnaires may have contributed to poorer response rates in 
day-case procedure. Most patients undergoing joint replacement surgery will be 
assessed pre-operatively in outpatient clinics and this offers an extra opportunity for 
data collection. Thirdly, the study was limited by the twelve PROMs comorbidities 
as the study had no influence on both their inclusion or specific wording used in the 
PROMs questionnaire. A committee of clinicians and public health experts selected 
these twelve PROMs comorbidities, on the basis of their relevance to explain 
heterogeneity amongst patients undergoing these index procedures. Therefore 
mapping of certain comorbidities posed challenges with regards to identifying 
comparable ICD-10 CM codes. Furthermore, patient interpretation of the twelve 
comorbidities could have moderated their responses leading to both under and over-
reporting. For example, in the PROMs questionnaire patients are asked about the 
presence of ‘Leg pain due to poor circulation’, which has only one specific 
corresponding ICD-10 CM code (M79.66), that coders in turn would interpret as 
‘Non-specific limb pain of the lower leg’. This particular PROMs comorbidity was 
probably designed to identify a specific arterial condition, i.e. “Intermittent 
claudication”. However, patients would not necessarily consider circulation an 
arterial problem and this can easily be misconstrued as either pain due to varicose 
veins or coxarthrosis (or OA) of the hip, explaining the disproportionately high 
incidence of this diagnosis in PROMs compared to administrative data. In the 
PROMs comorbidity ‘Problems caused by stroke’, the overreporting can be 
explained by a lack of available ICD-10 CM codes describing chronic problems, i.e. 
physical and mental, occurring after having undergone a stroke specifically. 
Investigating the exact diagnosis behind the patient-reported comorbidity through 
review of medical notes could have elucidated any potential inaccuracies in defining 
matching ICD-10 CM codes to the PROMs comorbidities. And finally, Arthritis 
acted as the primary diagnostic code in joint replacement surgery and it was 
therefore not possible to report on agreement between secondary diagnostic codes in 
HES and PROMs data. However, around 71% of hip replacement patients reported 
having arthritis, this was only marginally lower than a large population cohort, which 
reported that 85% of patients undergoing hip replacement had a primary diagnosis of 
arthrosis or arthritis187. This could in turn support the reliability of patient’s self-
reported arthritis. 
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4.4.3 Comparison with other studies 
Although, several studies have compared the accuracy of administrative data to 
medical record review, universally accepted as the ‘gold standard’, and consistently 
reported underestimation by administrative data22,188-191, only one previous study 
reported on agreement between patient-reported and administrative data and found 
similar agreement for the comorbidities of Diabetes and High blood pressure186. 
Comorbidity extraction by clinical coders is dependent on the availability of patient 
health records to identify secondary diagnostic codes. These records, however, may 
not always be available thereby limiting coders to information secondary data 
sources, such as discharge summaries databases and other IT systems192. In the NHS, 
clinical coders act within guidance that dictates that comorbidities can only be coded 
if there is evidence for them in the medical record as described by the admitting 
clinician for that particular encounter193,194. This is subsequent to the perception that 
information available from previous encounters, i.e. pre-assessment or previous 
admissions, is thought to be out-dated and therefore its use is advised against as a 
direct source to obtain comorbidity information. Including this information from 
previous encounters might, however, improve the accuracy of existing administrative 
data.  This does have financial implications because of the Payment by Results (PbR) 
structure that incorporates some comorbidity information in determining 
reimbursement for healthcare in the NHS. Only certain types of comorbidities, 
however, can influence the level of payment and therefore others might be 
considered less of a priority to local coding departments195, providing further 
explanation for underreporting of certain comorbidities in administrative data. 
While the impact of chronic heart and lung disease and diabetes on risks associated 
with general anaesthetic and postoperative recovery is well documented196,197, other 
comorbidities may not be considered, by clinicians, as relevant to a particular 
hospital episode and therefore not routinely documented. This may also explain some 
of the discordance between patient-reported and administrative data reported 
comorbidities and be especially pertinent for outpatient procedures because of the 
relatively reduced patient contact time in the secondary care healthcare setting.  
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4.4.4 Explaining overreporting 
Patients consistently overreported Depression compared to HES data in all four 
procedures.  Although self-reported Depression in the PROMs questionnaire wasn’t 
collected using a validated measure, Depression has been shown to be associated 
with increased length of stay; mortality; readmission and can impact on 
HRQoL198,199. Therefore the PROMs questionnaire might be a useful tool in 
screening for Depression, most validated HRQoL measures contain at least one 
psychosomatic element47,54 and correlating the self-reported to a generic HRQoL 
measure can help establish the validity of self-reported depression going forward.  
In addition, Kidney disease and Cancer (within the last 5 years) were overreported by 
patients and this was further supported by their low PPV. There may be a number of 
reasons for this relationship. For example, Kidney disease is part of the annual 
Quality and Outcomes Framework (QOF) checks in the primary care setting and 
patients are routinely invited for blood tests to determine their kidney function. This 
continuous re-iteration of their kidney function by their primary care physician is 
likely to lead to a greater number of patients reporting this disease. For Cancer, 
clinicians might not feel comfortable to actively ask patients if they have had cancer 
in the past five years, especially when they do not believe it will influence outcomes.  
 
4.4.5 Explaining underreporting 
PROMs data underreported both Heart and Lung disease in both joint replacements 
compared to HES data. In terms of Heart disease, this may be contributed to patients 
who don’t consider ‘Atrial Fibrillation’ (AF), which represented almost a quarter of 
the diagnostic codes captured by administrative data (Table 4.1), a serious heart 
disease but rather a minor problem. This finding has been previously reported in a 
qualitative survey of patients with AF, which also found that healthcare professionals 
were twice as likely to recognise severe consequences associated with AF200. 
However, it is important to recognise that AF is a meaningful comorbidity due to its 
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association with increased complication rates and prolonged length of stay201. For 
lung disease, the majority were coded as ICD-10-CM code J45.9 (‘Asthma, 
unspecified’), and although the PROMs questionnaire specifically mentioned 
Asthma as one of the examples, patients might have only experienced asthma as a 
child and do not use any regular treatment for this. There is currently no standardised 
criteria to assign this comorbidity variable in administrative coding and may explain 
this discordance. Besides the increased prevalence of Heart and Lung disease, 
PROMs data also identified fewer patients with Nervous system disease, which was 
more prominent in joint replacement surgery. This decreased reporting was mainly 
determined by occurrence of ICD-10-CM code indicating ‘Epilepsy’. Although, 
patients might not consider epilepsy specifically a Nervous system disease, it is felt 
that patients who take preventive medication for seizures would normally consider 
‘ticking the box’ on the PROMs questionnaire. Medical therapy compliance has been 
reported to be dependent on information provision202 and therefore might explain 
patients underreporting certain comorbidities in our sample.  
 
4.5 CONCLUSIONS 
 
This study has demonstrated that the concordance between patient-reported and 
administratively extracted comorbidities was, apart from three commonly 
encountered, inadequate in most comorbidities as reported by patients. There was a 
further trend towards decreased concordance in most comorbidities in day-case 
procedures over joint replacement surgery, which further establishes the validity of 
patient-reported comorbidities, particularly for healthcare services delivering 
outpatient-based interventions. Contemporary health information systems are ill 
equipped to facilitate integration of information collected directly from patients by 
either health surveys or checklists. Medical practitioners should assist with this 
process and objectify comorbidities in a standardised manner and as a consequence 
both patient administration systems and health services research can benefit directly 
from better utilisation of patients as a direct source of health information, ultimately 
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leading to more accurate patient data, which can potentially influence reimbursement 
or explain variations between providers.   
 
4.6 KEY POINTS ARISING FROM STUDY THREE 
 
x The concordance between administrative and patient-reported comorbidities 
was poor except in three common conditions (Heart disease, High blood 
pressure and Diabetes) with increased discordance caused by overreporting in 
PROMs in day-case procedures compared to mainly inpatient procedures. 
x Current guidance in the NHS in terms of comorbidity extraction from clinical 
medical records relies on physician’s objectifying comorbidities during 
patient encounters providing no standardised accumulation of them for use in 
risk adjustment of data at a later stage. 
x Patients are a primary source of health information, collecting comorbidities 
through PROMs can improve our understanding of patients’ heterogeneity.  
x In order to explain variations in healthcare, risk adjustment strategies should 
rely on a variety of data sources. Doing this in a more standardised manner 
has the potential to initiate quality improvement efforts. 
x There is need to further establish the value of patient-reported comorbidities 
and their potential to predict traditional outcomes. 
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Chapter 5  
 
RISK PREDICTION IN HIP 
REPLACEMENT SURGERY 
USING A SIMPLE SELF-
REPORTED COMORBIDITY 
ADJUSTED RISK (SCAR) INDEX  
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5.1 INTRODUCTION 
 
The importance of identifying explanatory variables for risk adjustment in outcome 
measurement for specific patient population groups has been highlighted in chapter 3. 
In more traditional outcome measurement, particularly in retrospective cohort 
analyses extracted from administrative data, heavy reliance on the accuracy of 
patient-related factors, such as comorbidities, influences the capability to adequately 
adjust for individual risk factors. Comorbidity, a pre-existing condition that is 
unrelated to the primary diagnosis, can influence a wide range of outcome measures 
and these can include mortality and morbidity as well as quality indicators of care 
utilisation203. The prevalence of patients with more than one comorbidity, i.e. 
multimorbidity, will continue to increase in this ageing society204. For risk 
adjustment in the analysis of population cohorts, combining several comorbidities to 
an overall risk index has clear advantages over single use of comorbidity. Whilst the 
ease of use is preferred over complexity, risk indices usually contain a set of 
comorbidities that are thought to be most relevant to explain variation in outcomes205. 
Most validated measures use a weight-based methodology to create an overall score 
that predicts outcomes better than accumulation alone, where higher reported scores 
are associated with worsening outcomes183. As previously described, the Charlson 
Comorbidity Index (CCI) remains the most popular tool, which normally relies on 
administrative data but has also been generated based on patient-reported data206.   
The previous studies have highlighted the inability of HES recorded comorbidities to 
predict HRQoL outcomes and discordance between those comorbidities and self-
reported comorbidities. To further assess the validity of self-reported information of 
participants in the national PROMs programme, a singular index could provide an 
inexpensive means of risk adjusting patients both before and after surgery. For 
patients undergoing joint replacement, in particular those with multimorbidity, 
functional outcomes will remain priority, however, the risk of death (mortality), 
although, increasingly rare, is an outcome that is naturally important to patients. The 
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delay in obtaining information from administrative data for risk adjustment means 
there is an opportunity for self-reported comorbidity data to replace or complement 
current risk adjustment strategies. 
The primary aim of this study was to identify whether a PROMs multimorbidity 
index can predict mortality in patients undergoing hip replacement surgery with the 
secondary aim to compare its performance against an established means of risk 
adjustment of administrative data using both the original and modified CCI.  
  
5.2 MATERIALS AND METHODS 
5.2.1 Study population 
The methodology of patients participating in the national PROMs programme has 
been previously described in section 2.1. For hip replacement patients, the baseline 
questionnaire is, in most cases, collected at the pre-admission clinic as compared to 
collection on the day of surgery, which is the predominate methodology in day-case 
procedures. The follow-up period is at 6 months. 
5.2.2 Data extraction 
The PROMs linked to HES database is divided into four index procedural code 
groups, for this study the code (hip) assigned by the PROMs questionnaire was used 
and this was validated using OPCS-4 codes describing the primary procedure as hip 
replacement/arthroplasty. The primary procedure codes that were included in this 
study have previously been described207.  
5.2.3 Outcomes 
The primary outcome of interest was all cause mortality measured at six months after 
admission, obtained from the administrative data component, which include 
mortality data over the period between completion of the baseline and follow-up 
questionnaire obtained through the Office of National Statistics (ONS). 
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5.2.4 Construction of Self-reported Comorbidity Adjusted Risk (SCAR) 
index 
Descriptive statistics were used to assess baseline demographics in this study 
population. To develop a Self-reported Comorbidity Adjusted Risk (SCAR) index, 
based on all twelve PROMs comorbidities, the entire cohort of patients was 
randomly divided into two equal groups; a development and validation group. The 
development group was used to test the association between PROMs comorbidities 
and assigned a ‘weighting’. Single variables were tested in univariate analysis in 
both groups. To assess the independent association between individual comorbidities 
and death at 6-month, multiple logistic regression models were constructed with 
death as the dependent variable and all 12 PROMs comorbidities as candidate 
independent variables. Stepwise backward selection was used to select only 
comorbidities with a p-value <0.10 to remain in the model. Using methodology 
originally described by Sullivan et al, the significant estimates from the model were 
then converted into an overall index by assigning a ‘weighting’ to each comorbidity. 
The number equalled its regression coefficient divided by the coefficient with the 
smallest absolute value, rounding this number to nearest integer number. Each 
comorbidity was then compared to the weakest significant variable comorbidity, 
which was assigned a value of 1, and therefore a ‘weight’ of 2 indicated double the 
log odds of mortality, and half as ‘strong’ as a value of 4. The individual scores 
could then be enumerated to a single index, where a higher number conveys higher 
risk. The components and their consequent weighting are shown in Table 5.1. The 
maximum score a patient could achieve was 15.  
5.2.5 Adjusting Charlson’s comorbidity index for the sample population 
The administrative data component (HES) allowed for extraction of Charlson’s 
comorbidities using Quan’s ICD-10 coding algorithm208, to calculate a CCI for each 
individual patient. The use of CCI in the target population has previously been 
validated21. Using the same method as described in the previous section, each 
individual Charlson comorbidity was assigned a new ‘weighting’ and comparison 
between original weightings are shown in table 5.2.  
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5.2.6 Model validation 
To test for face validity, the ability of the SCAR index to discriminate between a 
patient who died and one who did not, was tested in the validation group. This 
process was repeated for the old and new Charlson weighting, to allow for 
comparison of performance between the newly developed SCAR and an established 
method. The first set of logistic regression models produced c-statistics, a measure of 
discrimination, and the generalised Nagelkerke R-square that explains variance 
(goodness of fit). The c-statistic (above 0.7 for reasonable and above 0.8 as strong) 
corresponds to the area under the curve (ROC) and is a model of discrimination. A 
value above 0.7 indicates reasonable beyond chance, whilst above 0.8 suggest good 
discrimination. A second and third set of models, which were first adjusted for 
demographics (age and gender) followed by further inclusions of self-reported 
general health as covariates in order to improve discrimination. For this study, IBM 
SPSS version 21 was used to conduct all statistical analysis.  
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Assigned weighting per 
disease 
PROMs conditions 
0 Lung disease  
Kidney disease 
Problems due to stroke 
Depression  
Diabetes mellitus  
 Nervous system disease 
 Arthritis 
1 
2 
High blood pressure  
Leg pain due to poor 
circulation 
3 Heart disease 
 Cancer 
6 Liver disease 
  
Total equals the score, for example: heart disease (3) and 
liver disease (6) equals (9) 
 
Table 5-1: Weighted index of PROMs comorbidities 
 
 
Original Empirical 
 
Charlson Weights 
Charlson comorbidity Weights 
 Myocardial infarction 1 5 
Congestive heart failure 1 4 
Peripheral vascular disease 1 3 
Cerebrovascular disease 1 0 
Dementia 1 5 
Chronic Pulmonary disease 1 1 
Rheumatic disease 1 2 
Peptic ulcer disease 1 0 
Mild liver disease 1 0 
Diabetes without chronic 
complications 1 0 
Diabetes with chronic complications 2 0 
Hemiplegia or paraplegia 2 0 
Renal disease 2 4 
Any malignancy 2 4 
Moderate or severe liver disease 3 9 
Metastatic solid tumour 6 11 
Aids(*) 6 0 
Total 33 48 
Table 5-2: Empirically assigned Charlson comorbidities weightings 
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5.3 RESULTS 
 
76.557 patients, who underwent elective hip replacement and participated in the 
national PROMs programme, were included. The demographics characteristics of 
patients in the overall and development group were similar (Table 5.3). The patients 
had an average age of 68 years (SD +/- 11.1) and the majority of patients were white 
females. The prevalence of PROMs reported comorbidities ranged from 0.5% for 
liver disease to 70.7% for arthritis and 39.6% for high blood pressure. The most 
commonly coded Charlson comorbidity was chronic pulmonary disease with 11,5% 
and peptic ulcer disease, mild liver disease and hemiplegia were only present in 0.1% 
of the patients. AIDS was absent and therefore excluded from the CCI models. The 
all cause mortality rate at six months was 0.6% in the entire sample population. 
5.3.1 Validation of the SCAR index 
The results of the multiple logistic regression models with 6-month mortality as 
dependent variable revealed that heart disease, high blood pressure, leg pain due to 
poor circulation, diabetes, liver disease and cancer (within the last 5 years) were all 
significantly associated (P<0.05) with mortality. The stepwise selection process 
further excluded diabetes due to its low coefficient and large standard error. The 
remaining comorbidities were assigned a ‘weight’ and were included in the index. 
The other seven PROMs comorbidities were all not significant and therefore 
assigned a weight of 0 (Table 5.1). The maximum achievable score was 15. 
 
5.3.2 Adjusting Charlson’s comorbidities index 
Of the Charlson components, the most commonly recorded was Chronic pulmonary 
disease (11.5%) in the logistic regression model; it was the ‘weakest’ predictor 
acting as the smallest absolute value to assign weights to other significant candidate 
predictors. The variable, Metastatic solid tumour, was most predictive of 6-month 
mortality, and was assigned a value of 11. The sample weights for the CCI were very 
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different to the original weights used by Charlson. For example, Dementia and 
Myocardial infarction were originally assigned a value of 1, and in this sample a 
value of 5. In general, the level of the individual weights were greater in the event 
they were assigned a weighting compared to the original Charlson. Seven of 
Charlson’s comorbidities were not predictive and therefore assigned a value of 0. 
The maximum achievable score for the original score was 33, based on the empirical 
evidence from the hip replacement patient population was 48.  
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All Development sample 
Number (N) 76557 38273 
Age (mean / SD) 68.12 (11.12) 68.2 (11.1) 
Gender  
  Male 40 39.9 
Female 60 60.1 
Baseline general health (%) 
  Excellent 3470 (4.5) 1774 (4.6) 
Very good 19977 (26.1) 9898 (25.9) 
Good 31967 (41.8) 15946 (41.7) 
Fair 14627 (19.1) 7342 (19.2) 
Poor 3220 (4.2) 1615 (4.2) 
missing 3296 (4.3) 1698 (4.4) 
Self-reported comorbidity (%) 
  Heart disease 7730 (10.1) 3858 (10.1) 
High blood pressure 30302 (39.6) 15083 (39.4) 
Problems caused by stroke 1201 (1.6) 586 (1.5) 
Leg pain due to poor circulation 5615 (7.3) 2815 (7.4) 
Lung disease 4970 (6.5) 2480 (6.5) 
Diabetes 6764 (8.8) 3454 (9) 
Kidney disease 1296 (1.7) 663 (1.7) 
Disease of nervous system 626 (.8) 298 (.8) 
Liver disease 406 (.5) 192 (.5) 
Cancer (within last 5 years) 3483 (4.5) 1772 (4.6) 
Depression 5780 (7.5) 2870 (7.5) 
Arthritis 54146 (70.7) 27101 (70.8) 
Charlson Comorbidities (%) 
  Myocardial infarction  672 (0.9) 317 (.8) 
Congestive heart failure 699 (0.9) 370 (1) 
Peripheral vascular disease 714 (0.9) 331 (.9) 
Cerebrovascular disease 173 (0.2) 78 (.2) 
Dementia 184 (0.2) 102 (.3) 
Chronic pulmonary disease 8804 (11.5) 4412 (11.5) 
Rheumatic disease 2586 (3.4) 1295 (3.4) 
Peptic ulcer disease 114 (0.1) 42 (.1) 
Mild liver disease 202 (0.3) 112 (.3) 
Diabetes without chronic complications 6405 (8.4) 3243 (8.5) 
Diabetes with chronic complications 164 (0.2) 82 (.2) 
Hemiplegia or paraplegia 115 (0.2) 51 (.1) 
Renal disease 1679 (2.2) 827 (2.2) 
Any malignancy, including leukaemia 750 (1) 374 (1) 
Moderate or severe liver disease 20 (0) 13 (0) 
Metastatic solid tumour 28 (0.0) 15 (0) 
AIDS (*) n/a n/a 
6 month mortality 487 (0.6) 228 (.6) 
* Excluded due to absence in sample. 
   
Table 5-3: Demographics of patients undergoing hip replacement in the national 
PROMs programme between 2009-2011 
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PROM
s Comorbidity 
 
 
 
 
 
Coefficient 
S.E. 
C.I. 
P-value 
H
eart disease 
0.76 
0.17 
(1.54/2.96) 
<0.01 
H
igh blood pressure 
0.24 
0.08 
(0.96/1.45) 
0.06 
Problem
s due to stroke 
0.3 
0.15 
(0.62/2.94) 
0.45 
Leg pain due to poor circulation 
0.53 
0.19 
(1.16/2.50) 
<0.01 
Lung disease 
0.19 
0.24 
(0.76/1.92) 
0.37 
D
iabetes m
ellitus (*) 
0.18 
0.2 
(0.80/1.79) 
<0.01 
K
idney disease 
0.45 
0.35 
(0/78/3.12) 
0.04 
N
ervous system
 disease 
-0.41 
0.7 
(0.17/2.60) 
0.36 
Liver disease 
1.41 
0.43 
(1.78/9.78) 
<0.01 
C
ancer (w
ithin last 5 years) 
0.83 
0.22 
(1.51/3.52) 
<0.01 
D
epression 
-0.16 
0.25 
(0.87/1.81) 
0.8 
A
rthritis 
-0.18 
0.15 
(0.63/1.11) 
0.22 
S.E = standard error 
 
 
 
 
C
.I.= C
onfidence Interval 
* Excluded from
 the final m
odel 
 
 
 
 
 Table 5-4: Logistic regression analysis of PROM
s comorbidities predicting 6-month mortality for patient undergoing hip replacement
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 Charlson comorbidity 
 
 
 
 
 
Coefficient 
S.E 
95%
 C.I. 
p-value 
M
yocardial infarction 
1.65 
0.29 
1.78-9.79 
<0.01 
C
ongestive heart failure 
1.62 
0.32 
1.86-8.92 
<0.01 
Peripheral vascular disease 
1.08 
0.39 
1.35-6.35 
<0.01 
C
erebrovascular disease 
-15.67 
4201 
0 
0.99 
D
em
entia 
1.53 
0.6 
1.43-15.07 
0.01 
C
hronic Pulm
onary disease 
0.32 
0.18 
0.96-1.98 
0.08 
R
heum
atic disease 
0.59 
0.28 
1.04-3.14 
0.03 
Peptic ulcer disease 
1.43 
1.02 
0.56-30.70 
0.16 
M
ild liver disease 
1.15 
0.64 
0.90-11.02 
0.07 
D
iabetes w
ithout chronic com
plications 
0.95 
0.75 
0.59-11.20 
0.21 
D
iabetes w
ith chronic com
plications 
0.07 
0.022 
0.70-1.65 
0.73 
H
em
iplegia or paraplegia 
-15.02 
5045 
0 
0.99 
R
enal disease 
1.27 
0.24 
2.23-5.68 
<0.01 
A
ny m
alignancy 
1.41 
0.33 
2.18-7.84 
<0.01 
M
oderate or severe liver disease 
2.81 
0.88 
2.95-92.62 
<0.01 
M
etastatic solid tum
our 
3.52 
0.65 
9.42-120.25 
<0.01 
A
ids(*) 
n/a 
n/a 
n/a 
  
(*) Excluded (not in sam
ple) 
 
 
 
 
 Table 5-5: Logistic regression analysis of Charlson' comorbidities predicting 6-month mortality for patients undergoing hip replacement
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5.3.3 Model performance 
Using the weights derived from the model developed in the development group, a 
SCAR score was generated for each patient in the validation set. The mean score was 
approx. 1.01 (SD 1.49) and the distribution of scores are displayed in Figure 5.1 and 
showed a non-normal distribution. In contrast, the majority of patients scored 0 
points using the newly assigned empirical weights in the CCI (Figure 5.2). Table 5.6 
shows the performance of the models for all three indices. The C statistics for models 
without additional predictors, showed similar performance of discrimination, 
although the model fit of the SCAR index was (0.08) lower than the empirical CCI. 
The ROC-curve of both the extended SCAR index and the modified CCI is displayed 
in Figure 5.3 & 5.4. In all of the models, the predictive accuracy increased upon 
adjustment with age, gender and general health in term of discrimination and 
proportionally to each other. However, both the original and empirical CCI had 
better model fit compared to the SCAR index.  
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Figure 5-1: Distribution of SCAR index in validation set 
 
 
Figure 5-2: Distribution of empirically assigned CCI 
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 M
odel and measure(s) 
SCAR 
index 
  
Original 
Charlson 
  
Empirically 
adjusted 
 
 
 
W
eights 
 
Charlson 
Index 
  
  
  
  
  
C
-statistics 
0.64 
 
0.65 
 
0.63 
95%
 C
.I. 
0.60-0.68 
 
0.61-0.68 
 
0.59-0.67 
R
-square 
0.043 
 
0.048 
 
0.051 
 
 
 
 
 
 
Index +demographics 
 
 
 
 
 
C
-statistics 
0.74 
 
0.76 
 
0.76 
95%
 C
.I. 
0.71-0.77 
 
0.73-0.79 
 
0.73-0.79 
R
-square 
0.063 
 
0.085 
 
0.086 
 
 
 
 
 
 
Index +demographics/general health 
 
 
 
 
 
C
-statistics 
0.76 
 
0.78 
 
0.78 
95%
 C
.I. 
0.73-0.79 
 
0.75-0.81 
 
0.75-0.81 
R
-square 
0.077 
  
0.101 
  
0.102 
A
bbreviations: SC
A
R
: Self-reported C
om
orbidity R
isk index; dem
ographics (A
ge&
G
ender) 
 Table 5-6: Summary of model performance for the 3 individual scores for elective hip replacement patients 
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Figure 5-3: ROC curve for 6-month mortality models of empirical 
CCI with inclusion of demographics and general health 
 
Figure 5-4: ROC curve for 6-month mortality models of SCAR index with 
inclusion of demographics and general health 
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5.4 DISCUSSION 
5.4.1 Principal findings 
Prediction of mortality following hip replacement surgery using a single index 
(SCAR) generated from twelve PROMs comorbidities did not preform better 
compared to an established method frequently used of risk adjustment where 
mortality is the outcome of interest. This was predominately caused by an inferior 
performance in the ability to explain variance. However, the discrimination of all 
models, including the SCAR index, were acceptable and comparable to previous 
studies209-211. The addition of age and gender, available from both the PROMs 
questionnaire and HES data component, offered better fitting models, in particular 
for the original and modified Charlson. Further improvements were achieved by 
addition of “fair” and “poor” self-rated general health, however, there were no 
additional differences between the patient-reported and administrative generated 
indices observed. 
Between both indices, several comorbidities (heart disease, liver disease, cancer and 
peripheral vascular disease) were consistently associated with mortality and therefore 
included in each of the models. As was highlighted in the pervious chapter, there 
were discrepancies between both data sources except for heart disease. The 
implication of this might be that there is potential for both data sources to 
complement each other and thereby improve their ability to predict mortality based 
on comorbidities. Identification of patients with comorbidities with low prevalence 
but high prediction capability, such as liver disease, is required to adequately adjust 
the data for clinical outcomes, where the focus is on smaller groups and/or 
individuals. In particular, in patient-centered care models, where better-informed 
patients will demand more personalised information. The method described in this 
study can easily be replicated in the event of adjustment of PROMs comorbidities to 
provide a better fit with a target population or with the outcome of interest. 
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5.4.2 Strengths and weaknesses of the study 
The introduction and previous studies have highlighted that the meaningfulness of 
the PROMs data is determined by the generalisability of the sample analysed. With 
an overall response rates of around 80% and of those a substantial proportion 
completing the follow-up questionnaire, the PROMs data in terms of hip replacement 
can be assumed to provide an accurate representation of the entire patient population 
in England and Wales. Furthermore, the accuracy of the data is strengthened by the 
consistency of the administrative data reported mortality rate with previous 
studies212-214. However, most of these studies reported on 90-day mortality and the 
follow-up period of 6-months in the PROMs programme was chosen in light of the 
impact of surgery on functional outcomes when the patients’ current health status has 
improved much beyond their preoperative pain and dysfunction level. Furthermore, 
the availability of administrative collected mortality, without data on timing of death 
and the inability to ascertain the cause of death, has influenced this study design. The 
risk of mortality associated with comorbidity is frequently measured by cox 
proportional regression models that aim to establish the potential ‘hazard’ that they 
pose within a certain follow-up period and allow for assignment of individual 
weightings20,209,210,215,216. The applicability is, however, dependent on the timing of 
death and the HES dataset only contained single time-point mortality. Therefore, the 
use of Sullivan’s methodology was considered appropriate by virtue of previous 
published studies applying this method similarly in their attempt to assign weights to 
independent predictors of mortality211,217. 
Both methods benefit from their ability to create a single index available for 
stratification of patients. For most clinical studies, it is usually not possible to 
analyse patients with particular outcomes in more than two groups at a time. An 
accumulated score with higher risk with increasing number can be adjusted to suit 
the likelihood of the outcome of interest20. For example, when the largest proportion 
of patients are free from comorbidity, comparison between patients with any score 
can be attempted, however, when most patients report at least one comorbidity then 
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comparison between that group and patients with higher index score can be 
undertaken.  
The advantage of a PROMs comorbidity accumulated score over scores that rely on 
administrative data relates to its timing. Having a simple score available at the time 
of the decision to operate can improve the informed consent process for both patients 
and surgeons. As previously mentioned, adjustment of the PROMs comorbidities to 
suit the target population is therefore required. The current comorbidities included in 
the questionnaire were not selected based on their relevancy to explain variation in 
hip replacement but due to the patients’ ability to report them accurately90. It is 
important to bear in mind that the sample used by Bayliss et al. had high incidence of 
comorbidities and focussed predominately on HRQoL outcomes. However, as the 
findings of study 2 suggested, only three PROMs collected comorbidities were 
predictive of HRQoL outcomes and therefore if others are considered non-relevant, 
further investigation into comorbidities that are most predictive of the outcomes of 
interest may be required. 
 
5.4.3 Comparison with other studies 
For patients undergoing elective hip replacement, comorbidity is a significant 
predictor of serious complications218,219, (long-term) mortality220,221 and increased 
length of stay222. The most frequently reported comorbidities are Cardiovascular 
disease, Renal disease and Dementia221,223. Bozic et al. analysed 40,000 patients and 
reported a large number of comorbidities that were associated with mortality at 90 
days and proposed the use of this information in counselling and risk adjustment 
following surgery224. Similarly, Jamsen et al. concluded that patients, with a 
diagnosis of ‘Dementia’, required more careful consideration before proceeding to 
surgery. Although, the HES component allowed for extraction the ICD-10-CM code 
‘Dementia’, and in this study it was also a significant predictor of mortality, it 
formed no part of the examples in the PROMs comorbidity (neurological disease) 
that seemed most fitting. Instead, it includes Multiple Sclerosis (MS) as example, 
which has not shown to be of influence on morbidity and mortality following 
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surgery225. The relevance of other comorbidities, such as diabetes, which is not 
considered to be associated with worsening clinical or HRQoL outcomes226, is 
however associated with increased incidence of wound infections.  
Self-reported general health has been an important predictor of poor HRQoL and 
mortality227, even in models adjusted for important covariate such as age and 
comorbidity. In our models, the ability to explain variance improved upon addition 
of “fair” and “poor” self-reported health, and this promotes the use in risk assessment 
model using PROMs linked to HES data. With the absence of functional status, 
which is a strong independent predictor of mortality228, as a variable in 
administrative data, self-reported general health will remain an important potential 
predictor in traditional and HRQoL outcomes research.    
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5.5 CONCLUSIONS 
 
Risk adjustment of mortality data using comorbidity information directly obtained 
from the patient is possible, however, traditional strategies that were specifically 
developed for this purpose performed better. There is a need for modification of the 
comorbidities chosen in the national PROMs programme to suit the specific patient 
population by inclusion of more relevant ones.  The opportunity for routine 
collection of this information lies in their ability to allow for segmentation of patients 
prior to surgery leading to improved and more standardised decision-making. For 
ageing populations living longer and with more comorbidities, the benefit of 
outcome data that are relevant to the individual will potentially allow for better 
patients’ choice and lead to less variation which coincides with the aims of the 
national PROMs programme as described in the introduction. Going forward, a 
future tool based on best available evidence that is easy to collect and provides 
relevant information can improve the informed consent process without the need for 
clinician’s subjective interpretation. 
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5.6 KEY POINTS ARISING FROM STUDY FOUR 
 
x Using a statistically reliable methodology to generate an accumulated index 
score predicting mortality based on patient-reported comorbidities is feasible, 
although, while it did provide similar statistical discrimination, the variance 
was less compared to an established risk index (Charlson’s). 
x The majority of patient-reported and administrative recorded (Charlson’s) 
comorbidities were not predictive of mortality and were therefore assigned a 
zero value. Substituting them for more relevant comorbidities could further 
improve the predictability of the models. 
x The inclusion of self-reported general health as independent predictor of 
mortality improved the modelling and can therefore provide an alternative to 
functional status in research lacking information on this. 
x The value of standardised PROMs questionnaires is in the fact that it can 
assist in segmentation of patients into groups before surgery, potentially 
allowing for a better informed consent process.  
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Chapter 6  
 
EXPLORING PATIENTS’ 
ACCEPTANCE ON ELECTRONIC 
ALTERNATIVE IN ROUTINELY 
COLLECTED PROMS IN 
VARICOSE VEINS PATIENTS: A 
MIXED METHOD STUDY 
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6.1 INTRODUCTION 
 
In order for PROMs to be meaningful, high response rates and fully completed 
questionnaires (unit response) are crucial to avoid response bias 83,229. Although, the 
response rates in joint replacement surgery in the national PROMs programme were 
satisfactory, the response rates in day-case procedures and in particular those for 
patients undergoing varicose veins surgery were poor as was highlighted in the 
introduction (Table 1.4). It is generally accepted that poor response rates are 
associated with young age83, social deprivation and poor subjective health94, and this 
was also recognised in the demographics of non-responding varicose veins patients 
in the national PROMs programme. Further potential explanations for low response 
rates can include the method of data collection, i.e. traditional paper-based versus 
technology. The PROMs programme was designed around pencil-and-paper 
methodology followed by a postal survey, however, this is thought to be resource 
intensive as a number of stakeholders are involved before data can be transformed 
into information. Therefore, introducing technology to aid data collection has the 
potential to improve response rates, data analyses and dissemination of findings. 
Previous studies have shown promising results in using a technological 
alternative230,231, however, these studies were specifically designed for research 
purposes and this can lead to bias. A further added benefit of using technology to 
capture PROMs data is that it is the preferred environment in terms of sensitive 
information232,233. Paper questionnaires can be lost at any point in time containing 
important personal information.  
The analysis of the PROMs data have primarily focussed on quantitative elements 
such as patient-related factors, i.e demographics, and there has been a lack of 
evidence in terms of qualitative factors such as the patient’s understanding and views 
of the national PROMs programme. Patients themselves can provide a novel view in 
order to further evidence factors explaining non-response in routinely collected 
PROMs.  
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This study had three aims: firstly to test the feasibility of using a user-friendly 
software platform that allows technology assisted collection of PROMs, second to, 
compare completion rates of an electronic alternative to the traditional paper-based 
questionnaire in a randomised setting in varicose veins patients. And thirdly, to 
explore patient-related factors in relation to their personal view on the questionnaire 
and overall PROMs programme as a potential explanation for unit non-response.  
 
6.2 MATERIALS AND METHODS 
6.2.1 Study population 
All patients referred for minimally invasive treatment for varicose veins at two 
hospital sites within one Hospital Trust in England were eligible to participate in this 
study. There were two main study arms, firstly the randomised trial, which aimed to 
investigate the feasibility of using novel technology platform (web app) as an 
alternative to traditional paper-and-pencil questionnaires and secondly the qualitative 
arm consisting of a qualitative survey generated from a series of semi-structured 
interviews. For both arms, patients were approached, at two teaching hospital part of 
the same hospital trust, before undergoing outpatient treatment by a trained 
researcher. During data collection, both hospitals were required to submit their 
PROMs data for all patients undergoing treatment; special approval had therefore be 
granted by the Department of Health. Ethical approval for this study was obtained 
from the NRES Committee North West-Preston (ref 12/NW/0371). 
 
6.2.2 Development of electronic version of PROMs questionnaire 
Through an iterative user-centred design process, an electronic version of the 
national PROMs programme Varicose Veins Questionnaire was developed 
(Appendix Y). This version was made available as a ‘web application’ on all existing 
novel technology platforms and interacted with regular finger touch, as on mobile 
devices, but was also usable on Personal Computers (PCs). The main aim was to 
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have a near identical design of the questionnaire with the same questions and colour 
scheme. The final questionnaire differed from the original paper-based EQ-5D form 
in terms of the EQ-VAS score, which for the study was designed as a thermometer 
and patients had to start from score 50. Furthermore, the web application 
development process was restricted in terms of the ability to reproduce the exact 
picture of legs included in the Aberdeen Varicose Veins Score and it was therefore 
decided to separate both legs into eight segments (front and back; left and right and 
upper and lower). The electronic version was tested on a small sample of patients 
using a 9.7-inch tablet device and the design was adjusted accordingly.  
 
6.2.3 Recruitment and follow-up 
Recruitment commenced in March 2013 and lasted until March 2014. A total of 128 
patients were eligible, of which 15 were excluded because they declined to 
participate, had no access to any novel technology platform or had limited 
understanding of the English language. After inclusion to the study, a further 17 
patients (15%) were excluded because of cancellation of the procedure whilst they 
were in the treatment room. Treatment was discontinued due to venous spasm, 
making catherisation impossible or there was presence of competent veins requiring 
no treatment.  After consent to the study, patients were randomised using “blocked 
randomisation” principle. The block was the day of data collection and patients were 
assigned to one of the groups alternating after each assignment. Leading to 48 
patients being randomised in the traditional paper-based (Group A) and 48 patients 
were assigned the electronic version (Group B) (Figure 6.1). 
Each individual patient was assigned a study number to allow for tracking in the 
groups and linkage to their follow-up questionnaire. The follow-up questionnaire 
was posted (Group A) or text messaged/emailed (Group B) three months after 
intervention. If they failed to respond, they were sent one additional reminder and 
this was in accordance with national PROMs programme methodology. Patients in 
Group B were not required to login to complete the questionnaire, the hyperlink that 
was incorporated in the email brought them directly to question 1 of their individual 
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questionnaire. The data was held anonymously on a remote server, which also 
allowed patients to revisit the questionnaire if they had failed to complete it the first 
time round. Although data security was discussed with the participants, none 
expressed any concerns.  Primary outcome was response rates to the follow-up 
questionnaire, secondary outcomes were improvement in Health-related Quality of 
Life (HRQoL), measured by the Aberdeen Varicose Veins Score (AVVQ) and 
EuroQol’s EQ-5D.  
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Figure 6-1: Flowcharts recruitment into randomised trial evaluating an electronic 
alternative to traditional paper-based PROMs questionnaire 
 
128 patients undergoing 
minimally invasive varicose 
veins surgery 
Excluded  (n= 32) 
i   Declined (n= 10) 
i   Had no access to technology (n= 5) 
i   Venous spams, procedure cancelled 
(n=17) 
Analysed  (n=30) 
Allocated to technology group 
(n= 48) 
i Received allocated 
intervention (n= 48) 
 
Analysed  (n=23) 
 
 
ALLOCATION 
       ANALYSIS 
FOLLOW-UP 
Randomised (n=96) 
ENROLLMENT 
Allocated to paper-based group 
(n= 48) 
i Received allocated 
intervention (n= 48) 
 
Lost to follow-up (failed to 
respond) (n= 18) 
 
Lost to follow-up (failed to 
respond) (n= 25) 
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6.2.4 Patient pilot interview 
 
To assess patients’ attitude towards the national PROMs programme and use of 
questionnaires to collect the data, four patients were invited to participate in face-to-
face semi-structured interviews held at an acceptable place to the participant and 
were digitally recorded for subsequent verbatim transcription. After having obtained 
informed consent, patients were asked open-ended questions to investigate their 
attitude towards surgery in general and the use of PROMs to evaluate quality of care 
and their views on the paper-based and electronic format of the questionnaire. 
During the interviews patients were giving time to elaborate on items they found 
important about health questionnaires. To further guide interviews, ‘prompts’ were 
given if patients did not cover certain topics as set out in interview schedule (Figure 
6.2).  
For example, most patients did not fully understand the purpose of the national 
PROMs programme and in particular the implication of their answers on service 
provision for future patients. In addition, they were told that the response rates in the 
varicose veins patients across England were poor and the study sought to improve 
them by exploring the feasibility of electronic means to capture data. Consequently, 
patients were shown the electronic version of the PROMs questionnaire on a tablet 
computer for comparison.  
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6.2.5 Development of patient survey 
Following the pilot interviews, 5 statements were generated in each theme that 
represented the items covered in the interviews in order to form a short survey that 
could be administered to a larger group of patients undergoing varicose veins surgery. 
The survey aimed to obtain a deeper understanding of the methodological issues 
affecting completion rates of the national PROMs programme. Each item was 
phrased as a statement e.g. ‘It is clear to me why I need to complete the PROMs 
questionnaire, ‘I am not aware that I will have to complete a follow-up questionnaire 
at three months’, ‘If available, I would prefer filling this in electronically’ and 
respondents rated the degree to which they agree with each statement on a likert 
scale (1=strongly disagree, 7=strongly agree). Patient characteristics and ownership 
of technology platforms were collected. The survey instrument was pilot tested for 
1. General attitude towards NHS & Surgery 
a. Necessity of intervention 
b. ‘Value for money’ concept 
c. Informed consent process 
2. Principles of PROMs 
a. Introduction to programme 
b. Better choice 
c. Current problems (low response 
rates) 
3. PROMs questionnaire specific 
a. Form 
b. Mode of data collection 
4. Electronic data capture 
a. Value 
Figure 6-2: General themes and their subsequent 
prompts used during semi-structured interviews 
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face validity among a sample of ten patients. Based on the feedback, minor changes 
were made to the wording of the items. Four statements were identified, which were 
consequently re-phrased to improve comprehension as per pilot study.  
 
 
6.2.6 Statistical analysis 
Data were analysed using IBM SPSS version 19 software. Simple descriptive 
statistics were used to report on primary outcomes in Stage 1 study. Independent t-
test was used to report on statistical difference between the groups.  
The interview transcripts were analysed using a thematic approach using NVivo 
software to organise the data. Four potential themes were identified from the 
interviews that were concurrent with the predetermined interview schedule. A second 
reviewer (SM) analysed the 2 of the 4 interviews to account for inter-rater reliability 
and control for bias.  
For the patient survey, responses to each of the items on the questionnaire were 
grouped into the following categories: disagree (scores of 1-2), neither agree nor 
disagree (scores of 3-5) and agree (scores of 6-7). The percentage (%) of patients 
falling into these three categories were computed separately for each item and 
tabulated.  
 
6.3 RESULTS 
6.3.1 Randomised trial 
There were no significant difference between the paper-based and electronic group in 
terms of age, gender, having had previous treatment and symptom period (Table 6.1).  
Although, the baseline condition specific (AVVQ) scores were comparable, there 
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was a significant difference in baseline EQ-5D index score (0.61 in Group A and 
0.76 in Group B).  
There was an obvious difference in response rates between both groups, 63% of 
patients in the paper-based group responded compared with only 48% in the 
electronic group, however, this difference was not statically significant (p=0.15) due 
to the relative small sample size. Non-responders seemed to be of younger age in the 
paper-based group (59 vs. 52.8), but this was also not significant (p=0.12). There 
was no difference between responders and non-responders in terms of presentation of 
different levels of symptoms (i.e chronic ulcer, eczema, pain and itchiness) caused 
by their varicose veins.  
In both groups there was statistically significant improvement in the mean 
postoperative EQ-5D index score. There was significantly greater improvement in 
AVVQ score in Group B compared to Group A (26,1 to 15,5 vs. 27,5 to 23,4 resp.) 
after treatment (p<0.04).  
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Table 6-1: Demographics and follow-up rate of patients in paper-based and electronic 
group undergoing minimally invasive varicose veins surgery 
 
6.3.2 Qualitative assessment of patients’ views  
6.3.2.1 Demographics 
There were 75 participants in the survey study and of those 57% were female and 
most were of white ethnicity. A wide age range was represented in the sample 
(mean= 54,6, range 26-91). Most participants (72%) had access to a Personal 
Computer (PC), and 22.7% of the total also had access to all novel technology 
platforms, i.e. PC/tablet and smartphone. To note, only 9.3% of this sample had no 
access to any form of platform and their average age was 70 years old. A third of 
patients were considered to have had an employment history that is associated with a 
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higher risk of developing varicose veins, such as hairdresser, bartender and teacher. 
To note, 28% of all participants were retired individuals.  
 
6.3.2.2 General Attitude towards surgery and national PROMs programme 
The majority of patients (97%) thought it was important to ask patients about their 
experiences following surgery and generally thought more patient involvement was 
needed in the NHS (76%). There was no consensus regarding the number of 
questionnaires being used in NHS, 40% didn’t think there were too many, whilst 
36% thought there were too many questionnaires.  
Quote M54: “There are not enough questionnaires in the NHS, this is how the NHS 
will know better how patients feel and can improve” 
Quote F45:  “I have filled in three questionnaire already today, they looked alike” 
 
The majority of patients (68%) found the aims of the national programme unclear, 
and 51% wanted to know the output of the programme before coming to the hospital 
if this was available. However, no one communicated that they had accessed the 
national website, nor was any information researched prior to surgery. 
Although, they were divided in terms of knowing the performance of the hospital 
against the national average in this particular treatment, the majority (83%) would 
consider travelling elsewhere if the quality of care was significantly better. A few 
patients emphasised that their own experiences with the hospital were more 
important compared to what would be available online: 
Quotes: F60 “My own experiences with this hospital are more important than data 
results” 
The majority of patients (71%) were not asked specifically by their treating surgeon 
to complete the PROMs questionnaire, and were also not aware that they were going 
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to be sent a follow-up questionnaire (92%). But in general, they did not mind filling 
in a follow-up questionnaire, or be reminded multiple times if they failed to complete 
it the first time. They did, however, understand that completing the questionnaire 
was voluntary (83%), as this was well identified from information displayed on the 
coversheet of the questionnaire. Patients mostly agreed (77%) to complete the 
questionnaire even though the data would be mainly used by the DoH. 
 
6.3.2.3 Principles of PROMs 
The majority of patients felt that the PROMs Varicose Veins questionnaire was easy 
to read (96%).  They agreed mostly that the questionnaire itself wasn’t too long 
(59%) and that it shouldn’t be shorter if that would affect the content and therefore 
the quality of the data (60%). 
Interestingly, a small majority of patients (43%) actually preferred completing the 
questionnaire on paper over an electronic alternative, with only 24% preferring 
electronic to paper. However, younger patients (<41) were significantly more likely 
to prefer electronic data capture. In addition, they were more likely to agree that 
electronic data capture would be quicker (78% vs. 48% in over 60s). 
Quote: F40: “Using a paper and pen is so much easier, you’ll focus more as you 
think it is more important” 
Quote M23: “A few clicks and you are done, it is better for environment as well.” 
Similarly, younger patients (<41) were more likely to agree with sharing their health 
data online than older individuals.  
As part of the AVVQ score, patients were required to draw their own varicose veins 
onto a predetermined picture of their own legs as it is weighted into the overall score. 
However, the majority of patients found it generally difficult to complete, although, 
they understood what was being asked (59% vs. 28%).  
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Quote M65: “I have been told I have Varicose Veins, but I do not know where they 
are” 
Quote M32: “It is difficult to draw my varicose veins on the back of my legs as I 
can’t see them myself” 
 
6.4 DISCUSSION 
6.4.1 Principle findings 
This chapter has demonstrated that patients were more likely to respond to a paper-
based questionnaire compared to an electronic equivalent. In both groups, older 
patients were more likely to respond to the follow-up questionnaire. Qualitative 
assessment of patients’ attitude towards the national PROMs programme and 
specifically the mode and content of the questionnaire used, revealed that patients 
preferred completing the questionnaire using paper-pencil method and thought the 
questionnaire itself was acceptable. Although, the response rates in the study were 
better than in the national programme, they remained suboptimal, possibly due to 
lack of understanding of the aims and questionnaire fatigue.  
 
6.4.2 Strengths and weaknesses of the study 
By adhering to the exact methodology of the national programme, the principal 
findings may be extrapolated to the wider varicose veins population. By separating 
this study into a quantitative and qualitative arm, the same patient population was 
sampled but consenting the same patient twice was avoided to reduce the possibility 
of increased anxiety in the patients. Collecting data on the day of treatment greatly 
benefited the ability to follow patients in the treatment process after completion of 
the questionnaire. Participation in the study was considered to be of minimal impact 
to the patients as they had already been asked to complete the PROMs questionnaire 
by clinical nursing staffing.  
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The intuitive approach chosen for development of the electronic version improved 
the patients’ acceptability and by making the electronic version available on all 
technology platforms discrimination was averted. At follow-up, patients in the 
electronic group were not required to login into the system, avoiding the scenario 
that patients were unable complete the questionnaire. In addition, verification of the 
email address took place to avoid ‘bounce’ rates. For follow-up questionnaires sent 
by post, a designated routine was set up using appropriate mail stamps ensuring 
delivery. Unfortunately, there was no possibility to gather information on acceptance 
of delivery. Furthermore, involvement of the responsible officers at the DoH 
provided an alternate view on the project to test face validity.  
The pilot nature and the small number of participants limited this study, in particular 
the randomised trial investigating the feasibility of an electronic alternative. During 
the study period, as part of the on-going programme, both centres remained 
mandated to upload their PROMs data, which coincided with this study. Although 
local ethical approval was granted, a delay of six months occurred which further 
impacted on the ability to collect data.   
 
6.4.3 Comparison with other studies 
Drummond et al. reported excellent acceptability of an electronic alternative to 
paper-and-pencil with almost perfect response rates as early as the mid nineties234.  
The administration of electronic questionnaires in preoperative clinics has been 
acceptable235-237 and nearly all research comparing electronic versus paper-based 
questionnaires have reported equal or improved response rates in the electronic 
group.  However, these studies have been specifically designed to test feasibility in a 
research setting and may not be an accurate representation of ‘real-life’. Only a 
single study done by Rolfson et al. reported similar findings of decreased response 
rates for the electronic version in hip replacement patients in a national PROMs 
programme238. The benefits of administrating electronic PROMs, such as economical 
considerations, data accessibility, improved data quality are all important items to 
consider for researchers, however, there are challenges that are mainly around 
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resistance of the research community in the design and integration phase of studies239. 
Overall, patients have responded positively to the introduction of electronic 
platforms in the collection of health surveys232,240.  
Patients undergoing joint replacement are more likely to respond in the national 
PROMs programme, benefiting from a relatively older age and a scheduled follow-
up. However, this follow-up appointment is scheduled between 6 and 8 weeks post 
surgery, and the PROMs questionnaire is collected after 6 months. This implies that 
these patients voluntarily responded to the follow-up questionnaire. A more plausible 
explanation for non-response is the lack of interest in returning the questionnaire, 
particularly in younger patients241. Participants’ lack of understanding of the trial, 
which is known to be inversely associated with their likelihood to respond could 
subsequently lead to further non-response242. In addition, explanation to patients of 
the need to complete the questionnaire, irrespectively of the clinical outcome, could 
motivate them and avoid alienation.  This may be particularly important in day-case 
procedures, as patients will have less contact time with their clinician and there is 
usually no routine follow-up scheduled.  
In surgical procedures with immediate effect, such as joint replacements, the use of 
PROMs to measure treatment impact has been more successful121, however, for 
treatments with predominately a preventive strategy, such as varicose veins, 
measuring quality through PROMs is more challenging. Routinely, patients will have 
had several interventions scheduled to treat one leg or have both legs treated with an 
interval. In this sample size, some questionnaires were completed and subsequent 
treatment was cancelled, leading to direct non-response if clinical teams did not bear 
this in mind. Completion rates are currently audited by hospital management in terms 
of quantity and do not distinguish if a patient actually underwent treatment. 
Identifying these patients early in the process can partially explain inadequate 
response rates.  
A key area that traditionally does not play an important role, after implementation of 
a quality improvement strategy, are the patients themselves. Although, they are 
important stakeholders in the development of questionnaires, their views on overall 
service evaluations are usually not routinely available. However, information on 
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patients’ views can influence and improve healthcare delivery243 or can endorse 
quality improvement initiatives244. As applied to the national PROMs programme, 
increasing patients understanding of the programme has the potential to improve 
response rates and this is particularly important in conditions treated predominately 
as a day-case.  
  
6.5 CONCLUSIONS  
 
The use of PROMs data to accurately assess and compare performance between 
different providers is influenced by their response rates. Identifying factors that 
determine patients’ non-response is an important step towards further adoption of 
PROMs data. The potential of the data by linkage to meaningful clinical data has 
helped in assisting service provision and longitudinal studies245.   
Although, technological advances will continue to replace traditional methods of 
data collection, patients themselves require further persuasion about its merits. 
Increasing the use of a patient-centred approach, championed by members of the 
responsible clinical team, should identify different types of patients and their 
(un)willingness to participate in their care and to provide feedback. Patients 
themselves and technology will have to act as partners to provide vital information to 
the system. For publically funded health system, the continuous search to contain 
costs will mean that varicose veins will remain an area of interest. In particular for 
patients referred with symptoms affecting daily life and who don’t have a clear 
indication for treatment (venous ulcer / bleeding varicosity / recurrent superficial 
thrombophlebitis or other skin problems). For these patients, the threshold for 
treatment should be dependant on strict referral criteria to avoid abuse in the system. 
Only here will routinely collected PROMs provide added benefit to test decision-
making. Patients who want treatment based on psychological symptoms alone will 
have their HRQoL impacted but in that case it is important to investigate the 
individual items that construct the score. Clinicians play a vital role in ensuring only 
those that are eligible will receive treatment for only those that benefit most from it.  
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6.6 KEY POINTS ARISING FROM STUDY FIVE 
 
x Patients were more likely to respond and preferred using traditional paper-
based questionnaire compared to an electronic alternative. 
x There were few issues with the content and design of the PROMs 
questionnaire providing no explanation to clarify low response rates in 
varicose veins patients. 
x A small proportion of patients (13%) completed their preoperative 
questionnaire, although, their procedure was subsequently cancelled, 
exclusion of these patients in the overall statistics can improve unit response 
rates.  
x Most patients were not asked to complete nor explained the need of 
completing the PROMs questionnaire, providing plausible explanation for 
unit non-response, particularly for the follow-up questionnaire. 
x Patients were overall positive about the presence of questionnaires in the 
NHS as a means to improve quality of care and were open to consider 
information on quality based on PROMs data in their decision of where to 
receive treatment. 
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Chapter 7  
 
CONCLUSIONS AND FUTURE 
WORK 
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7.1 CONCLUSIONS 
 
This thesis has investigated the appropriateness of evaluating quality of care using 
routinely collected PROMs on a national setting and provided evidence that the data 
generated by the national programme has potential to enhance readily available 
administrative data, however, the current programme setup in terms of data analysis, 
collection and feedback requires further adjustments to improve meaningfulness for 
patients and clinicians alike.  
The need for measuring quality from the patients’ perspective to facilitate the 
transformation from a physician-led towards a patient-driven health service has been 
extensively highlighted by publications ranging from Michael Porter to 
Governmental reports6,32. Particularly, in surgery where there is generally a clear 
start and end-point and most treatments have the potential to improve symptoms that 
affect HRQoL, the preferred approach is by applying validated health surveys, i.e 
PROMs. There is value in collecting this on a national scale where it, in theory, can 
inform policymakers on the effectiveness of different treatments for the same 
conditions; allow for provider comparison; track performance over time and compare 
treatment for different conditions246. However, implementation of the national 
PROMs programme has produced limited evidence on individual or system level 
change that has led to improvements in quality of care. The findings of study 1 
highlighted the difficulties in analysing PROMs data in the context of inguinal hernia 
surgery, as limited response rates did not allow for provider comparison and the 
usability of a generic HRQoL measure (EQ-5D) to establish clinical need was 
restricted due to a large proportion of patients reporting perfect health preoperatively. 
It was, however, feasible to compare different treatments on a aggregate level for the 
same condition and this was dependent on appropriate case-mix adjustment relying 
on the accuracy of clinical coding and the availability of patient-reported factors used 
for risk adjustment of the data.  
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Using these patient-reported factors for subsequent risk adjustment of HRQoL data 
for patients undergone inguinal hernia repair implied that similar patient-reported 
factors (comorbidities and general health) were associated with patient not reporting 
full/perfect health for each of the PROMs index procedures.  These factors were 
similar across both techniques, however, open technique produced additional factors 
that appeared to be influenced by the relatively larger sample size. In accordance 
with these findings, a reduction in HRQoL outcomes following treatment could be 
predicted with the same factors in both techniques. It could therefore be concluded 
that it was likely that differences in outcomes could be contributed in a greater extent 
to difference in surgical technique rather than to heterogeneity between the groups. 
The importance of this finding is in the fact that future changes in outcomes with a 
similar population mix, can be contributed to differences in process rather than 
patient characteristics. 
Besides the three PROMs comorbidities, Depression, Leg pain due to poor 
circulation and Arthritis, which were consistently predictive of HRQoL scores in 
inguinal hernia patients, other comorbidities were found to be predictive, however, 
there was no consistency between the groups for both preoperative and postoperative 
HRQoL. Although, research has shown that patients can reliably report on their own 
pre-existing conditions, the analysis of Chapter 4 on all four PROMs index 
procedure revealed that patients persistently overreported certain comorbidities 
compared to administrative data recorded. This was particularly evident in the day-
case procedures (inguinal hernia and varicose veins) and it is here that larger gaps 
exist and PROMs data enhances administrative data and could prove to be a more 
reliable source.  
The appraisal of PROMs data was further expended to assess the capability of 
patient-reported comorbidities to predict traditional outcomes. Although, mortality 
after elective hip replacement is a rare occurrence, it remains an important indicator, 
particularly in an increasingly ageing population. The ability of a patient generated 
comorbidity index (SCAR index) to predict mortality preformed slightly worse 
against an established method of risk adjustment using administrative data. 
Refinement of the comorbidities chosen to the individual procedure could lead to 
improved modelling, especially if further adjusted to an appropriate outcome of 
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interest. The value here would be to allow for preoperative risk stratification of 
patient groups and to provide more representative and patient centred information to 
the patient.  
However, it is important to bear in mind that factors, which can assist in explaining 
variation, could change over time requiring constant modification of the modelling 
for it to remain accurate. Yet, this feature will be pertinent in securing credibility of 
the PROMS data if provider comparisons will be successfully undertaken in this 
growing environment of (public) accountability. At present, the dissemination of 
PROMs data results is limited to overall group performance on indicator level 
providing no basis for quality assessment and improvement by individual providers. 
Qualitative assessment of patient’s views on the PROMs programme confirmed the 
lack of public awareness of the national PROMs programme. Although, the response 
rates in joint replacement surgery were adequate due to favourable demographics, 
response rates in day-case procedures are unsatisfactory, this can possibly be 
explained by a lack of understanding of the need for completing PROMs 
questionnaires. The patients’ willingness to participate at baseline was found to be 
acceptable, however, receiving a questionnaire after three months without a 
comprehendible explanation is a likely contributor of unit non-response to the 
follow-up questionnaire. In this group, introduction of an electronic alternative seems 
less feasible but could provide cost-savings and improve feedback to clinical teams.  
Collecting health information directly from the patient will remain important, as they 
are the ultimate end-user of care. Increasingly, public accountability will force health 
systems alike to invest in their ability to classify performance using validated quality 
metrics that are used for the purpose they were originally designed for. For routinely 
collected PROMs to be successful and meaningful, five steps are crucial: 
x Improve data analysis; for PROMs to be meaningful to both clinical teams 
and patients, appropriate case-mix and risk adjustment is of critical 
importance. This in turn will allow for comparisons between healthcare 
professionals or organisations and improve patient segmentation. (Bi)Annual 
risk adjustment can identify important trends to explain variation.  
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x Improve dissemination of programme findings, ensuring cooperation from 
clinician with the programme is vital to improve response rates and to allow 
for better usability of data. Rewarding good performance and engagement 
with national programme in annual appraisals or revalidation remains an 
important option to consider. 
 
x Increase awareness to patients directly by improvement of the 
communication by hospitals, i.e clinical teams and leaflets / poster, and 
indirectly through media and digital channels such as the NHS Choices 
website (http://www.nhs.uk) to improve patient participation; stressing the 
importance of participation in order to improve care for everyone.  
 
x Improvement of unit response rates could be achieved by adjusting the design 
and providing an electronic alternative, however, caution has to be taken into 
account and rigorous testing will be necessary before implementation. Further 
adjustment of the information contained in the questionnaire and assessment 
of reliability of patients reporting this, will help improve data quality. 
 
x Each individual step in the cycle has the potential to improve data quality and 
this enhances the credibility of data in order to improve engagement from 
both clinicians and patients.  
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Figure 7-1: Proposed PROMs feedback loop to improve relevance of national PROMs 
programme 
  
Data analysis (case-mix and risk adjustment)
Data dissemination
Physician engagementPatient participation
Improving unit response rates (changes to content /mode and design)
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7.2 UNANSWERED QUESTIONS AND FUTURE RESEARCH 
 
The role of PROMs data augmented by administrative data investigated in this thesis 
is part of a wider quality of care framework that aims to combine health information 
from different sources generated by healthcare providers and patient’s experiences in 
order to provide the foundations for improvements in the system. These 
improvements should be based around their relevance to patients and their ability to 
independently assess performance. 
In first instance, future research should be aimed at additional testing of the 
comparability of treatment options for the same condition in other index procedures 
included in the national PROMs programme using appropriate case-mix and risk 
adjustment strategies. Data analysis should focus on each of the explanatory factors, 
i.e. procedure codes, the organisation (Hospital Trusts) and its guidelines, and the 
individual surgeons that contribute to difference in outcomes and in doing so could 
enhance the credibility of the PROMs data. This could then lead to better 
segmentation of patient groups before surgery using data reports generated by 
nationally collected PROMs data, rather than using general statistics of mortality and 
morbidity that is currently used in the majority of informed consent process. PROMs 
data can inform the surgeon and the individual patient about; 
x The likelihood and possible margin of improvement of HRQoL outcomes 
x The individual risk of patient-reported adverse events 
x Average length of stay  
x To set baseline expectations 
Using a standardised approach for the decision-making process, assisted by both 
condition specific (where applicable) and generic HRQoL scores, could allow for 
improved capability to measure treatment indication in order to explain variation 
between clinicians and/or providers. For example, for inguinal hernia patients, the 
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exact symptoms or reason why it affects their daily life could provide a better insight 
in the preoperative variation in patient presenting with symptoms. The Carolinas 
Comfort Scale (CCS), developed specifically for mesh inguinal hernia repair, is 
known to provide better assessment of QoL compared to SF-36, however, it only 
provides a single overall score by combining preoperative and postoperative data247. 
A condition specific inguinal hernia score that allows for comparison between before 
and after surgery should be developed to determine the viability of establishing a 
threshold supporting the decision-making process. Moreover, a condition-specific 
score is better at establishing clinical need and set baseline expectations. Patient 
groups with few or no symptoms are at risk of reporting a reduction in HRQoL in the 
event of postoperative complications and the use of generic HRQoL measure is 
therefore suboptimal. The use of a threshold in conjunction with information 
generated from the referral guideline could limit variation and further improve 
comparability of PROMs data.  
For clinicians, further efforts should be directed to increase their understanding of 
the importance of PROMs in outcomes assessment. In the absence of clinical 
registries that are externally audited, such as the ACS’s NSQIP programme as 
described in the introduction (Section 1.1.3) that does add burden to hospitals both 
financially and on clinical teams, the NHS in England and Wales will remain reliant 
on data from administrative and patient in origin. Understanding the limitations and 
strengths of each data source is vital in quality of care measurement. The accuracy of 
information on pre-existing conditions, i.e. comorbidities, relies on the quality of 
data contained in medical records (for clinical registry and administrative data) and 
PROMs questionnaires (Figure 7.2). This is also applicable to collecting outcomes, 
where inpatient complications are recorded in clinical notes or at follow-up 
appointments. Both patients and clinicians play a vital role in generating information 
and both should be targeting in order to increase data reliability. However, further 
validation of all of the described levels of data is possible by comparing it to 
observational data that is readily available from primary care providers. For research 
on patient in the NHS, the Clinical Practice Research Datalink (CPRD) data can 
provide information on health status as well as outcomes, i.e. surgical site infections, 
following elective surgery. The patient’s GP practice provides the central point of 
care from where a patients is referred into the system and it is here that PROMs data 
 166 
can assist in choosing which providers are most suitable. For example, one centre 
might have better outcomes treating patients above the age of 80 years based on 
outcomes. The introduction of freedom of provider choice in 2007 has not led to 
significant migration of patient groups for the reason that individual patients are not 
simple market-based consumers with an unified demeanour, but rather vary in terms 
of health literacy, mobility and their overall needs. They are currently mostly 
concerned about retaining the public and universal access aspect of the system and 
would trade that in for freedom of choice. However, in a system that is essentially 
free of barriers and patients are willing to consider going elsewhere provided the care 
at that location is better, they require better and more easily available information. 
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Figure 7-2: Three level data for outcome measurement within the surgical care pathway
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Finally, existing measures of overall health status, i.e generic HRQoL measure such 
as the EQ-5D, fail to appreciate the impact of disease on overall wellbeing. As 
generic HRQoL measures are dependable on age and pre-existing conditions, it only 
provides us with information about health and it’s influence on quality of life. 
Comparison of HRQoL outcomes using generic measures across different conditions 
is hampered by difficulties in equally estimation of counterfactual pathways, even 
amongst elective surgical procedure., For example, patients after hip replacement 
will likely return to full health appropriate for their age and comorbidity status and 
before symptoms caused by coxarthrosis impacted their HRQoL, however, treatment 
for varicose veins patients is less likely to lead such large difference following 
treatment. The continued use of patient-reported outcomes, in particular the 
quantification of health-related quality of life in surgery, will remain a priority for 
health systems to evaluate provider performance and identify variation. Although, 
the use of a generic HRQoL index (EQ-5D) can assist in stratification of patients, the 
existence of confounders, i.e. previous or on-going experience of other medical 
conditions, in a rapidly ageing society will make decisions about resource allocation 
difficult. Prioritisation of treatments on a system level could benefit from additional 
information, such a subjective wellbeing measures, which aim to objectify a patient’s 
life satisfaction based on emotional reactions and cognitive judgements. Having 
patients with poor life satisfaction undergo treatment that does not improve their 
quality of life seems wasteful and therefore comparison between a condition specific 
and generic HRQoL, and subjective wellbeing is warranted.  
  
 169 
Appendix T 
Baseline characteristics of patients reporting readmission Yes/No for both open and 
laparoscopic group in study period.  
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Appendix U 
D
istributions of patient reporting posteroperative adverse events overall and by length of stay. (difference is reported as unadjusted O
dds R
atios 
(O
R
) w
ith 95%
 C
.I and p-value) 
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Appendix V  
Individual PROMs comorbidities and their corresponding ICD-10-CM codes with 
description 
PROMs Comorbidity ICD-10-CM codes Description 
            Heart Disease I03-09 Chronic rheumatic heart disease   I10.0;I10.9 Hypertensive heart disease   I20 Angina Pectoris   I25 Chronic ischaemic heart disease   I31 Other diseases of pericardium   I34-36 Valve disorders   I42 Cardiomyopathy   I44-45 Conduction disorders   I48-49 Atrial fibrillation and flutter, other cardiac arrhythmias   I50 Heart failure   I51 Complications and ill-defined descriptions of heart disease   Q22-26 Congenital malformations of heart and valves       High blood pressure I10 Essential hypertension   I15 Secondary hypertension             Problems caused by stroke G81 Hemiparesis   G82 Para/tetraplegia   G83.0;G83.1;G83.2 Mono (di)plegia of limbs       Leg pain when walking M79.66 Leg pain, unspecified due to poor circulation           Lung disease J40 Bronchitis, not specified as acute or chronic   J41 Simple or mucopurluent chronic bronchitis   J42 Unspecified chronic bronchitis   J43-45 Emphysema, Chronic obstructive pulmonary disease (COPD), Asthma   J47 Bronchiectasis   J60 Coal worker pneumoconiosis   J61 Pneumoconiosis due to asbestos   J62-63 Pneumoconiosis due to dust / other inorganic dust 
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  J64 Unspecified pneumoconiosis   J65 Pneumoconiosis associated with tuberculosis   J66-70 Other airway disease    J82 Pulmonary eosinophilia, NOS   J84-86 Other interstitial pulmonary diseases   J98-99 Other respiratory disorders   D86.0 Sarcoidosis of lung   B66.4 Paragonimiasis of lung   A16 Tuberculosis of the lung       Diabetes E10 Insulin dependant diabetes mellitus (IDDM)   E11 Non insulin dependant diabetes mellitus (NIDDM)   E12 Malnutrition-related diabetes mellitus   E13 Other specified diabetes mellitus   E14 Unspecified diabetes mellitus       Kidney disease N03 Chronic nephritic syndrome   N04 Nephrotic syndrome   N05 Unspecified nephritic syndrome   N07 Hereditary nephropathy   N11 Chronic tubulo-interstitial nephritis   N13-15 Chronic and reflux uropathy / Tubolo-interstitial disease   N18 Chronic kidney failure   N19 Unspecified kidney failure   Q61 (Multiple) Renal cyst   C65 Malignancy of renal pelvis   D09.1 Carcinoma in-situ (CIS) of urinary organs   D30.0;D30.1 Benign neoplasm of urinary organs       Nervous system disease G10 Huntington disease   G11-13 Hereditary ataxia / Spinal muscular atrophy / System atrophies   G20 Parkinson disease   G21 Secondary parkinsonism   G22 Parkinsonism in diseases classified elsewhere 
  G23-25 Other degenerative diseases of basal ganglia / dystonia / other extrapyramidal   G30-32 Degenerative diseases of nervous system   G35 Multiple Sclerosis (MS)   G40 Epilepsy   G80 Cerebral palsy   G90.8;G90.9 Disorder of autonomic nervous system   G91 Hydrocephalus   G96.8;G96.9 Disorder of central nervous system   G98 Nervous system disorder not other specified       
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Liver disease K70 Alcohol fatty liver   K71 Toxic liver disease   K72.1;K72.9 Chronic hepatic failure   K73 Chronic hepatitis   K74 Fibrosis and cirrhosis of liver   K76 Other diseases of liver   Q44.6 Cystic disease of liver   D01.5 Carcinoma in-situ (CIS) of liver   D37.6 Neoplasm of uncertain or unknown behaviour of liver   B18-19 Chronic viral hepatitis / unspecified hepatitis   I82.0 Budd-chiari syndrome       Cancer C00-75 Malignant neoplasms   Z85 Personal history of malignant neoplasm   D37-48 Neoplasm of uncertain or unknown behaviour       Depression F32 Mild depressive episode   F32 Recurrent depressive episode       Arthritis M02 Reactive arthropathies   M03 Post-infective and reactive arthropathies   M05 Seropositive rheumatoid arthritis   M06 Other rheumatoid arthritis   M07 Psoriatic and enteropathic arthropathies   M08-9 Juvenile arthritis   M10-12 Other arthropathies (gout etc)   M13-14 Other arthritis   M15 Poly arthrosis   M16 Coxarthrosis   M17 Gonarthrosis   M18-19 Other arthrosis 
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APPENDIX Z
                       Version 1. 15.08.13 
  
 
Patient-reported Outcome Measures: Varicose Veins survey 
 
 
 
Please read each of the following statements carefully and select the answer for 
each statement that best reflects your own views about the PROMs. 
 
 
To what extent do you agree or disagree that…? 
Please tick one box only for each statement  
 
                           1 ------- 2 ------- 3 ------- 4 ------- 5 ------- 6 ------- 7 
                                                                                  Strongly                           Neither                            Strongly 
                                            disagree                           agree or                              agree  
General attitude towards NHS and Surgery                                                        disagree 
 
Q1 The symptoms I am experiencing warrant an 
operation on my varicose veins today 
 
1  2  3  4  5  6  7  
Q2 There are different treatment options 
available to treat varicose veins.  
I was asked about my choice of treatment  
       
Q3 I trust my surgeon to chose the right 
treatment for me         
Q4 I don’t want to participate too much in the 
decision-making process        
Q5 This is a simple procedure and I am not 
worried about undergoing it 
 
       
Q6 I have been given sufficient information and 
know what I can expect today 
 
       
Q7 It is important that this operation is free of 
charge 
 
       
Q8 If there is no improvement in symptoms in 
the majority of patients undergoing varicose 
veins surgery, funding by NHS should be cut. 
       
Q9 If there is no improvement in quality of life 
in the majority of patients, funding by NHS 
should be cut. 
       
Q10 My quality of life is affected by having 
varicose veins         
  
Patient reported outcomes in surgery        
Q11 I think it is important that patients are asked 
about their experience after surgery 
 
       
Q12 The information captured by the PROMs 
questionnaire is not routinely fedback to your 
surgeon and is only used by the Department 
of Health: I would still be happy to complete it 
 
       
Q13 More patient involvement is needed in the 
NHS        
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Q14 Currently there is no funding available in the 
NHS to routinely follow you up after your 
surgery; therefore it is acceptable that my GP 
does this. 
 
       
Q15 There are too many questionnaires in the 
NHS 
 
       
Q16 The data collected by the PROMs 
questionnaire can identify how this hospital 
compares to the national average, I want to 
know this before my operation 
       
Q17 It does not matter to me how this hospital 
preforms to the national average with 
regards to this operation 
       
Q18 If the quality of care in my local hospital is 
worse than a hospital further away, I would 
consider going there instead of my local 
hospital for my operation 
       
 
 
 
 
 
 
 
 
 
 
 
 
Section 2. PROMs questionnaire specific  
 
                           1 ------- 2 ------- 3 ------- 4 ------- 5 ------- 6 ------- 7 
                                                                                       Strongly                             Neither                          Strongly 
                                            disagree                            agree or                          agree 
                             disagree 
 
Q19 It is clear to me why I need to complete the 
questionnaire before my surgery 
 
       
Q20 I am not aware that I will have to complete a 
follow up questionnaire at 3 months  
 
       
Q21 I understand that my participation is voluntary 
        
Q22 The PROMs questionnaire is easy to read  
        
Q23 The PROMs questionnaire is too long 
        
Q24 The questionnaire should be shorter, even 
though that might decrease quality of the 
questionnaire 
 
       
Q25 If available, I would prefer filling this in 
electronically        
Please use this space to provide any other comments or suggestions. (e.g. regarding the PROMs 
questionnaire and patient involvement in the NHS)................... 
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Q26 Looking at question 7 on the blue PROMs 
questionnaire 
It is clear to me what I need to draw. 
       
Q27 Looking at question 25  
It is difficult to interpret what I need to do here        
 
 
 
 
 
 
 
 
 
 
 
 
                           1 ------- 2 ------- 3 ------- 4 ------- 5 ------- 6 ------- 7 
                                                                                       Strongly                             Neither                          Strongly 
                                            disagree                            agree or                          agree 
                             disagree 
Electronic data collection 
 
Q28 Using electronic means to capture data is 
quicker than using paper forms 
 
       
Q29 I prefer using mobile devices compared to 
Personal Computer (PC) to share health 
information 
 
       
Q30 My health information should be available 
on one system and be accessible to all 
doctors that treat me (GP&surgeon) 
 
       
Q31 I do not want to be reminded multiple 
times about my follow up questionnaire if I 
don’t return the first follow-up 
questionnaire 
       
 
 
 
Section 3. Personal Wellbeing & Health Policy 
 
                           1 ------- 2 ------- 3 ------- 4 ------- 5 ------- 6 ------- 7 
                                                                                       Strongly                             Neither                          Strongly 
                                            disagree                            agree or                          agree 
                             disagree 
 
Q32 I would be more satisfied with life and be 
happier if I did not have varicose veins        
Q33 Doctors should be more interested in my 
overall wellbeing as part of my care process        
Q34 Questionnaires such as PROMs are used by 
the government to decide if operations such 
as varicose vein surgery are good ‘value-for-
money’.  
I am aware that my answers to these 
questions can affect which operations the 
NHS will fund. 
       
Please use this space to provide any other comments or suggestions. (e.g. regarding the PROMs 
questionnaire and patient involvement in the NHS)................... 
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Q35 The surgeon that has scheduled the 
operation for me has asked me to complete 
the PROMs questionnaire 
       
Q36 Any operation that can improve patients’ 
wellbeing and quality of life is worth funding 
by the NHS. 
 
       
Q37 I would sacrifice my spare time to help 
improve the NHS by actively engage with 
patient support groups if my doctor would ask 
me 
       
Q38 My expectation of the NHS is influenced by 
the media coverage of the NHS        
Q38 Decisions about the NHS should be made by 
(If selected multiple; write number next to 
ticked box in order of importance) 
1- most etcetera 
  Healthcare professionals    … 
  Managers                            … 
  Policymakers                       … 
  Patients                               … 
 
           
Sex:  Male / Female           Age: ______       Occupation : _______________      Ethnicity: __________________                                     
 
I own a:  PC     Tablet       Smartphone ______________ 
 
 
      Thank you for your help! 
 
 
Please use this space to provide any other comments or suggestions. (e.g. regarding the PROMs 
questionnaire and patient involvement in the NHS)................... 
EQ-5D profile: 
 
AVVQ: 
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